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Abstract 
DNAJC3 is a novel member of the DNAJ family with two domains linked to co-chaperone 
functions, namely the tetratricopeptide repeat (TPR) and J domain. Out of the two domains, the 
TPR domains are the least characterized. Therefore, the aim of this study was to characterize and 
elucidate additional functions of DNAJC3 TPR domains through in silico, in vitro and ex vivo 
approaches. Through multiple sequence and structural alignment as well as electrostatic potential 
analysis, DNAJC3 TPR domain were found to be most similar to TPR-containing proteins with 
Hsp90 or Hsp70 independent functions. In vitro pull down assays illustrated that DNAJC3 TPR 
domains did not interact with either cytosolic Hsp90 and Hsp70 or Grp78 and Grp94 directly, 
however a potential indirect interaction with Grp94 and Hsp90 was observed in mammalian 
lysates, via pull down assays; suggesting the formation of a complex between the proteins 
mediated by a specific substrate. DNAJC3 TPR domains were found to bind indiscriminately to 
both native and heat denatured substrates in a dose dependent manner. DNAJC3 TPR domains 
bound to β-galactosidase with greater affinity than malate dehydrogenase (MDH), suggesting that 
DNAJC3 TPR domains might exhibit substrate specificity that has not been reported before. 
Preliminary ex vivo analysis of DNAJC3 in mammalian cells showed that induced stress conditions 
did not alter the cytosolic or endoplasmic reticulum (ER) localization, or levels of DNAJC3 
protein, suggesting that the protein is not stress inducible. However, protein levels of DNAJC3 
were dramatically reduced by Hsp90 inhibitor novobiocin at 500 µM. Transient knockdown 
DNAJC3 did not change the protein levels of either Grp78 or Grp94, but decreased the protein 
levels of Hsp70/Hsp90 organizing protein HOP. On the other hand, protein levels of DNAJC3 
were increased in HOP depleted cells. In conclusion, this study was the first to experimentally 
demonstrate that DNAJC3 TPR domains do not interact directly with Hsp90, Hsp70, Grp78 or 
Grp94, and therefore DNAJC3 is unlikely to participate in traditional co-chaperone interactions 
with those proteins via its TPR domain. However, the J domain is known to interact with Grp78. 
The discovery that DNAJC3 TPR domains resemble that of TPR-containing proteins with 
functions independent of Hsp90 or Hsp70 suggests that DNAJC3 might link the Hsp70/Grp78 
chaperone machinery to non co-chaperone related functions, which requires further analysis.  
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Chapter 1: Literature review 
 
1.1 The chaperoning function  
The folding and assembly of proteins into their functional form was thought to be a spontaneous 
process that required no assistance, a hypothesis heavily supported by Anfinsen’s observation of 
reversible denaturation and renaturation of ribonuclease in vitro (Anfinsen, 1973). It was not until 
the mid-1970s that the concept of the molecular chaperone was introduced by Fohlman et al 
(1976). They found that the active neurotoxic subunit of the Taipan snake venom proteins was 
surrounded by two other protein subunits that not only increased the toxin’s specificity, but also 
protected the neurotoxin subunit from degradation, acting almost as chaperones (Fohlman et al., 
1976). During the same period, Laskey and colleagues discovered the chaperoning activity of 
nucleoplasmin on histones, were it helped the histones assemble into functional nucleosomes 
(Laskey et al., 1978). This was the first time that the term “molecular chaperones” was used. 
Although both groups had illustrated the existence of chaperoning molecules, it was not until 30 
years ago that the concept of the chaperoning function was clarified. It was noted that the over 
expression of a special type of protein, heat shock protein 70 (Hsp70), was induced by heat shock 
and was able to disrupt complexes of unfolded protein that had formed due to the changes in the 
cellular environment caused by the heat (Pelham, 1984, Lewis and Pelham, 1984). Although 
Pelham conducted various experiments with the Hsp70 family (Munro and Pelham, 1986, Bienz 
and Pelham, 1986), the molecular chaperoning concept was made famous by John Ellis (Ellis, 
1987). This was based on his observations on the assembly of Rubisco assisted or chaperoned by 
a Rubisco binding protein (Ellis et al., 1987, Ellis and van der Vies, 1988). Nowadays, the term 
“molecular chaperones” is used to describe a group of structurally unrelated proteins that are able 
to help correctly fold or refold nascent proteins that are newly synthesised, misfolded, denatured 
or aggregated into their functional conformations (Ellis, 1987, Young et al., 2004), hence the 
chaperoning function and molecular chaperones are essential to maintaining cell homeostasis.  
1.2 Heat Shock Proteins (HSP) 
The detection of “puffs” on the chromosomes of heat shocked Drosophila chromosomes by 
Ferruccio Ritossa represented one of the greatest discoveries in the understanding of cellular 
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survival mechanisms and escalated the study of an important group of cellular genes (Ritossa, 
1962). The protein products of these genes were identified a few years later through the work of 
Alfred Tissières (Tissières et al., 1974). These proteins have been termed Heat Shock Proteins 
(Hsps) due to the fact that they were first observed to be induced after heat shock treatment of 
cells. However, the expression of Hsps can be induced by various stresses such as hypoxia, 
oxidative stress, free radical damage, UV damage, various mutation and even diseases. Since the 
expression of Hsps can be triggered by a variety of stress conditions, it has been suggested that 
these proteins be called “stress proteins” instead of heat shock proteins (Bagatell and Whitesell, 
2004).  
1.3 Heat shock proteins functioning as molecular chaperones 
Although Hsps are over expressed during stress conditions, they are also known to be 
constitutively expressed within the cells during homeostasis. The biological functions of Hsps are 
numerous and vary, from the modulation of folding, degradation and translocation of protein, to 
buffering of cell mutations and regulation of cell survival and apoptosis (Ellis, 1987; Feldman and 
Frydman, 2000; Frydman, 2001, Tutar and Tutar, 2010, Tkáčavá and Angelovičova, 2012). The 
ability of Hsps to perform such diverse functions within the cell by assisting the function of other 
proteins without becoming part of the final protein product, has resulted in some Hsps being 
grouped as molecular chaperones (Hartl, 1995, Rutherford, 2003 and Young et al., 2004). The 
protein folding process is the primary function of chaperones. Chaperones are able to distinguish 
between unfolded and native proteins based on segments of hydrophobic residues exposed by 
unfolded proteins (Fink, 1999, Yim et al., 2013). Hsps are a highly abundant and conserved group 
of proteins that is mainly classified based on their molecular sizes in kilodaltons (kDa). Currently, 
there are six Hsp families which are localized in various cell compartments and have varying 
functions (Table 1.1). These include the Hsp100, Hsp90, Hsp70, Hsp60, Hsp40 and small Hsps 
families. Although most Hsp chaperones are involved primarily in ensuring proper protein folding 
conformations, it has been noted that some proteins can only be chaperoned by a single class of 
Hsps, suggesting that there might be a process that directs specific substrates to specific Hsps for 
folding. In addition, molecular chaperone activity has been shown to require the cooperation of 
different classes of Hsps to fulfil their role (Fink, 1999, Deuerling and Bukau, 2004, Yim et al., 
2013).  
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Table 1.1: Sub-cellular localization and function of the six known Heat shock protein 
families 
Family Molecular 
weight 
(kDa) 
Example 
members 
Localization Function References 
Small 
Hsps/HSPB 
18–40 Hsp10, 
Hsp17, 
Hsp22-23, 
Hsp27-28 
Mitochondria, 
cytoplasm, 
perinuclear, 
nucleus   
ATP independent substrate 
aggregation suppression. 
Apoptosis inhibition. 
Protection of cells from 
heat and oxidative stress 
Van Montfer et al., 
2001, Haslbeck et 
al., 2005, Arrigo, 
2005 
Hsp40/DNAJ  DNAJA1, 
DNAJB4, 
DNAJC3, 
DNAJC7, 
DBAJC21 
Endoplasmic 
reticulum, 
nucleus, 
mitochondria, 
cytosol, 
ribosomes  
Stimulation of Hsp70 
ATPase activity, substrate 
binding, suppression of 
protein aggregation 
Tsai et al., 1996, 
Cheetham and 
Caplan, 1998, Qiu 
et al., 2006; Rosser 
and Cyr, 2007 
Hsp60/HSPD 58-65  Hsp58, 
Hsp60, 
Hsp65 
Mitochondria Protein folding and 
assembly of translocated 
proteins. Maintenance of 
mitochondrial functions and 
biogenesis 
Cheng et al., 1990, 
Bukau and 
Horwich, 1998, 
Shan et al., 2003 
Hsp70/HSPA 67-76 Hsp68, 
Hsc70, 
Hsp70, 
Hsp72-73, 
Hsp75, 
Grp78 
Cytoplasm, 
nucleus, 
mitochondria, 
endoplasmic 
reticulum, 
lysosomes 
ATP-dependent protein 
folding and degradation. 
Translocation of proteins 
across membranes 
Mayer and Bukau, 
1998; 2005; Fink, 
1999; Pratt and 
Toft, 2003 
Hsp90/HSPC 82-96 Hsp90α, 
Hsp90β, 
Grp94, 
TRAP1, 
Hsp90N 
Cytoplasm, 
nucleus, 
mitochondria, 
endoplasmic 
reticulum, 
plasma 
membrane 
ATP-dependent chaperone 
activity. Involved in protein 
folding, degradation, 
controlling cell 
proliferation, differentiation 
and apoptosis 
Sreedhar et al., 
2004, Sreedhar and 
Csermely, 2004, 
Chiosis et al., 2004 
Hsp110/HSPH 80-110 Hsp100, 
Hsp104 
Cytoplasm, 
nucleus, 
mitochondria, 
plasma 
membrane 
ATP-dependent protein 
renaturation or degradation, 
Reactivation of stress 
denatured proteins from 
aggregates  with Hsp70   
Sanchez and 
Lindquist, 1990, 
Kruger et al., 1994, 
Schirmer et al., 
1996, Lee et al., 
2004, Miot et al., 
2011 
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1.4 Heat shock protein 90 (Hsp90) 
Hsp90 (HSPC) is the most abundant molecular chaperone and soluble protein in eukaryotic cells, 
comprising about 1-2 % of total soluble protein under homeostatic conditions and these levels have 
been shown to increase up to 10-fold during stress conditions (Lai et al., 1984, Borkovish et al., 
1989, Buchner, 1999, Whitesell and Lindquist, 2005). Similar to other chaperones, Hsp90 is 
involved in the folding, transportation, maturation and degradation of proteins, however unlike 
other chaperones such as Hsp70 which bind to unfolded proteins; Hsp90 interacts with specialized 
client proteins such as kinases (Xu and Lindquist, 1993), steroid hormone receptors (Picard et al., 
1990) and transcription factors (Minet et al., 1999). At present over 300 client proteins whose 
maturation, folding and activity is depended on Hsp90 have been discovered (for a comprehensive 
list see http://www.picard.ch/downloads/Hsp90interactors.pdf). Hsp90 client proteins are involved 
in a range of biological roles within the cells such as controlling cell cycle progression, cell growth 
and cell death by influencing cellular signalling from kinases and steroid receptors (Picard et al., 
1990, Pratt and Toft, 2003, Picard, 2002, Jackson, 2013). Due to the specialized functions of Hsp90 
client proteins, Hsp90 has been associated with the regulation of several factors involved in 
buffering cell mutations (Rutherford and Lindquist, 1998, Sangster et al., 2008, Rohner et al., 
2013), cell survival promotion/ anti-apoptosis (Schulte et al., 1995, Sato et al., 2000, Fortugno et 
al., 2003 Zhao and Wang, 2004) and the preservation of the transformation state of several cell 
types (Chiosis et al., 2004). Additionally, Hsp90 has been shown to be essential for cell viability 
and survival, since inhibition of Hsp90 by various drugs lead to the degradation of client proteins 
via the ubiquitin proteasome system resulting in arrested cell growth (Schulte et al., 1998, Marcu 
et al., 2000a). 
Hsp90 structure and function 
Hsp90 has three conserved domains, an N-terminal ATP-binding domain, a C-terminal domain 
which is responsible for dimerization, and a middle domain that connects the N and C terminal 
domains (Figure 1.1) (Didenko et al., 2012, Jackson, 2013). Currently five isoforms of Hsp90 have 
been identified (Figure 1.1). These include two cytosolic isoforms, Hsp90α (HSPC2) and Hsp90β 
(HSPC3), which differ in their expression pattern within the cell. While the β form is constitutively 
expressed, the α form is inducible by stress conditions (Csermely et al., 1998). Hsp90β is an 
essential gene for development of the mouse, while the main phenotype in knockout mice for 
Hsp90α is a defect in spermatogenesis (Voss et al., 2000, Grad et al., 2010). The two isoforms 
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share a nucleotide identity of about 76 % (Moore et al., 1986, Csermely et al., 1998, Sreedhar et 
al., 2004a) and amino acid identity of 86 % and 93 % similarity (Chen et al., 2005). The third 
isoform of Hsp90, HSPC5, also known as TRAP1 (mitochondrial tumour necrosis factor receptor-
associated protein 1) or Hsp75 localizes to the mitochondrial matrix, where it is found in lower 
levels suggesting a specialized function in the cell (Song et al., 1995, Chen et al., 1996). TRAP1 
shares 35 % sequence identify to the cytosolic isoforms (Picard, 2002). The fourth isoform, Grp94 
(glucose-regulated protein with molecular mass of 94 kDa) or HSPC4, localizes and is retained in 
the ER lumen. Grp94 is the most abundant protein in the ER and shares 50 % identity with the 
cytosolic Hsp90 isoforms (Gupta, 1995). The last isoform of Hsp90, Hsp90N, was identified as 
being membrane associated (Grammatikakis et al., 2002). Hsp90N is roughly 70 kDa in size and 
shares high sequence similarity with Hsp90α although it has a shortened N-terminal domain which 
consists of only 30 amino acids. Functionally, Hsp90N has been shown to bind to the Ras protein 
with a higher affinity than other Hsp90 isoforms (Powers and Workman, 2006). This isoform is 
controversial in that some authors do not believe there is sufficient evidence to support the 
presence of Hsp90N as a separate gene (Zurawska et al., 2008).  
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Figure 1.1: Schematic diagram of the three highly conserved functional domains of Hsp90 
isoforms. (A) Hsp90 exists as a dimer within the cell. Located at the N-terminus domain is the ATP binding domain. 
A flexible linker region connects the N-terminus and Middle domain. The Middle domain is responsible for the 
binding of Hsp90 clients and certain co-chaperones. While the C-terminus binds TPR-containing co-chaperones and 
is also thought to have a client binding site. The N- terminus is also the binding site of Hsp90 inhibitors geldanamycin 
(GA), 17-AAG and radicicol, while the C- terminus is the binding site of novobiocin (NOVO) and cisplatin (B) The 
domain organisation of the five isoforms of Hsp90, highlighting the differences found between the proteins. Although 
all isoforms have the three domains indicated in A, the N-terminus is slightly varied, with Hsp90N missing the 
majority of this domain. TRAP1 is missing the linker charged region and both TRAP1 and Grp94 are missing the 
highly conserved MEEVD motif located at the end of the C-terminus. In Grp94, this motif is replaced by the ER 
retention KDEL motif. (Adapted from Buchner, 1999, Sreedhar et al., 2004a, Whitesell and Lindquist, 2005). 
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The N-terminal domain of Hsp90 is the most highly conserved and most intensively studied 
domain of the three Hsp90 domains. The domain is comprised of approximately 220 amino acids 
and has been shown to bind both ATP and ADP (Prodromou et al., 1997a, Grenert et al., 1997). 
Hsp90 is classified as a member of the GHLK ATPase family, along with bacterial DNA gyrase, 
the DNA repair protein MutL and several bacterial histidine kinases because of the structurally 
unique ATP binding site (Dutta and Inouye, 2000). Hsp90 chaperone activity is known to be ATP 
dependent and ATP hydrolysis causes a conformational change within the protein that allows it to 
bind and release client proteins (Figure 1.2) (Prodromou et al., 1997a; 1997b; 2000). The N-
terminal ATP-binding site is also the binding site of several Hsp90 inhibitors such as geldanamycin 
(GA) and its analogues 17-N-allylamino-17-demethoxygeldanamycin (17-AAG) and radicicol 
(Grenert et al., 1997; Stebbins et al., 1997; Roe et al., 1999), and is also involved in the binding 
of Hsp90 client proteins (Prodromou et al., 1997a). Connecting the N- terminus and Middle 
domain of Hsp90 is a flexible charged linker region that can vary in size and is only present in 
eukaryotic cells. This region is completely missing in mammalian TRAP1 (Figure 1.1) (Gupta, 
1995). The linker region has been show to participate in the interaction of Hsp90 with steroid 
receptors (Cadepond et al., 1993, Dittmar et al., 1997, Kosano et al., 1998) and kinases (Miyata 
and Yahara, 1995). However through mutational studies, it was found that the absence of the linker 
region did not affect the essential functions of Hsp90 (Louvion et al., 1996). The Middle domain, 
which is also similar to that of GHKL proteins (Meyer et al., 2003, 2004, Pearl and Prodromou, 
2006), is known as the binding site for most Hsp90 client proteins and some of the Hsp90 co-
chaperones (Ali et al., 2006). The last domain is the C-terminal domain which is responsible for 
the constitutive dimerization ability of Hsp90, which is essential for functionality (Minami et al., 
1994, Nemoto et al., 1995, Meng et al., 1996, Chadli et al., 2000). Also located at the C-terminus 
is another less characterized ATP-binding site. It is believed that this site opens up when the N-
terminal ATP-binding site is occupied and has also been shown to have weak but detectable 
binding affinity for both ADP and GTP (Sӧti et al., 2002). Hsp90 inhibitors novobiocin (NOVO), 
cisplatin and taxol are known to bind the C-terminal ATP-binding site (Marcu et al., 2000a, 2000b, 
Donnelly and Blagg, 2008). The highly conserved MEEVD motif is located at the extreme end of 
the C-terminus in the cytosolic isoforms (Figure 1.1). This motif has been shown to be vital for 
the interaction of Hsp90 with a specialized group of co-chaperones that contain a tetratricopeptide 
repeat (TPR) motif, which will be discussed in depth in section 1.4.1 below. 
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The mitochondria and ER isoforms of Hsp90, TRAP1 and Grp94 both lack the MEEVD motif 
(Figure 1.1) that is required for the interaction with TPR-containing co-chaperones. For Grp94, 
the MEEVD motif is replaced by a KDEL motif, an ER retention signal, resulting in Grp94 being 
predominately an ER lumen residential protein (Munro and Pelham, 1987, Argon and Simen, 1999, 
Marzec et al., 2012). However, Grp94 has shown to be secreted by pancreatic acinar cells (Bruneau 
et al., 1998) and a subpopulation has been found on the cell surface (Altmeyer et al., 1996, Frasson 
et al., 2009, Koo and Apte, 2010). Secreted and cell surface Grp94 has been shown to lack the N-
terminal ER targeting signal peptide and C-terminal retention motif (Eletto et al., 2010, Marzec et 
al., 2012). Similar to cytosolic Hsp90, Grp94 has three domains, an N-terminal domain linked to 
the Middle domain by a charged linker region and a C-terminal domain (Figure 1.1). The N-
terminal domain is the site of ATP binding, together with the charged linker region as well as a 
number of residues from the Middle domain which make up the catalytic loop are required to assist 
in ATP hydrolysis (Dollins et al., 2007, Frey et al., 2007). The N-terminal domain is also the 
binding site of client proteins such as dendritic cell receptors (Biswas et al., 2002, Berwin et al., 
2003) and inhibitors such as GA, radicicol or their derivatives (Chavany et al., 1996, Schulte et 
al., 1998, 1999). In vitro competitive binding assays and co-crystallization studies illustrated that 
ATP/ADP and Grp94 inhibitors bind the same pocket located opposite the substrate binding site 
(Schulte et al., 1998, 1999, Soldano et al., 2003, Dollins et al., 2007). By binding to the nucleotide 
binding site, GA and radicicol are able to affect the ATP dependent activity of Grp94 towards 
substrates (Wearsch and Nicchitta, 1997, Vogen et al., 2002). Interestingly, a nucleotide analogue 
N-ethylcarboxamidoadenosine (NECA) has been shown to bind specifically to Grp94 due to the 
unique nature of the entry site to the nucleotide binding site, suggesting that Grp94 specific 
compounds can be designed or discovered and used in Grp94 specific inhibition (Rosser and 
Nicchitta, 2000). Besides assisting the hydrolysis of ATP through the catalytic loop, no additional 
functions have been linked to the Middle domain, which is known to bind substrates and co-
chaperones in cytosolic Hsp90 (Ali et al., 2006). Unlike in cytosolic Hsp90s, the charged linker 
region that connects the N-terminal and Middle domain is essential in Grp94, because it assists 
and mediates conformational changes required for ATP hydrolysis which affects the binding 
between Grp94 and its substrates (Hainzl et al., 2009). Similar to other Hsp90s, the C-terminal 
domain is the domain responsible for constitutive homodimerization of Grp94, which is mediated 
by a stretch of 44 hydrophobic amino acids (Nemoto et al., 1996, Wearsch and Nicchitta, 1996). 
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In cytosolic Hsp90s, the C-terminal domain is the binding site of the inhibitor NOVO (Marcu et 
al., 2000a, 2000b). The binding site for NOVO centers around the K559KQEEKK564 sequence 
(Matts et al., 2011), however this site is not accessible while the protein is in the closed 
conformation, suggesting that binding to this site by various substrates is linked to the 
conformational equilibrium of the whole protein (Dollins et al., 2007). Interestingly, this site is 
not conserved in Grp94 proteins. On the other hand,  the SPC sequence adjacent to the NOVO 
binding site found in cytosolic Hsp90s, which is a part of the conformational control point affecting 
the dimerization of the protein (Ratzke et al., 2010), is conserved in the Grp94 protein (Dollins et 
al., 2007, Marzec et al., 2012). Overall, this observation suggests that NOVO might still be able 
to bind to the C-terminal domain of Grp94 as the binding of the inhibitor could be linked to the 
conformation state of the proteins as opposed to the sequence itself. At present the client binding 
site on Grp94 has yet to be identified or defined, however it is thought to be located along the 
Middle and C-terminal domain of the protein (Marzec et al., 2012).  
Similar to other Hsp90 proteins, the most important function of Grp94 is linked to its chaperoning 
activities, where it assists in folding, assembly or degradation of secreted and membrane proteins 
(Eletto et al., 2010, Marzec et al., 2012). However, unlike other ER chaperones such as Grp78 and 
refolding enzymes such as protein disulfide isomerase (PDI) and the calreticulins, Grp94 is highly 
selective of its client proteins. This is illustrated by its ability to chaperone specify members within 
a protein family while excluding others as well as by the many secretory and membrane proteins 
that do not require the chaperone for proper folding (Randow and Seed, 2001, Yang et al., 2007, 
Morales et al., 2009). However in special cases, entire protein families such as insulin-like growth 
factors (IGF)-I and -II require the chaperoning activity of Grp94 for maturation and in the absence 
of the Grp94, precursor IGF proteins accumulate in the ER and are targeted for ER mediated 
degradation (ERAD) (Ostrovsky et al., 2009, 2010). Like other ER protein folding components 
such as Grp78, Grp94 expression is upregulated in response to ER stress in an attempt to increase 
protein folding or degradation efficiency in order to restore ER homeostasis (Chang et al., 1989, 
Eletto et al., 2010, Marzec et al., 2012). A complex made up of various ER proteins including 
Grp78 and Grp94 was identified and proposed to permanently exist as stable multichaperone 
complex within the ER rather than being formed in response to the folding needs of specific client 
protein (Meunier et al., 2002). However this was later disproved based on the measurement of the 
mobility of tagged- Grp94 and Grp78 (Snapp et al., 2006). An alternative explanation to the 
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formation of the complex could be linked to the requirements of the type of client protein requiring 
folding or maturation assistance. Certain proteins require both Grp78 and Grp94 at the same time, 
while others require assistance from the two chaperones at different stages of their maturation or 
folding (Eletto et al., 2010). In other cases, certain proteins require Grp78 but not Grp94 activity 
and vice versa as seen in the case of IGF proteins, which associate with Grp94 and not Grp78, 
suggesting that Grp78 is not always required during the Grp94 cycle (Ostrovsky et al., 2009, 2010).  
1.4.1 Hsp90 co-chaperones 
Whereas client proteins are defined as proteins that require chaperones such as Hsp90 for 
maturation and activity, co-chaperones are described as non-client binding proteins that participate 
or facilitate the function of chaperones. Examples include proteins like p23 and the Hsp70/Hsp90 
organizing protein (HOP) (Caplan, 2003). Some co-chaperones may have chaperone activity 
themselves and can bind both the client and chaperone, while others are unable to bind clients and 
are mainly regulators of chaperone activity or function (Caplan, 2003). Hsp90 interacts with 
several co-chaperones which assist its chaperoning functions or cycle (Figure 1.2). The co-
chaperones form multichaperone complexes with Hsp90 and its substrates during the Hsp90 cycle. 
Hsp90 co-chaperones are diverse and it has been suggested that the type and combination of the 
co-chaperones within the complexes can determine the type of client protein with which Hsp90 
interacts. Hsp90 co-chaperones can be categorized into two groups, namely non-TPR-containing 
and TPR-containing co-chaperones (Caplan, 2003, summarized in Table 1.2). 
Non-TPR co-chaperones of Hsp90 include p23, cell division cycle 37 (Cdc37) and activator of the 
Hsp90 ATPase (Aha1). These three proteins are structurally diverse and have different functions 
within the Hsp90 cycle. The co-chaperone p23 is known to bind and stabilize Hsp90 in its closed 
conformation or ATP bound state by inhibiting its ATPase activity, prolonging the interaction of 
Hsp90 with client proteins. It has also been shown to be involved in stimulating the release of the 
client proteins when ATP is hydrolyzed (Young and Hartl, 2000, Sullivan et al., 2002, McLaughlin 
et al., 2006). Aha1 binds the Middle domain of Hsp90, activating ATP hydrolysis and this is 
thought to lead to the release of client protein (Mayer et al., 2002, Meyer et al., 2004, Retzalaff et 
al., 2010). Cdc37 is known to interact specifically with kinase client proteins, binding to the N-
terminal domain, where it competes for the ATP binding site, thus inhibiting ATPase activity 
(Grammatikakis et al., 1999, Matts and Caplan, 2007).  
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The majority of Hsp90 co-chaperones contain the TPR domain, which binds to the highly 
conserved MEEVD motif that is located at the C-terminal domain of Hsp90α and Hsp90β 
(Scheufler et al., 2000, Young et al., 2003). TPR-containing co-chaperones are structurally 
conserved but functionally diverse, binding and acting at different points in the Hsp90 cycle. The 
first TPR co-chaperone to have a role in the Hsp90 cycle is HOP which acts as an adaptor protein 
between Hsp90 and Hsp70, enabling the transfer of client proteins from Hsp70 to Hsp90. HOP is 
thought to stabilize the open conformation of Hsp90 (ADP bound state) and also inhibit ATP 
hydrolysis (Young et al., 2001, Schmid et al., 2012). Other TPR co-chaperones of Hsp90 include 
the protein phosphatase PP5, cyclophilin 40 (Cyp40), FK506-binding family of immunophilins 
(FKBP51/52) and the E3 ubiquitin ligase C-terminus Hsc70 interacting protein (CHIP), which 
have distinct functions during the cycle, from changing the phosphorylation state of Hsp90 and 
client proteins, transportation of Hsp90-client complexes or facilitating proteosome-targeted 
degradation (Cyr et al., 2002, Davies and Sanchez, 2005, Cox and Johnson, 2011, Mollapour and 
Neckers, 2012).  
At present no isoforms of the cytosolic Hsp90 co-chaperones, both non-TPR and TPR-containing, 
have been identified in the ER or the mitochondria (Caplan, 2003). Thus there are currently no 
known equivalent of Hsp90 co-chaperones for TRAP1 and Grp94. Both chaperones lack the 
EEVD motif that is essential for the interaction with TPR-containing co-chaperones. The 
possibility that ER/mitochondrial co-chaperones that perform similar functions to cytosolic co-
chaperones might exist is feasible, although they are yet to be discovered (Caplan, 2003). Another 
plausible scenario is that ER equivalents of cytosolic co-chaperones are structurally different and 
interact via novel mechanisms in the organelles. For example the ER resident protein cyclophilin 
B is an ER isoform that lacks the TPR domains contained in its cytosolic relative Cyp40. 
Cyclophilin B has been shown to interact with a multichaperone complex that also contained 
Grp94, although whether this interaction is direct or indirect is yet to be determined (Meunier et 
al., 2002). 
12 
 
  
 
Figure 1.2: Schematic diagram illustrating the Hsp90 pathway. The pathway begins with the binding of the unfolded client protein by Hsp70 and 
its co-chaperones Hsp40 and HOP (early complex). HOP acts as a linker protein between Hsp70 and Hsp90 by binding to the C-terminus of both chaperones using 
distinct TPR domains. Aha1, a co-factor of Hsp90 disassociates HOP/Hsp70/Hsp40 interaction to Hsp90 and promotes the conformational change of Hsp90. An 
ATPase dependent interaction occurs between Hsp90 and its co-factor, p23 (intermediate complex), displacing Aha1 and this interaction stabilizes the closed 
conformation of Hsp90. After the maturation of the client protein, ATP hydrolysis occurs, causing Hsp90 to undergo a conformational change back to an ADP 
bound state, followed by the dissociation of the late complex and the release of the client protein (adapted from Mahalingam et al., 2009, Li et al., 2013).. 
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1.5 Heat shock protein 70 (Hsp70) 
The Hsp70 (HSPA) family is the most studied and highly conserved class of molecular chaperones. 
Hsp70 proteins are often regarded as the housekeeping chaperones as they are a crucial component 
in the maintenance of cellular homeostasis. Hsp70 proteins are also known to be involved in 
various functions such as protein folding and degradation (Hartl and Hayer-Hartl, 2002), protein 
translocation (Ryan and Pfanner, 2001), complex assembly and disassembly (Chromy et al., 2003) 
and protein aggregation suppression (Mayer and Bukau, 1998, 2005, Fink, 1999; Pratt and Toft, 
2003). Currently there are thirteen known human isoforms of Hsp70 which are localized in various 
organelles (Kampinga and Craig, 2010). Heat-shock cognate 70 (Hsc70) or HSPA8 is the cytosolic 
constitutive form, while Hsp72 (HSPA1A) is stress inducible. During stress conditions, Hsp72 has 
greater affinity for unfolded proteins and is known to promote the refolding of aggregated proteins 
and targeting of irreversibly damaged proteins for degradation via the lysosomal or ubiquitination 
pathway (Mayer and Bukau, 1998, 2005, Agarraberes and Dice, 2001, Hӧhfeld et al., 2001, 
Callaham et al., 2002). Glucose-regulated protein with molecular mass of 78 kDa (Grp78), also 
known as binding immunoglobulin protein (BiP) or HSPA5, and mitochondrial Hsp70 (mtHsp70), 
are the ER and mitochondrial Hsp70 isoforms, respectively (Munro and Pelham, 1986, Ting and 
Lee, 1988, Domanico et al., 1993, Wadhwa et al., 2002). Hsp70 proteins have three conserved 
domains, namely an N-terminal ATPase domain, a substrate binding domain and a C-terminal lid, 
which has the GPTIEEVD motif at the extreme end of the domain (Figure 1.3) (Flaherty et al., 
1990; Zhu et al., 1996; Fink, 1999, Daugaard et al., 2007). 
 
 
 
Figure 1.3: Schematic representation of Hsp70 structural domains. An ATPase binding domain of 
about 44 kDa is located on the N-terminus of the protein and is the binding site of ATP and ADP. The substrate 
binding domain of about 15kDa is located in the middle of the protein and is the binding site of Hsp70 client 
proteins/substrates. The lid domain is located on the C-terminus of the protein and is the binding site of the majority 
of Hsp70 co-chaperones through interactions with the EEVD motif (adapted from Fan et al., 2003). 
 
14 
 
Hsp70 proteins are known to have ATP dependent activity with the ATPase domain on the N-
terminus as the site of ATP hydrolysis. This hydrolysis of ATP results in a conformational change 
which regulates the binding capabilities of the substrate binding domain. In the ATP bound form, 
Hsp70 has low affinity for substrate binding, while ATP hydrolysis to ADP stimulated by the 
Hsp70 co-chaperone, Hsp40/DNAJ, results in a conformational change which increases the 
binding affinity for substrates (Mayer and Bukau, 1998; 2005, Kampinga and Craig, 2010). The 
substrate binding domain of Hsp70 is highly conserved amongst the different isoforms, although 
subtle differences have been observed. The mechanism by which these differences infer isoform 
specific function is however unknown (Mayer and Bukau, 2005). Binding and releasing of 
substrates by the substrate domain is dependent on the ATP-ADP cycle (Mayer and Bukau, 2005). 
The GPTIEEVD motif (different from Hsp90 MEEVD motif) is located on the extreme end of the 
C-terminus of some Hsp70 isoforms and is responsible for the interaction of the chaperone with 
TPR-containing co-chaperones such as HOP (Scheufler et al., 2000; Odunuga et al., 2003).  
Grp78, the ER homologue of Hsp70 and mtHsp70, the mitochondria resident protein, are two of 
the Hsp70 isoforms that lack the EEVD motif essential for the interaction with TPR-containing 
co-chaperones. Grp78 resides in the lumen of the ER; secretion out of the ER is prevented by the 
presence of the KDEL ER retention motif at the C terminus of the protein (Munro and Pelham, 
1987, Takemoto et al., 1992, Zhang et al., 2010a). Grp78 is involved in protein translocation into 
the ER, protein folding, targeting of misfolded proteins for ER-associated degradation (ERAD) 
and sensing ER stress (Hendershot, 2004, Roller and Maddalo, 2013). As an ER stress sensor, 
Grp78 is able to regulate ER stress caused by the accumulation of unfolded proteins resulting in 
the unfolded protein response (UPR) (Lee, 2005). Grp78 regulates ER stress by activating various 
components of the UPR signalling pathway. In brief, upon ER stress, Grp78 releases three ER 
transmembrane signal transducers; PKR-like ER kinase (PERK), inositol-requiring enzyme 1 
(IRE1) and activating transcription factor 6 (ATF6) (Rutkowski and Kaufman, 2004). The release 
of PERK causes attenuation of protein synthesis through the phosphorylation of the eukaryotic 
translation initiation factor 2 α subunit (eIF2α), thereby halting protein synthesis and alleviating 
the protein load in the ER (Shi et al., 1998). The release of ATF6 and IRE1 results in the 
upregulation of ER proteins involved in protein folding and degradation such as chaperones 
(Grp78, Grp94), folding enzymes (PDI) and co-chaperones (DNAJ) (Ye et al., 2000, Yoshida et 
al., 2000, Calfon et al., 2002). To further relieve ER stress caused by the accumulation of unfolded 
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proteins, Grp78 works in conjunction with ER resident DNAJ co-chaperones to refold aggregated 
proteins or target misfolded proteins for degradation, until ER homeostasis is restored (Feldheim 
et al., 1992, Brightman et al., 1995, Shen et al., 2002, Hosoda et al., 2003, Shen and Hendershot, 
2005, Oyadomari et al., 2006, Rutkowski et al., 2007).   
1.5.1 Hsp70 co-chaperones 
Similar to Hsp90, Hsp70 has co-chaperones that facilitate its chaperoning function. Hsp70 
chaperones can also be divided into two groups, namely DNAJ and non-DNAJ co-chaperones. 
DNAJ proteins regulate the chaperone functions of Hsp70 by passing substrates to Hsp70 and 
controlling the ATPase cycle of the chaperone (Fan et al., 2003). The DNAJ proteins will be 
discussed in depth in the following section.  
The C-terminal domain of Hsp70, similar to Hsp90 also contains the conserved EEVD motif that 
allows TPR-containing co-chaperones to interact with that domain. HOP acts as an adaptor protein 
between Hsp70 and Hsp90, allowing the exchange of client proteins between the two chaperones 
(Chen et al., 1996). CHIP can negatively regulate the refolding activity of Hsp70 by affecting its 
ATPase activity, while at the same time assisting in chaperone mediated protein degradation 
(Connell et al., 2001). While co-chaperones like CHIP and HOP bind both Hsp70 and Hsp90, there 
are also Hsp70 specific non-DNAJ co-chaperones. Hsp70 interacting protein (HIP) stabilizes the 
ADP bound state of Hsp70, which in turn enhances its chaperoning activity (Hӧhfeld et al., 1995). 
Bcl-2-associated athanogene isoforms 1-5 (BAG1-5) are non-TPR nucleotide exchange factor co-
chaperones that negatively regulate Hsp70 chaperone function by causing the disassociation of 
ADP or competing with the co-chaperone HIP, therefore destabilizing the protein (Nollen et al., 
2001). BAG5 has also been shown to bind to CHIP, affecting its ability to target proteins for 
degradation (Kalia et al., 2011).  
It is interesting to note that some of the TPR co-chaperones such as HOP and CHIP act as co-
chaperones for both Hsp90 and Hsp70 (Table 1.2). HOP has three functional TPR domains; TPR-
1, TPR-2A and TPR-2B. TPR-1 is known to bind selectively to Hsp70, while TPR-2A selectively 
binds Hsp90 (Chen et al., 1996, Lässle et al., 1997, Southworth and Agard, 2011, Lee et al., 2012). 
In the case of CHIP, only one TPR domain is present and this domain can bind indiscriminately to 
both Hsp90 and Hsp70 (Smith, 2004). TPR domain specificity between Hsp90 and Hsp70 has been 
linked to unique amino acid residues upstream of the EEVD motif (Scheufler et al., 2000), and 
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mutation studies have shown that TPR-1 can be mutated to interact with Hsp90 and vice versa for 
TPR-2A (Odunuga et al., 2003).  
 
Table 1.2: Partial list of co-chaperones of Hsp90 and Hsp70  
Co-chaperone Binding 
partner 
Binding site TPR/ Non-
TPR 
Function Reference 
Aha1 Hsp90 Middle 
domain 
Non-TPR Effective stimulator of Hsp90; 
ATPase activity and triggers the 
release of client proteins from 
the Hsp90 complex 
Mayer et al., 2002 
BAG1-5 Hsp70 Middle 
domain 
Non-TPR Nucleotide exchange factor and 
modulator of Hsp70 activity 
Nollen et al., 2000, 
Mayer et al., 2005 
Cdc37 Hsp90 N-terminal Non-TPR Kinase binding co-chaperone; 
Slows down the ATPase cycle 
of Hsp90, extending the holding 
time of clients 
Mandal et al., 2007, 
Gary et al., 2008 
CHIP Hsp90/ 
Hsp70 
C-terminal of 
Hsp90 and 
Hsp70 
TPR Proteosome-targeted 
degradation facilitator; Inhibits 
Hsp70 protein refolding activity 
Ballinger et al., 
1999, Meacham et 
al., 2001 
Cyp40 Hsp90 C-terminal TPR Co-chaperone activity unknown Ratajczak et al., 
1996, Duina et al., 
1996, 1998, 
Carrello et al., 2004 
HIP Hsp70 N-terminal TPR Stabilizes Hsp70 in its ADP 
bound state 
Nollen et al., 2001, 
Li et al., 2013 
HOP Hsp90/ 
Hsp70 
C-terminal TPR Adaptor protein of Hsp90 and 
Hsp70; Mediates substrate 
transfer between Hsp70 and 
Hsp90 
Southworth and 
Agard, 2011, Lee et 
al., 2012 
Hsp40/DNAJ Hsp70 N-terminal Non-TPR* Targets unfolded proteins to 
Hsp70 and stimulates the 
ATPase activity of Hsp70. 
Tsai et al., 1996, 
Greene et al., 1998, 
Fan et al., 2003, 
Kampinga and 
Craig, 2010 
p23 Hsp90 N-terminal  Non-TPR Stabilizes the interaction of 
Hsp90 and client proteins in 
ATP bound state (closed 
conformation) by inhibiting the 
ATPase function of Hsp90 
Freeman et al., 
2000, McLaughlin 
et al., 2006 
PP5 Hsp90 C-terminal TPR Changes phosphorylation state 
of Hsp90, co-chaperones and 
client proteins 
Das et al., 1998, 
Vaughat et al., 2008 
* Exception is DNAJC7 and DNAJC3 which contain TPR domains 
 
1.6 Heat shock protein 40 (Hsp40) 
The most abundant and diverse group of molecular chaperones is the Hsp40 or DNAJ family 
members, defined by the presence of the canonical J domain (Cheetham and Caplan, 1998). 
Currently there are forty-nine known DNAJ members expressed in humans and localized in 
17 
 
various compartments such as the cytoplasm, nucleus, mitochondria and ER (Walsh et al., 2004, 
Qui et al., 2006). Homologues of DNAJ proteins have been identified in different organisms such 
as Saccharomyces cerevisiae and Escherichia coli (E. coli), where twenty-two and six members 
have been identified, respectively (Walsh et al., 2004). DNAJ proteins are divided into different 
types based on their structural domains (Figure 1.4). DNAJA (Type 1) which has four members of 
four domains, namely consists of a J domain, a glycine/ phenylalanine (Gly/Phe) rich domain, a 
cysteine (Cys) repeat region and a C-terminal domain. DNAJB (Type 2) which has thirteen 
members, lacks the Cys repeat region found in DNAJA proteins, but has the J domain, Gly/Phe 
rich domain. DNAJC (Type 3) is the largest DNAJ group with thirty-two members and only has 
the J domain conserved, and unlike DNAJA and DNAJB groups, this domain can be located at 
any position along the protein (Cheetham and Caplan, 1998, Vos et al., 2008, Kampinga and Craig, 
2010). DNAJC proteins are considered to have more specialized functions compared to DNAJA 
and DNAJB members, due to the presence of unique domains which are not normally linked to 
DNAJ functions (Sterrenberg et al., 2011). The existence of a fourth DNAJ group has been 
proposed (Botha et al., 2007). The so-called Type 4 DNAJ proteins have a compromised histidine, 
proline, and aspartic acid (HPD) motif, (Figure 1.4) (Botha et al., 2007). This motif is located 
within the J domain and is essential for stimulation of the ATPase DNAJ co-chaperoning activity 
towards Hsp70 proteins. The majority of proposed Type 4 DNAJ proteins are found in parasitic 
organisms such as Plasmodium falciparum (Botha et al., 2007). At present a putative Type 4 DNAJ 
protein, DNAJB13 has been identified in humans, mice and zebrafish and is thought to have J 
domain independent functions (Guan and Yuan, 2008, Yang et al., 2008). Interestingly, the 
coelacanth homologue has an intact HPD motif (Tastan Bishop et al., 2013).  
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Figure 1.4: Schematic diagram of the different families of DNAJ protein. Classification of DNAJ 
proteins is based on the presence of the different domains. The J domain is present in all DNAJ and is involved in 
facilitating the interaction between DNAJ and Hsp70. The Gly/Phe rich domain is found in DNAJA and DNAJB 
members and the zinc domain which consists of 4 CysXXCysXGlyXGly repeats, where X indicates any amino acid, 
is only present in DNAJA proteins. Type 4 is a newer group of DNAJ proteins with a corrupted HPD motif (adapted 
from Qiu et al., 2006; Botha et al., 2007, Rosser and Cyr, 2007). 
 
The signature domain of all DNAJ proteins is the J domain which is made up of approximately 70 
amino acids and is highly conserved across all organisms. Structurally, the J domain is made up 
of four alpha helices, with a loop region between helix II and III that contains the highly conserved 
and functionally important HPD motif (Cheetham and Caplan, 1998). DNAJ proteins are known 
to stimulate the ATPase activity of Hsp70 proteins through the J domain, and the HPD motif is 
essential for this interaction, as mutation studies targeted at the motif lead to the loss of ATPase 
stimulation of Hsp70 (Feldheim et al., 1992; Wall et al., 1994; Tsai and Douglas, 1996). The 
Gly/Phe domain found in DNAJA and DNAJB members is thought to also interact with Hsp70 
proteins and assists J domain interaction with the ATPase domain of Hsp70 by stabilizing the 
complex. Although the Gly/Phe domain assists in the stimulation of Hsp70 ATPase activity, the 
presence of the domain is not essential as the J domain has been shown to be able to interact and 
stimulate Hsp70 ATPase activity in the absence of this domain in numerous DNAJC members, 
(Wall et al., 1994), as well as isolated J domains from E. coli (Greene et al., 1998, Wittung-
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Stafshede et al., 2003, Horne et al., 2010). The zinc finger domain, also referred to as the Cys-
repeat region found only in DNAJA members, has a Cys rich region that has a 
CysXXCysXGlyXGly motif repeated four times where the X can represent any amino acid (Figure 
1.4). Proteins with similar repeats have been found to be involved in DNA binding (Song et al., 
1995). The Cys-rich domain is thought to be involved in the presentation of substrates to Hsp70, 
as well as the stabilization of Hsp70-substrate complexes (Szabo et al., 1994; Banecki et al., 1996). 
The C-terminal region of DNAJ protein remains largely uncharacterized, however in DNAJA and 
DNAJB members, this domain is thought to contain the substrate binding domain and is essential 
for their co-chaperoning function (Lu and Cyr, 1998a, 1998b, Sha et al., 2000). However, with 
DNAJC members, this domain usually contains varied domains that are not classically linked to 
DNAJ proteins, and the diversity of these domains is thought to be crucial for functionality and 
substrate specificity observed in various DNAJC members (Cheetham and Caplan, 1998, Fliss et 
al., 1999, Kampinga and Craig, 2010).  
The most recognised functions of DNAJ proteins is their ability to act as co-chaperones to Hsp70 
proteins, where they assist the protein during its chaperoning functions by recruiting Hsp70 
towards client proteins, presenting client substrates to Hsp70 and stimulating the ATPase activity 
required for Hsp70 ATP dependent chaperone functions (Liberek et al., 1991, Cheetham and 
Caplan, 1998, Qiu et al., 2006, Kampinga and Craig, 2010). Hsp70 chaperone activity is ATP 
dependent; the chaperone binding affinity for client substrates is regulated by the phosphorylation 
state of the nucleotide (Cheetham and Caplan, 1998, Qiu et al., 2006, Kampinga and Craig, 2010). 
Bound to ATP through the ATPase domain, Hsp70 has low binding affinity for client substrates. 
Interaction with the J domain of DNAJ proteins via the HPD motif stimulates Hsp70 ATPase 
activity which results in the hydrolysis of ATP to ADP (Wall et al., 1994, Tsai and Douglas, 1996). 
The change in the phosphorylation state of the nucleotide causes a conformational change in Hsp70 
which increases the chaperones binding affinity towards client proteins (Wall et al., 1994, Tsai 
and Douglas, 1996, Qui et al., 2006). Overall, Hsp70 chaperone activity is ATP dependent and 
cyclic in nature as it requires repeat cycles of ATP hydrolysis (stimulated by DNAJ proteins) and 
nucleotide exchange (catalysed by nucleotide exchange factors), enabling it to bind and release 
client substrates (Figure 1.5) (Fink, 1999; Mayer and Bukau, 2005; Qiu et al., 2006; Rosser and 
Cyr, 2007, Kampinga and Craig, 2010, Sterrenberg et al., 2011). 
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Figure 1.5: Systematic diagram illustrating the functions of DNAJ as a co-chaperone to 
Hsp70. The cycle begins with the binding of the client by DNAJ. This is followed by the recruitment of Hsp70 in 
its ATP bound form by its co-chaperone DNAJ. ATP hydrolysis is stimulated by DNAJ, which results in the increase 
of the affinity of Hsp70 for substrate binding, as well as the release of DNAJ from the complex. The next step is the 
binding of the NEF (nucleotide exchange factor) which has a higher binding affinity for Hsp70-ADP than Hsp70-
ATP. ADP dissociates from Hsp70 allowing the re-binding of ATP, returning Hsp70 to a state where it has low binding 
affinity for the substrate. This is followed by the release of NEF and the substrate (adapted from Kampinga and Craig, 
2010). 
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1.7 DNAJC3 
DNAJC3 also known as ERdj6 or p58IPK (58 kDa inhibitor of protein kinase), is a novel DNAJC 
protein that contains two functional co-chaperone domains, namely the TPR and the J domain 
(Oyadomari et al., 2006, Rutkowski et al., Petrova et al., 2008, Tao et al., 2010, Svärd et al., 2011). 
DNAJC3 was first discovered in influenza virus infected cells where it was shown to act as an 
inhibitor of double stranded (dsRNA)-activated protein kinase (PKR) (Lee et al., 1990, 1992, 
1994). DNAJC3 has also been identified as a co-chaperone of Grp78 and an inhibitor of PKR-like 
ER kinase (PERK) during ER stress (Yan et al., 2002, van Huizen et al., 2003, Rutkowski et al., 
2007). The following sections will discuss the existing data on DNAJC3 in depth, from its 
functions, roles in diseases and structural organization. 
1.7.1 Functions of DNAJC3  
1.7.1.1 DNAJC3 functions during viral infection 
DNAJC3 was first identified in influenza virus infected cells as an inhibitor of the interferon and 
dsRNA induced protein kinase PKR, an important component of the cellular antiviral response 
(Lee et al., 1990, 1992, 1994). In the presence of dsRNA or polyanions, PKR undergoes 
dimerization and autophosphorylation (Galabru and Hovanessian, 1987, Langland and Jacobs, 
1992, Thomis and Samuel, 1993, Langland et al., 1995) which in turn causes the phosphorylation 
of the alpha subunit of eukaryotic Initiation factor 2 (eIF2) on serine 51 (Merrick, 1992). The 
phosphorylation of the alpha subunit of eIF2 results in the attenuation, or in some cases the 
inhibition, of protein synthesis. Viruses due to their RNA genome with essential secondary 
structures have been shown to activate PKR activity (Katze, 1995). During viral infections, the 
presence of viral dsRNA triggers the autophosphorylation of PKR, which triggers a domino effect 
that ultimately results in the decrease of protein synthesis or the shutdown of protein synthesis 
machinery within the cell (Gale and Katze, 1998). Although this action prevents the formation of 
host proteins, the process also ensures that no viral proteins are produced, preventing the 
replication of viral particles and stopping the life cycle of the virus. However, some viruses such 
as the influenza virus have found ways to evade this defence system by using the host’s own 
regulatory systems against it, in this case a natural inhibitor of PKR, DNAJC3 (Katze et al., 1988, 
Lee et al., 1990, 1992, 1994, Korth et al., 1996, Goodman et al., 2007, 2009, 2011). Under 
homeostatic conditions, DNAJC3 is normally inactive due to its association with its own inhibitors 
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such as p52rIPK (Gale et al., 1998, 2002), recently renamed as p88rIPK.due to its 88 kDa size (Luig 
et al., 2010). Inhibition of DNAJC3 by p88rIPK occurs through direct interaction although the 
mechanism of regulation is still unknown (Melville et al., 1997, 2000, Gale et al., 2002, Luig et 
al., 2010),  
In influenza viral infection, the presence of viral dsRNA does not trigger the autophosphorylation 
of PKR that would result in the shutdown of protein synthesis. Instead when the virus infects the 
cells, it recruits or activates DNAJC3, which will in turn bind to PKR using its TPR motif 6, which 
has been shown to have limited homology to the eIF2α subunit, the natural substrate of PKR 
(Polyak et al., 1996, Tang et al., 1996, Gale et al., 1996). By binding to PKR, DNAJC3 blocks its 
autophosphorylation preventing the phosphorylation of the alpha subunit of eIF2 and allowing 
protein synthesis to occur normally, which will result in viral protein being produced (Figure 1.6) 
(Gale et al., 1996, Tan et al., 1998). The matrix protein (M2) of both influenza A and B virus is 
the viral protein that binds to DNAJC3, enhancing the autophosphorylation of PKR which affects 
the infected cell’s life cycle and virus replication (Guan et al., 2010). Recently, Luig et al., (2010) 
have shown that influenza virus stimulated mitogen-activated protein kinase (MAPK)-activated 
protein kinases (MAPKAPKs) MK2 and MK3. This study demonstrated that active MKs recruit 
and bind directly to p88rIPK which is in complex with DNAJC3 and the complex recruits and binds 
PKR. This binding results in the inhibition of PKR activity (Luig et al., 2010). In addition, the 
nucleoprotein in influenza a virus was also found to interact with DNAJC3 with an unidentified 
DNAJ protein, referred to as Hsp40, which is thought to be another inhibitor of DNAJC3 (Melville 
et al., 1997). The interaction between the nucleoprotein and Hsp40 results in the release of 
DNAJC3, allowing it to bind to PKR, preventing the kinase from phosphorylating eIF2α (Sharma 
et al., 2011).  
DNAJC3 has also been shown to be downregulated in Coxsackie virus B3 (CVB3) infected cells, 
which leads to mitochondrial mediated apoptosis (Chau et al., 2007), suggesting that unlike 
influenza infected cells, the upregulation of DNAJC3 promotes cell survival and counteracts 
apoptosis induced by CVB3 (Zhang et al., 2010b). In CVB3-infected cells, inhibition of CVB3 
induced apoptosis is accomplished by the activation of the PI3K/Akt pathway which requires the 
activation of activating transcription factor 6a (ATF6a) a protein responsible for the expression of 
chaperones in response to ER stress (Haze et al., 1999) and the upregulation of a mitochondrial 
membrane protein mitofusin 2 (Zhang et al., 2010b). 
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A plant orthologue of DNAJC3 has been identified in Nicotiana benthamiana and Arabidopsis 
thialiana (Bilgin et al., 2003). Bilgin et al., showed that DNAJC3 interacts with the helicase 
proteins of tobacco mosaic virus (TMV) and tobacco etch virus (TEV), were it is thought to assist 
in virus replication and pathogenicity. The knockdown of DNAJC3 in virus infected plants lead to 
the reduction of virus titre and ultimately death of the host cell. Cell death in DNAJC3 depleted 
cells was attributed to the phosphorylation of eIF2α by PKR in response to the presence of viral 
dsRNA (Bilgin et al., 2003). 
 
 
 
Figure 1.6: Schematic diagram illustrating the inhibitory activity of DNAJC3 on PKR during 
Influenza viral infection.  In the presence of dsRNA, PKR undergoes autophosphorylation which leads to the 
phosphorylation the α subunit of eIF2, resulting in protein synthesis being suppressed. During influenza virus 
infection, the virus synthesises dsRNA which would normally activate PKR. However, the virus has evolved a 
mechanism that activates PKR’s cellular inhibitor, DNAJC3 upon infection. The binding of DNAJC3 and PKR 
prevents the autophosphorylation of the kinase which blocks its activation and ability to phosphorylate eIF2. The 
consequence of PKR inactivation permits the synthesis of viral proteins along with host protein (Lee et al., 1990; 
1994). 
 
1.7.1.2 DNAJC3: Dual functions during the unfolded protein response (UPR) 
Initially, DNAJC3 was thought to be an ER membrane-bound protein facing the cytosol, where it 
interacted with Hsp70 (Yan et al., 2002, Oyadomari et al., 2006). However, the discovery of the 
cleavable ER signal peptide at the N-terminus of DNAJC3 identified the protein as an ER 
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residential lumen protein (Rutkowski et al., 2007). The same group also illustrated that DNAJC3 
that functions in the cytosol as PKR inhibitor represents a subpopulation that likely arose as a 
result of inefficiency in the translocation of the protein or, that under certain conditions, sufficient 
amounts of DNAJC3 can accumulate in the cytosol (Rutkowski et al., 2007).  
In the ER, DNAJC3 has been shown to play an important role during the unfolded protein response 
(UPR), which is a response to ER stress resulting in the accumulation of unfolded proteins in the 
ER (Schröder and Kaufman, 2005, Walter and Ron, 2011). UPR ultimately results in the 
attenuation of protein synthesis alleviating the protein load in the ER as well as the upregulation 
of genes that code for ER chaperones such as Grp78 and components of the ER associated 
degradation pathway (Kaufman, 1999, Zhang and Kaufman, 2006, Ron and Walter, 2007, 
Wiseman et al., 2010, Patil and Walter, 2011). Activation of UPR has been observed in numerous 
diseases such as cancer, diabetes, obesity, autoimmune conditions and neurodegenerative 
disorders, resulting in the UPR pathway becoming a therapeutic target to treat these diseases 
(Wang and Kaufman, 2012, Cornejo and Hetz, 2013, Hetz et al., 2013, Lee and Ozcan, 2014). 
DNAJC3 has been shown to act as a co-chaperone to Grp78 during the early stages of UPR, where 
it aids in the processing of unfolded proteins that accumulate in the ER by binding to the proteins 
and transferring them to Grp78, as well as stimulating the ATPase activity of the protein (Figure 
1.7) (Oyadomari et al., 2006, Rutkowski et al., Petrova et al., 2008, Tao et al., 2010, Svärd et al., 
2011). At the later stages of UPR, DNAJC3 has been found to have a role in downregulating or 
inhibiting the activity of ER-like PKR (PERK) (Yan et al., 2002, van Huizen et al., 2003). PERK 
acts in a similar way as cytosolic PKR, where it attenuates protein synthesis by phosphorylating 
eIF2α during UPR, preventing the synthesis of protein which would normally be translocated to 
the ER for processing, alleviating the burden to the ER (Harding et al., 1999, 2000). However, at 
the later stages when homeostasis has been restored to the ER, DNAJC3 inhibits PERK, resulting 
in the recovery of protein synthesis suppressed during UPR (Harding et al., 2000, 2002) (Figure 
1.7). 
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Figure 1.7: Schematic diagram illustrating the dual function of DNAJC3 during UPR. Under 
homeostasis, Grp78 is bound to ER-like PKR (PERK), inhibiting its kinase activity on eIF2α, allowing protein 
synthesis to occur. Upon ER stress, UPR is activated and at the early and mid-stages, Grp78 releases PERK and 
assumes its role as a chaperone, with DNAJC3 acting as 1 of the 7 ER DNAJ co-chaperones helping to reduce the 
load of unfolded proteins within the ER. Simultaneously, released PERK phosphorylates eIF2α resulting in the 
attenuation of protein synthesis, reducing the load of unfolded protein translocated in the ER. At the late stages of 
UPR when ER homeostasis has been restored, DNAJC3 resumes its functions as an inhibitor of PERK, preventing its 
phosphorylation of eIF2α, allowing protein synthesis to resume. 
 
1.7.2 Role of DNAJC3 in disease 
Similar to other molecular chaperones and DNAJ proteins, DNAJC3 has been implicated in 
disease. This section will review the role of DNAJC3 in cancer and diabetes. 
Cancer  
DNAJC3, like other DNAJ proteins has been found to play a role in cancer biology (Mitra et al., 
2007, Sterrenberg et al., 2011). Studies have shown that DNAJC3 has anti-apoptotic functions, 
where it protects cells against TNF-α and dsRNA induced cell death (Tang et al., 1999). In NIH3T3 
cells, over expression of DNAJC3 has been shown to lead to malignant cell formations which, 
when injected into nude mice, caused tumours (Barber et al., 1994, Korth et al., 1996). Another 
example of the role of DNAJC3 as an oncoprotein is related to its function as the inhibitor of PKR, 
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which plays an important role as an effector of apoptotic cell death (Tan and Katze, 1999), meaning 
that by inhibiting PKR, DNAJC3 can suppress apoptosis. Through the use of isobaric tags for 
relative and absolute quantitation (iTRAQ) quantitative proteomics profiling, expression of 
DNAJC3 was found to be upregulated in metastatic SW620 colon carcinoma compared to the 
paired primary SW480 colon carcinoma, although the implications of this observation is still 
unknown (Ghosh et al., 2011). 
In breast cancer cells, overexpression of endoplasmic reticulum protein 29 (ERp29) an ER luminal 
residential protein involved in protein unfolding and secretion, delays the initiation of 
tumourigenesis in MBA-MB-231 breast cancer cells (Bambang et al., 2009). Overexpression of 
ERp29 promotes the activation (phosphorylation) of p38 which negatively regulates the expression 
of eIF2α and promotes G0/G1 arrest resulting in the attenuation of cell proliferating (Aguirre-
Ghiso et al., 2001, 2003). At the same time, the overexpression of ERp29 upregulates the 
expression of DNAJC3 which in turn inhibits the phosphorylation of eIF2α by PERK, affecting 
the downstream pro-apoptotic ATF4/CHOP/caspase-3 signalling pathway (Gao et al., 2012). This 
demonstrates a link between the activation of p38 and upregulation of DNAJC3 in cell growth 
arrest and survival caused by ERp29. 
DNAJC3 has also been implicated in circumventing UPR promoted apoptosis in response to 
glucose shortages associated with malignant tumour expansion or growth (Huber et al., 2013). 
Glucose shortages associated with tumour expansion are known to trigger UPR and this results in 
the promotion of apoptosis through the PERK-CHOP pathway. However, the expression of 
DNAJC3, a known PERK inhibitor (Harding et al., 2000, 2002, Yan et al., van Huizen et al., 
2003), has been shown to attenuate the PERK/CHOP pathway, negating the protective apoptotic 
response triggered by UPR (Huber et al., 2013).  
Diabetes 
Maintenance of ER homeostasis is crucial for the survival of a cell as it is the site of protein folding, 
modification, and trafficking of secretory and membrane proteins (Kaufman, 1999, 2002, 
Rutkowski and Kaufman, 2004). Disruption of ER homeostasis caused by ER stress triggers UPR, 
which attempts to restore balance to the ER and if this is not possible, will trigger ER-stress 
mediated apoptosis (Harding et al., 1999, Ferri & Kroemer, 2001, Marciniak et al., 2004, Li et al., 
2006, Szegezdi et al., 2006). Pancreatic β cells which are responsible for the secretion of insulin, 
are highly dependent on the ER as this is the site of synthesis of proinsulin, the precursor of insulin 
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(Alarcón et al., 2002, Lipson et al., 2006, Zhuo et al., 2013). Therefore if UPR triggers ER-stress 
mediated apoptosis due to its inability to restore ER homeostasis after ER stress, pancreatic β cell 
numbers are depleted resulting in the onset of diabetes (Harding et al., 2001, Oyadomari et al., 
2002a, 2000b, Zhang et al., 2006). DNAJC3 is known to be upregulated during ER stress and acts 
as a co-chaperone to Grp78 where it assists in the folding and degradation of proteins in an attempt 
to restore ER homeostasis and inhibits PERK activity once homeostasis is reached allowing protein 
synthesis to resume (Yan et al., 2002, van Huizen et al., 2003, Oyadomari et al., 2006, Rutkowski 
et al., 2007). Knockdown of DNAJC3 is known to increase the expression of ER stress induced 
genes such as CHOP and PERK, which are also involved in ER-mediated apoptosis when ER 
homeostasis cannot be restored (Yan et al., 2002). Ladiges et al., and Oyadomari et al., through 
the use of DNAJC3 knockout mouse model illustrated that the depletion of DNAJC3 triggers ER-
mediated apoptosis, reducing the amount of pancreatic β cells and affecting functionality which 
gradually results in the onset of diabetes (Ladiges et al., 2005, Oyadomari et al., 2006). However, 
Rutkowski et al., have reported that the diabetic phenotype observed in DNAJC3 knockout mice 
is considerably mild compared to the knockdown of essential UPR pathway regulatory proteins 
such as ATF6, IRE1 or PERK (Rutkowski et al., 2007).  
1.7.3 Structural organisation and properties of DNAJC3 
DNAJC3 is a member of the DNAJ protein family. The protein is comprised of three different 
functional domains, the J domain at the C-terminus, the middle region has nine TPR motifs which 
are arranged in a tandem array and make up approximately 60 % of the protein’s sequence and a 
cleavable ER signal peptide of about 25 amino acids at the N terminus (Figure 1.8) (Barber et al., 
1994, Lee et al., 1994, Tao et al., 2010, Svärd et al., 2011).   
The J domain of DNAJC3, composed of residues 393 to 455 and located at the extreme C-terminus 
(Svärd et al., 2011), has been shown to be able to interact and stimulate the ATPase activity of 
both Hsp70 (Melville et al., 1997) and Grp78 (Tao et al., 2010, Svärd et al., 2011). The J domain 
of DNAJC3 has four helices (I, II, III, and IV). Helix I and VI are shorter compared to helix II and 
III. The canonical HPD motif conserved in DNAJ family members is located between helices II 
and III (Figure 1.8) (Svärd et al., 2011). The HPD motif is essential for the stimulation of Hsp70 
ATPase activity as shown by numerous mutational studies of the motif (Feldheim et al., 1992; 
Wall et al., 1994; Tsai and Douglas, 1996).  
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Figure 1.8: Structural organisation of DNAJC3 (A) Schematic representation of DNAJC3 domains. A 
cleavable ER signal peptide (yellow) is located at the N-terminus, the 9 TPR motifs (blue) make up the middle domain 
and the J domain (orange) is located at the C-terminus. Highlighted on the upper side by the black bars are the regions 
where known DNAJC3 associating proteins bind. These include PKR, p88rIPK, Grp78/ Hsp70, Hsp40/DNAJ and the 
self-interacting region of DNAJC3. Also included are the central regions of homology to eIF2α, the natural substrate 
of PKR (B) The resolved 3D structure of DNAJC3 (pdb id: 2Y4T) represented in ribbon form. The cleavable ER 
signal peptide is missing from the structure, the 3 TPR domains made up from the 9 TPR motifs are coloured red, blue 
and orange, representing TPR domains 1, 2 and 3, respectively. The J domain located at the C-terminus is coloured 
green and the HPD motif is coloured purple (adapted from Gale et al., 1996, Melville et al., 1999, Tao et al., 2010, 
Svärd et al., 2011). 
 
Tetratricopeptide repeat (TPR) motif  
Protein-protein interactions form the foundation of numerous biological functions within the cell. 
The interaction between these proteins can be facilitated by structural, chemical or even physical 
means. Proteins with unique motifs that function as mediators or scaffolds between proteins have 
been identified, such as the WW domain that specifically binds sequences that are proline rich and 
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contain tyrosine (Bork and Sudol, 1994, Blatch and Lässle, 1999). Out of all the scaffolding motifs 
or domains, the tetratricopeptide repeat (TPR), is one of the best studied. The TPR motif was first 
identified by Sikorski et al. (1990) when they discovered that several proteins in yeast contained 
a repeated degenerate amino acid sequence that was 34 amino acid long (Sikorski et al., 1990). It 
was observed that the numbers of TPR motifs within a protein sequence varies, between three and 
sixteen being most common, and are usually arranged one after the other into domains, although 
single TPR motifs have been found within proteins (Lamb et al., 1995, Blatch and Lässle, 1999, 
D’Andrea and Regan, 2003, Allan and Ratajczak, 2010, Zeytuni and Zarivach, 2012).  
To date, there are over 5000 TPR-containing proteins identified from different organisms through 
the use of bioinformatics analysis. Over a 100 resolved structures are currently available in the 
Protein Data bank (Zeytuni and Zarivach, 2012). TPR-containing proteins have been found to be 
part of numerous multiprotein complexes and play a role in cellular processes such transcriptional 
regulation, co-chaperone functions, protein translocation to the mitochondria, chloroplast and 
peroxisome activity, as well as the regulation of cell cycle and kinase activity (Goebl and 
Yanagida, 1991, Lamb et al., 1995, Brocard and Hartig, 2006, Baker et al., 2007, Mirus et al., 
2009). TPR-containing proteins are not only present and required in eukaryotic cells, but are also 
found in bacteria (Gatsos et al., 2008, Zeytuni et al., 2011) and viral pathogens (Callahan et al., 
1998). The subcellular localization of TPR-containing proteins is also diverse, as proteins have 
been found in the cytosol, nucleus, mitochondria, peroxisomes, ER and chloroplasts (Blatch and 
Lässle, 1999). 
TPR motif primary structure 
The TPR motifs are described as highly degenerate 34 amino acid repeats usually found in tandem 
arrays, but singular motifs have been found to occur in some proteins (Lamb et al., 1995, Blatch 
and Lässle, 1999, D’Andrea and Regan, 2003). The sequences of the various single TPR motifs 
when aligned illustrate a consensus pattern of small and large hydrophobic amino acid residues 
that are mostly conserved at positions 4, 7, 8, 11, 20, 24, 27 and 32 (Figure 1.9A) (Lamb et al., 
1995, Blatch and Lässle, 1999, D’Andrea and Regan, 2003, Zeytuni and Zarivach, 2012). 
However, residues at positions 8, 20 and 27 favour alanine/glycine, alanine and alanine residues, 
respectively, whereas the other sites favour residues with either small, large or aromatic 
characteristics rather than a specific amino acid (D’Andrea and Regan, 2003, Zeytuni and 
Zarivach, 2012). However, residue conservation can be found outside the above listed site, 
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between TPR motifs that are functionally similar or equivalent (Blatch and Lässle, 1999). It has 
also been suggested that residue conservation at the turns between two helices or adjacent helices 
can play an important role in both structure and function (D’Andrea and Regan, 2003, Zeytuni and 
Zarivach, 2012).  
 
 
 
Figure 1.9: TPR motif sequence and structure. (A) Sequence alignment of the first TPR motif of Hsp70 
binding proteins (HOP; AAA58682.1, HIP; NP_003923.2, SGT; NP_003012.1 DNAJC7; NP_003306.3). (B) 
Schematic representation of the secondary structure of the TPR motif highlighting the position of the conserved amino 
acid residues. The ribbon cartoon depicts the helix turn helix confirmation adopted by the TPR motif. Black arrows 
indicate the position of the conserved residues, while the grey arrows indicate the highly conserved residues at 
positions 8 (glycine/alanine), 20 (alanine) and 27 (alanine) (adapted from D’Andrea and Regan, 2003). 
 
TPR secondary and tertiary structure 
Through the use of secondary structural predictions, the TPR motif was proposed to be made up 
of two alpha-helical structures, namely helix A and helix B (Figure 1.9 B). The conserved 
consensus residues at position 4, 7, 8 and 11 are located on helix A, while residues 20, 24, 27 and 
32 are found on helix B (Figure 1.9B) (Blatch and Lässle, 1999, D’Andrea and Regan, 2003). The 
two helical units (A and B) of TPR motifs adopt a basic helix-turn-helix fold (Figure 1.9B). 
Adjacent motifs are arranged in a parallel fashion, which results in a spiral repeat of anti-parallel 
alpha-helices that form a super helical structure (D’Andrea and Regan, 2003, Zeytuni and 
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Zarivach, 2012). Initially the TPR motifs were thought to form a “knob and hole” structure that 
was made up of two amphipathic alpha helices that were separated by a spacer region (Hirano et 
al., 1990, Sikorski et al., 1990). This structure was regarded as a snap helix and was thought to 
mediate protein-protein interactions between TPR-containing proteins and ligands through the 
knob of the TPR domain snapping into the hole of the ligand. In addition, the helix A and B of a 
single TPR motif was thought to be arranged in a linear formation and the anti-parallel arrangement 
was observed between adjacent TPR motifs (Hirano et al., 1990, Sikorski et al., 1990). However, 
the resolution of the TPR domain of PP5 (Das et al., 1998) proved that the predicted arrangement 
of the helical subunits and TPR motif arrangement was incorrect, and the helical structure of the 
TPR motif adopted an anti-parallel arrangement. Furthermore, an additional elongated helix was 
found to be located at the C-terminus of the TPR domain; this extra helix is present in numerous 
resolved TPR structures and is thought to act as a capping or stabilizing helix that is essential for 
the solubility or solubilisation of the isolated TPR domains (Das et al., 1998, D’Andrea and Regan, 
2003). 
To date, several crystal structures of the TPR domain of other proteins have been solved and this 
has highlighted the variability found in the packing of the TPR helical domains. TPR structures of 
proteins such as peroxin 5 (PEX5), TOM20 and Cyp40 have been shown to have dramatic 
differences in the way the TPR domains fold, compared to most of the TPR domains from other 
proteins such as HOP and PP5. In, PEX5, the six TPR motifs do not fold into a super helical 
structure but form independent TPR clusters that do not conform to the canonical super helical 
structure (Gatto et al., 2000). In the case of Cyp40, TOM20 and Trypanosoma brucei PEX5, the 
two helical structures of the TPR motif do not fold into the helix turn helix structure, but instead 
form a single elongated helix (Abe et al., 2000, Kumar et al., 2001, Taylor et al., 2001).   
Ligand binding diversity of TPR domains 
TPR-containing proteins have been shown to be able to bind to a vast number of diverse ligands. 
This ability is linked to the concave and convex surfaces that result from the unique super helix 
fold, and also the different properties of the amino acid residues that are located within those 
surfaces (Zeytuni and Zarivach, 2012). What is interesting is that the ligands usually do not share 
sequence or structural similarities; rather the binding between TPR domain and ligand is usually 
highly specific. However, in some cases, the TPR domain displays surface residues within its 
binding cleft which will interact in a specific manner with its chosen ligand (Zeytuni and Zarivach, 
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2012, Cortajarena and Regan, 2006, Cortajarena et al., 2008). For other interactions, ligand 
specificity can be linked to the electrostatic potential of the binding surface which is imparted by 
the properties of the amino acid residues within that area, or the hydrophobicity and size of the 
residues which might support hydrophobic interactions between the ligand and the TPR domain 
(Zeytuni and Zarivach, 2012, Cortajarena and Regan, 2006, Cortajarena et al., 2008). Through the 
study of several TPR-ligand interactions, it should be noted that binding specificity cannot be 
attributed to a single specific property but rather that several factors in different combinations are 
required and this cooperation gives TPR domains the ability to bind to diverse ligands. An example 
of ligand diversity and function of TPR domains can be observed in TPR-containing proteins that 
interact with Hsp90 and or Hsp70, such as HOP. HOP TPR domains have five highly conserved 
residues that form the carboxylate clamp with is required for the interaction with the EEVD motif 
of Hsp90 or Hsp70. In addition, it has been reported that within the HOP TPR domains are residues 
that confer binding specificity to either Hsp90 or Hsp70, resulting in TRP-1 binding Hsp70 binding 
and TPR-2A binding Hsp90 (Odunuga et al., 2003).  
1.7.3.1 DNAJC3 TPR motifs  
Structurally, the TPR motifs of DNAJC3 follow the same helix-turn- helix conformation for each 
individual motif and adjacent motifs are arranged in a parallel fashion (D’Andrea and Regan, 
2003). The first resolved structure of DNAJC3 was from mice (Tao et al., 2010), however the 
structure lacked the J domain. The crystal structure showed that a monomer of DNAJC3 has 
nineteen helices that form three TPR domains which are grouped in clusters of six helices linked 
by an elongated helix (Tao et al., 2010). The domains are arranged in a head to tail fashion and 
this arrangement differs from that of many TPR proteins which have multiple TPR motifs as they 
are normally packed into a super-helix (D’Andrea and Regan, 2003, Zeytuni and Zarivach, 2012). 
A human DNAJC3 crystal structure was resolved in 2011 by Svärd and colleagues which included 
the J domain that was lacking in the murine structure. This structure showed that although there 
was sequence conservation between the murine and human DNAJC3 protein, the shape of the 
structures differed. It is unclear, however, whether this difference in shape is important to any 
physiological functions of the protein (Svärd et al., 2011). The TPR domains of DNAJC3 share 
structural homology with several TPR-containing proteins such as HOP (Scheufler et al., 2000), 
PP5 (Das et al., 1998), CHIP (Zhang et al., 2005) and the N-terminal domain of TOM70 (Wu and 
Sha, 2006). Despite the structural conservation, the primary amino acid sequences of the different 
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TPR domains differ vastly. The listed proteins have all been shown to interact with their ligands 
through a large groove and these grooves are also present in all three DNAJC3 TPR domains. 
Although all TPR domains form and interact through the groove, which can also be referred to as 
the concave surface, the properties of this groove differ significantly. An example is the 
electrostatic potential of the concave surface; in TPR-containing proteins that interact with Hsp90 
and Hsp70 such as HOP and PP5, the electrostatic potential of the groove is mainly positive (Das 
et al., 1998, Scheufler et al., 2000).  
1.7.3.1.1 Interactions of DNAJC3 TPR motifs 
Inhibitors of DNAJC3 
Different TPR motifs of DNAJC3 are known to associate with various proteins (Figure 1.8). An 
example of this is seen for p88rIPK, is a natural negative regulator of DNAJC3 activity (Luig et al., 
2010). p88rIPK inhibits DNAJC3 through a direct interaction with the seventh TPR motif (in TPR3). 
Mutational studies of TPR motif 7 resulted in the mutant DNAJC3 being a better kinase inhibitor 
than the wild type, proving the mutated protein lacked the negative regulatory domain. It is 
interesting to note that a region of p88rIPK has been shown to share limited homology with the 
charged linker region of Hsp90, although it is unknown whether this region is involved in the 
interaction with TPR motif 7 of DNAJC3 (Gale et al., 2002). An unknown member of the 
Hsp40/DNAJ family has also been identified as a possible inhibitor of DNAJC3 activity (Melville 
et al., 1997, 1999, Guan et al., 2010). The Hsp40 was identified in a purified lysates fraction and 
its inhibition activity verified in vitro (Melville et al., 1997). Melville et al. (1997) demonstrated 
that in influenza infected cells, dissociation of Hsp40 and DNAJC3 is required to inhibit the 
function of PKR. At the same time, the same association between DNAJC3 and Hsp40 was found 
to be disrupted during the recovery process after heat shock, suggesting a regulatory role for 
DNAJC3 independent of viral infection (Melville et al., 1999). Recently, the inhibitory effect of 
DNAJC3 on PKR during influenza virus infection has been linked to the formation of a complex 
between DNAJC3 and influenza matrix proteins (M1 and M2) that is mediated by Hsp40 (Guan 
et al., 2010). Although the actual binding site for Hsp40 on DNAJC3 is currently unknown, 
mutational studies conducted on the seventh TPR motif of DNAJC3 strongly suggest that the motif 
might be the binding site for Hsp40, as mutations resulted in stronger inhibitory effects of 
DNAJC3. If the Hsp40 bound to a different region it would have probably negated the effects 
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observed with the loss of p88rIPK binding site (Melville et al., 1997, 1999). However, it should be 
noted that the removal of TPR motif 5 was also shown to increase the inhibitory functions of 
DNAJC3, implying that this site could also be a potential binding site for DNAJC3 inhibitors 
(Tang et al., 1996). 
 Kinase binding  
TPR motif 6 of DNAJC3 (in TPR2) is the binding site of PKR and this region has been identifies 
as being crucial for its inhibitory functions (Lee et al., 1994, Gale et al., 1996). Mutational studies 
on TPR motif 6 negated the ability of DNAJC3 to inhibit PKR functions in vivo and in vitro (Lee 
et al., 1994, Gale et al., 1996). Interestingly, the region within DNAJC3 found to share homology 
with eIF2α, the natural substrate of PRK, includes TPR motif 6 (Lee et al., Melville et al., 2000). 
The eIF2α protein is required for translation initiation within the cell; the initiation factor is 
phosphorylated on serine 51 (Merrick, 1992, Samuel, 1993) by PKR when activated by interferons 
or by the presence of highly structured RNA molecules or dsRNA (Dauber and Wolff, 2009). The 
phosphorylation of eIF2α eventually leads to the attenuation of protein synthesis and this acts as a 
defence mechanism in virus infected cells, since it prevents or limits the synthesis of viral proteins 
or the spread of viral infection. The shared homology between eIF2α and the region encompassing 
DNAJC3 TPR motif 6 could explain why TPR motif 6 is the binding site for PKR. 
Self-association 
Another interesting region of DNAJC3 identified was the N-terminus 166 amino acids region 
which includes TPR motif 1 to TPR motif 3 (TPR1) and parts of TPR motif 4 (in TPR2). This 
region shares significant homology with another TPR-containing protein, PP5 (Melville et al., 
2000). This region mediates interactions between DNAJC3 molecules (Gale et al., 1996). This 
ability of the TPR domain to allow self-interaction has also been found in other TPR-containing 
proteins (Nyarko et al., 2007, Krachler et al., 2010). However, although studies show that TPR 
motif 1-3 allowed self-association, the oligomeric state of DNAJC3 in vivo has not been 
extensively studied and it remains unclear whether it is important for function and regulation. 
Nevertheless, truncations of TPR motifs 1-3 have been shown to be non-essential for the 
interaction with and inhibition of PKR (Polyak et al., 1996). Despite these published interactions, 
there have been no studies conducted on the interactions of DNAJC3 with chaperones, Hsp90 or 
Hsp70, despite the presence of the TPR domain in this protein. 
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1.8 Motivation 
DNAJC3 is one of only two DNAJ proteins to have TPR domains, the other being DNAJC7. 
DNAJC7 has seven TPR domains and a J domain located at the C-terminus of the protein, while 
DNAJC3 has nine TPR motifs together with the J domain at the C-terminus. DNAJC7 has been 
shown to interact with both Hsp70 and Hsp90 (Brychzy et al., 2003) and can regulate the functions 
of Hsp70 through its J domain and TPR domains and Hsp90 through the TPR domain (Brychzy et 
al., 2003, Moffatt et al., 2008). DNAJC3 and DNAJC7 are known to localize to different 
compartments of the cell, namely the cytosol in the case of DNAJC7, the ER lumen in the case of 
DNAJC3, although a subpopulation of the latter has been found in the cytosol, the majority of the 
protein resides in the ER lumen (Rutkowski et al., 2007). Similar to DNAJC7, the J domain of 
DNAJC3 is able to stimulate the ATPase activity of cytosolic Hsp70 leading to the inhibition of 
PKR (Melville et al., 1999). DNAJC3 also stimulates the ATPase activity of Grp78 during UPR 
caused due to ER stress, where it helps to restore ER homeostasis (Oyadomari et al., 2006, 
Rutkowski et al., 2007, Tao et al., 2010; Svärd et al., 2011).  
At present, there have not been any studies conducted to demonstrate an interaction between 
DNAJC3 TPR domains and Hsp90 or Hsp70, even though this domain is present in known co-
chaperones of Hsp90 and or Hsp70. The only proposed co-chaperone function for DNAJC3 TPR 
domains is linked to TPR1, which binds selectively to unfolded protein through its hydrophobic 
peptide-binding groove. The J domain of DNAJC3 is able to stimulate the ATPase activity of 
Grp78 (Tao et al., 2010). Since DNAJC3 is proposed to have three functional TPR domains (Tao 
et al., 2010, Svärd et al., 2011), and a function has been proposed for only one of the domains, this 
begs the question as to the purpose or functions of the other TPR domains. The ER homologues 
of Hsp90 and Hsp70, Grp94 and Grp78, do not possess the EEVD motif of their cytosolic 
counterparts which is normally required for the interaction with TPR domains (Argon and Simen, 
1999, Fewell et al., 2010). Hence the mechanism of interaction of Grp94/Grp78 with the TPR 
domains may be different to that of cytosolic proteins such as the Hsp70/Hop/Hsp90 machinery. 
Therefore it is possible that DNAJC3 may represent an example of new and unique interactions of 
TPR domains with chaperones. In addition, there are currently no known co-chaperones of Grp94, 
although DNAJC3 was recently found to be in a complex with Grp94 along with other proteins 
(Jansen et al., 2012), raising the question as to whether DNAJC3 could possibly be the missing 
Grp94 co-chaperone. 
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1.9 Hypothesis 
The TPR domains of DNAJC3 are involved in non-canonical interactions with Hsp70 and Hsp90 
chaperones.  
1.10 Aims and objectives 
1.10.1 Aim 
Characterization of the structure and function of DNAJC3 TPR domains 
1.10.2 Objectives 
 In silico analysis of DNAJC3 TPR domains 
 Development of bacterial systems to over-express DNAJC3 and other 
chaperones for functional studies. 
  In vitro analysis of protein-protein interactions of DNAJC3 TPR domains 
 Preliminary ex vivo analysis of DNAJC3 in mammalian cells  
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Chapter 2: Materials and Methods 
 
2.1 Sequence retrieval and analysis 
The amino acid sequence for Homo sapiens DNAJC3 (Accession number NP_006251.1) was 
retrieved from the National Centre of Biotechnology Information (NCBI) database. Using the 
retrieved Homo sapiens DNAJC3 amino acid sequence, pBLAST (Basic local Sequence 
Alignment Tool) (Altschul et al., 1990) and Psi-BLAST (Position-Specific Iterative BLAST) 
(Altschul et al., 1997) were conducted to identify DNAJC3 homologues from various species 
(Table 3.1). Reverse BLAST was conducted on every amino acid sequence identified in the first 
round of BLAST and Psi-BLAST to ensure that the retrieved sequences represented the protein 
DNAJC3 in the selected species. Sequence selection was based on two criteria; namely an E-value 
of 0 or close to 0 and sequence percentage coverage higher than 75 %. 
2.2 Multiple sequence alignment 
To eliminate or reduce the chances of receiving biased results, four multiple sequence alignment 
programs were used to align the DNAJC3 amino acid sequences, namely ClustalW (Thompson et 
al., 1994), MAFFT (Katoh et al., 2002), T-COFFEE (Notredame et al., 2000) and Promals3D (Pei 
et al., 2008). Each program uses specific algorithms to elucidate the different interrelations that 
exist between a set of sequences. For each program, a FASTA format file was uploaded to the web 
servers, and alignment conducted under the default parameters. After the completion of the 
alignment, the resulting output was edited using the BioEdit software (Hall, 1999).  
2.3 Phylogenetic analysis 
The Promals3D DNAJC3 multiple sequence alignment result obtained in section 2.2 was used to 
construct a phylogenetic tree in order to infer the evolutionary relationships between the different 
DNAJC3 sequences from different species (Table 3.1). The tree was constructed using the 
Molecular Evolutionary Genetics Analysis 5 (MEGA5) program (Tamura et al., 2011). 
Evolutionary models were calculated and the best two models selected based on low Bayesian 
information criterion (BIC) score. The selected models were used for phylogenetic analysis, while 
the tree was generated using the Maximum Likelihood analysis (Tamura et al., 2011) with the 
following parameters: bootstrap consensus tree surmised from 1000 replicates and any tree 
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partitions replicated in less than 75 % of the bootstrap analyzes were collapsed. For the calculation 
of the evolutionary distances, the MEGA5 program used the Jones-Taylor-Thornton (JTT) 
evolutionary model (Jones et al., 1992). 
2.4 Motif identification and comparison 
Several TPR-containing co-chaperones of Hsp90 and Hsp70 were selected based on literature 
(Caplan, 2003) and the amino acid sequences were retrieved from NCBI. The following co-
chaperones were selected for analysis; DNAJC7 (NP_003306.3), CHIP (NP_005852.2), TOM34 
(NP_006800.2), SGT (NP_003012.1), HIP (NP_003923.2), HOP (AAA58682.1) and PP5 
(NP_006238.1). The co-chaperones and DNAJC3 sequences were submitted to several motif 
identification programs; namely Simple Modular Architecture Research Tool (SMART) (Schultz 
et al., 1998 and Letunic et al., 2012), Eukaryotic Linear Motifs (ELM) (Dinkel et al., 2012), 
Multiple Em for Motif Elucidation (MEME) (Bailey et al., 2009) and PROSITE (Sigrist et al., 
2002). Multiple programs were used to maximise the identification of all possible motifs within a 
protein. All programs were used under the default parameters. The identified motifs from all four 
programs were compiled and protein domains were represented using DOG 2.0 software (Ren et 
al., 2009). 
2.5 TPR domain alignment and comparison 
Using the sequences of co-chaperones listed above (section 2.4), the amino acid sequences for the 
TPR domains were manually isolated from the rest of the sequence and grouped based on the 
chaperone (Hsp90, Hsp70 or both) with which they are known to interact. Multiple sequence 
alignment was conducted using the Promals3D program.  
2.6 HHpred structural homologue detection, retrieval and alignment 
The Protein Data Bank (pdb) coordinate file for Homo sapiens DNAJC3 (PDB id: 2Y4T) was 
retrieved from the RCSB Protein Data Bank, an online repository for three-dimensional (3-D) 
structures of various biological molecules such as proteins and nucleic acids (Berman et al., 2000). 
The 2Y4T.pdb file was manually manipulated using the free word processor gedit software, 
separating DNAJC3 into the three identified TPR domains, yielding 2Y4T_domain1.pdb, 
2Y4T_domain2.pdb and 2Y4T_domain3.pdb which represented DNAJC3 TPR1, 2 and 3, 
respectively (numbering from the N to the C-terminus of the protein). The three TPR domain files 
(2Y4T_domain1.pdb, 2Y4T_domain2.pdb and 2Y4T_domain3.pdb) were loaded into the HHpred 
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server (Söding et al., 2005) to identify putative structural homologues. The best structural 
homologues were selected based on E-value, structure resolution and template range. The retrieved 
structures were subjected to multiple sequence alignment using the Promals3D program, which is 
able to utilise both the FASTA and pdb format for alignments. The resulting alignments were 
analyzed using BioEdit software. Structural alignment of the structural homologues and DNAJC3 
TPR domains was conducted using the Pymol Molecular Graphics system (DeLano and Lam, 
2005). 
2.7 Structural modelling of DNAJC7 and DNAJC3 TPR domain mutations 
The Homo sapiens DNAJC7 sequence was submitted to the internet based modelling server 
HHPred to identify templates. A model for DNAJC7 was constructed by MODELLER under 
HHpred (Sali et al., 1995) using DNAJC3 (2Y4T) as a template. Mutation of DNAJC3 TPR 
domain amino acids was selected based on the residues shown by Odunuga et al. (2003) to play a 
crucial role in the formation of the carboxylate clamp between HOP TPR domains and 
Hsp70/Hsp90 chaperone EEVD motif interactions, namely (K8, N12, N43, K73, R77) in TPR-1 
of HOP and K229, N233, N264, K301, R305 in TPR-2A of HOP. The residue numbers correspond 
to the alignment conducted in section 2.4. The five residues were mutated in all three DNAJC3 
TPR domains (TPR1: L8K, K12N, R59N, A96K and Q100R, TPR2: R8K, Q12N, L59N, E96K 
and K100R and TPR3:I8K, E12N, R59N, E96K and D100R.) and the models built using 
MODELLER under HHpred with DNAJC3 (2Y4T) as the template. Model validation was 
conducted by submitting the generated models to the online based MetaMQAP server (Pawlowski 
et al., 2008) and Verify3D (Eisenberg et al., 1997). 
2.8 Electrostatic potential analysis 
Electrostatic potential analysis of DNAJC3 TPR domains and structural homologues was 
conducted using the freeware DeepView/Swiss-PdbViewer with default parameters (Guex and 
Peitsch, 1997). 
2.9 Mammalian cell lines and growth conditions 
The MCF-7 breast carcinoma cell line (ATCC accession number HTB-22) and the HEK293T cell 
line (ATCC accession number CRL-1573) were a kind gift from Prof Sharon Prince (Department 
of Human Biology, University of Cape Town). The cells were cultured in Dulbecco’s Modified 
Eagle Medium (DMEM) containing Glutamax™  and supplemented with 10 % (v/v) heat-
40 
 
inactivated fetal calf serum (FCS), 100 U.ml-1 penicillin-streptomycin-amphotericin (PSA) 
(Gibco, Invitrogen UK) and incubated at 37 °C in a 10 % CO2 incubator. The HEK293T cells were 
cultured in Dulbecco’s Modified Eagle Medium (DMEM) containing Glutamax™ and 
supplemented with 10 % (v/v) heat-inactivated fetal calf serum (FCS), 100 U.ml-1 penicillin-
streptomycin-amphotericin (PSA), 500 µg/ml Geneticin (G418) and incubated at 37 °C in a 5 % 
CO2 incubator. 
2.10 Total RNA extraction from MCF-7 carcinoma cell line  
MCF-7 breast carcinoma cells were grown to confluency in a 75 cm2 cell flask. The cells were 
rinsed twice with phosphate buffered saline (PBS) (140 mM NaCl, 2.7 mM KCl, 10 mM Na2PO4, 
1.8 mM KH2PO4, pH 7.4). Cells were lifted with 1 % (v/v) trypsin supplemented with 0.3 % (w/v) 
ethylenediaminetetraacetic acid (EDTA) and were stained with equal volume of trypan blue 
(Sigma-Aldrich, Germany) and counted using a haemocytometer. For total RNA extraction, MCF-
7 cells were lysed in 1 ml TRI® Reagent (Sigma-Aldrich, Germany) per 5 – 10 x 10-6 cells. The 
homogenate was incubated at 30 °C for 5 minutes, after which 0.2 ml of chloroform per 1 ml of 
TRI® Reagent was added. The mixture was vigorously shaken for 15 seconds and incubated at 30 
°C for 3 minutes. Samples were centrifuged at speeds not higher than 12000 x g for 15 minutes at 
4 °C, with the samples separating into three distinct layers. The upper aqueous layer which 
contained RNA was transferred to a new eppendorf tube and 0.5 ml of isopropanol per 1 ml of 
TRI® Reagent was added to precipitate the RNA. The mixture was incubated at 30 °C for 10 
minutes and centrifuged at 12000 x g for 15 minutes at 4 °C. The resulting supernatant was 
decanted and the pellet was washed in 75 % (v/v) ethanol prepared with RNAse free water (1 ml 
per 1 ml TRI® Reagent used). The pellet was resuspended by vortexing and centrifuged for 5 
minutes at 4 °C at 7500 x g. After centrifugation, the supernatant was decanted and the pellet air 
dried. The dried pellet was dissolved in 50 µl of RNAse-free water, incubated at 55 °C for 10 
minutes and stored at -70 °C for long-term storage or -20 °C for short-term storage.  
2.11 Generation of bacterial expression plasmid for DNAJC7 
The complementary deoxyribonucleic acid (cDNA) was synthesized from total RNA isolated in 
section 2.10 through reverse transcription polymerase chain reaction (RT-PCR) using the 
RevertAid™ Premium first Strand cDNA Synthesis Kit (Fermentas, USA), according to 
manufacturer’s instructions. The primer pair LZMC7-1F (5’-
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AAAGGATCCATGGCGGCTGCCGCGAGTGCG-3’) and LZMC7R (5’-
AAAGTCGACTTAGCCAAATTGAAAAAAGAAATTCCCTGG-3’), which introduced 
restriction sites  BamH1 and Sal1 at the 5’ and 3’ ends, respectively, were used to amplify the 
DNAJC7 coding sequence from the synthesized cDNA. The PCR product was excised from a 1 % 
(w/v) agarose gel in Tris-acetate-EDTA (TAE [40 mM Tris acetate, 1 mM EDTA]) buffer and 
cleaned and concentrated using the ZymoClean™ Gel DNA Recovery kit (Zymo Research, USA), 
according to manufacturer’s instructions. The resultant PCR product was ligated into the cloning 
vector, pGEM-T-Easy® (Promega, USA), to generate the intermediate plasmid, pGEMDNAJC7. 
Restriction digest with BamH1 and Sal1 was conducted to verify the success of the ligation 
procedure. The pGEMDNAJC7 and the pGEX 4T-1 vector were digested with BamH1 and Sal1, 
to introduce compatible ends and resolved on a 1 % (w/v) agarose gel in TAE buffer. The insert 
(DNAJC7) and the pGEX 4T-1 backbone vector were gel purified using the ZymoClean™ Gel 
DNA Recovery kit. The coding sequence for DNAJC7 was ligated into pGEX 4T-1, resulting in 
the expression vector pLZMC7 that encoded GST-tagged DNAJC7. Verification of the plasmids 
was conducted by sequencing with pGEX5’ and pGEX3’ primers (Inqaba Biotechnology). 
2.12 Generation of bacterial expression plasmids for DNAJC3 
Mammalian expression plasmids mP58.FL1-pCDNA3 (Addgene, 21883) and mP58.dJ1-
pCDNA3 (Addgene, 21884), carrying the coding sequence for full length DNAJC3 (including ER 
signal peptide, TPR and J domains) and DNAJC3 that was lacking the J domain (but contained the 
ER signal peptide and TPR domains) was constructed by Oyadomari et al., 2006. The mP58.FL1-
pCDNA3, mP58.dJ1-pCDNA3 and pGEX 4T-1 plasmids (the vector chosen for bacterial 
expression) were digested with BamH1 and Xho1, to generate compatible sticky sites. The digested 
coding sequences of DNAJC3 were ligated into pGEX 4T-1, resulting in the expression vectors, 
pLZMC3FL and pLZMC3dJ that encoded GST-tagged DNAJC3FL and DNAJC3dJ. In addition, 
constructs coding for DNAJC3 lacking the ER signal peptide were also constructed. This was 
accomplished by designing primers, DNAJC3F (5’- 
AAAGGATCCGCGGATGTGGAGAAGCATC-3’, DNAJC3R (5’-AAACTC 
GAGTTAATTGAAGTGGAACTTAAATCTGAAC-3’) and DNAJC3dJR (5’-
AAACTCGAGTTATCGTTTCTGTGACTGCTTCAGTAAC-3’) that amplified DNAJC3 coding 
region from mP58.FL1-pCDNA3 eliminating the N-terminal region that coded for the ER signal 
peptide. The resulting PCR products were ligated into pGEM-T-Easy® and then subcloned into 
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the expression vector pGEX 4T-1 using BamH1 and Xho1 restriction sites, resulting in the 
expression vectors, pLZMC3ΔER and pLZMC3ΔJ/ER. The new pLZMC3FL, pLZMC3ΔER, 
pLZMC3dJ and pLZMC3ΔJ/ER constructs were verified by restriction digest analysis and 
sequencing with pGEX5’ and pGEX3’ primers (Inqaba Biotechnology). 
2.13 Optimization and Over expression of GST- tagged DNAJC3 constructs 
Recombinant expression constructs pGEX 4T-1, pLZMC3FL, pLZMC3ΔER, pLZMC3dJ and 
pLZMC3ΔJ/ER were transformed separately into various competent E. coli cell strains (Table 2.1) 
and incubated overnight at 37 °C. Single colonies were inoculated into 2X Yeast Tryptone (YT) 
broth (1.6 % [w/v] tryptone, 1 % [w/v] yeast extract and 0.5 % [w/v] NaCl) supplemented with 
appropriate antibiotics at final concentrations listed in Table 2.1 and grown overnight with shaking 
at 37 °C. A total of 1 ml of the overnight culture was inoculated into fresh 100 ml 2X YT broth 
(supplemented with antibiotics) and grown at 37 °C with shaking until the culture reached an OD600 
reading of between 0.4 and 0.8. At this point, various expression conditions were utilised to 
determine the optimum conditions for the expression of GST-tagged DNAJC3 proteins. Protein 
expression was induced by the addition of isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final 
concentration of either 1 mM or 0.5 mM. A total of 1 ml samples were collected at 0-4 hours post 
induction and used to determine optimum protein expression time. In addition to the 2X YT broth, 
four different growth medium were also to express the protein, 2X YT broth with 2 % (w/v) 
glucose, 2X YT broth with 0.5 M sorbitol, glucose minimal medium (0.4 % [w/v] glucose, 2 mM 
MgSO4, 0.1 mM CaCl2, 33.7 mM Na2HPO4, 22 mM KH2PO4, 8.55 mM NaCl, 9.35 mM NH4Cl) 
and auto-induction medium (1 % [w/v] tryptone, 0.5 % [w/v] yeast extract, 25 mM Na2HPO4, 25 
mM KH2PO4, 50 mM NH4Cl, 5 mM Na2SO4, 2mM MgSO4, 0.5 % [v/v] glycerol, 0.05 % [w/v] 
glucose and 0.2 % [w/v] α-lactose). Using the normal 2X YT broth, cells were also expressed 
under four different conditions: 20 °C for 4 hours with 1 mM IPTG, 37 °C for 0.5 hours with 1 
mM IPTG, 37 °C for 4 hours with 0.5 mM IPTG and 37 °C with 1 mM IPTG for 4 hours. For post 
expression treatments, cell were harvested by centrifugation at 4 °C for 10 minutes at 6000 x g and 
the pellet resuspended in PBS (2.5 ml of PBS per 1 g of cells) containing lysozyme and 
phenylmethylsulfonyl fluoride (PMSF) at a final concentration of 1 mg/ml and 1 mM, respectively. 
The resuspended mixture was divided equally into six tubes (a total of 1 ml per tube). For the 
treatments, five of the tubes were treated with one of the following detergents, Nonidet-P 40 
(NP40), N-Laurylsarcosine (Sac), Triton-X, Tween-20 and Durrapol 2000 at concentrations 
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ranging between 1- 10 % (v/v), with the remaining untreated tube serving as a control. Samples 
were incubated with shaking at 37 °C for 1 hour and frozen at -80 °C overnight. The frozen lysates 
were thawed on ice, followed by 10 rounds of sonication for 30 seconds with 15 second cooling 
periods in between. Lysate clarification was done by centrifuging at 10000 x g for 30 minutes at 4 
°C after which total protein, pellet and supernatant fractions were collected. All samples were 
analyzed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) using a 12 
% (v/v) polyacrylamide gel, followed by Coomassie blue staining and Western analysis. 
2.14 Batch purification of GST-tagged DNAJC3 proteins 
E. coli cells expressing the different GST-tagged DNAJC3 proteins were treated as previously 
described in section 2.12. The clarified cell lysate was added to pre-washed Protino® Glutathione 
Agarose resin (Thermo Scientific, USA) and the mixture incubated for 30 minutes at room 
temperature with gentle shaking. Sedimentation of the mixture was done by centrifuging at 500 x 
g for 5 minutes. The supernatant was decanted, and the resin washed three times with 10 bead 
volumes of PBS. Each wash step was followed by centrifugation at 500 x g for 5 minutes. After 
the wash steps, 1 bead volume of GST elution buffer (50 mM Tris pH 8, 10 mM glutathione) was 
added to the agarose resin and incubated with gentle shaking at room temperature for 10 minutes, 
followed by centrifugation at 500 x g for 5 minutes. The elution step was repeated three more 
times, with the resulting supernatant being transferred to fresh eppendorf tubes. The success of the 
purification protocol was evaluated by SDS-PAGE and Coomassie blue staining. 
2.15 Over expression and batch purification of His-tagged peptides Grp78 and Grp94284-543 
His-tagged Grp78 (BiP) (pQE10-BiP, kind donation from Professor Zimmermann, Universität des 
Saarlandes, Germany) and His-tagged middle domain of Grp94284-543 (HSP90B1- Addgene, 
30976) were expressed in M15 [pREP4] and BL21 (DE3) E. coli cells, respectively. Protein 
expression for His-tagged Grp78 and His-tagged Grp94284-543 was induced with IPTG at a final 
concentration of 1 mM at 37 °C and 0.5 mM at 18 °C, respectively. Cells were harvested by 
centrifuging at 6000 x g at 4 °C for 20 minutes. The resulting pellet was resuspended in cold His 
lysis/wash buffer (10 mM Tris pH 7.4, 300 mM NaCl, 50 mM imidazole), lysozyme and PMSF 
were added to a final concentration of 1 mg/ml and 1 mM, respectively and the pellet frozen at -
80 °C overnight. The following day, the pellet was thawed on ice and sonicated five times for 30 
seconds bursts, followed by 30 seconds cooling periods. The sample was clarified by centrifuging 
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at 16000 x g for 30 minutes at 4 °C. The supernatant was added to nickel charged Chelating 
Sepharose™ Fast Flow resin (GE HealthCare, UK) and binding was conducted at 4 °C overnight 
with shaking. The overnight mixture was centrifuged at 1500 x g for 2 minutes, the supernatant 
discarded and the beads washed three times with lysis/wash buffer, followed by centrifugation at 
1500 x g for 2 minutes. His-tagged proteins were eluted twice with cold His elution buffer (10 mM 
Tris pH 7.4, 300 mM NaCl, 400 mM imidazole) and the supernatant containing the eluted protein 
stored at -20 °C until further use. The success of the purification protocol was once again evaluated 
by SDS-PAGE and Coomassie blue staining.  
 
Table 2.1: Genotype of E. coli strains used in this study 
Strain Genotype 
DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15 Δ(lacZYA-
argF)U169, hsdR17(rK- mK+), λ– 
JM109 endA1 glnV44 thi-1 relA1 gyrA96 recA1 mcrB+ Δ(lac-proAB) e14- [F' traD36 
proAB+ lacIq lacZΔM15] hsdR17(rK-mK+) 
BL21(DE3) F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) 
BL21 C41 (DE3) F– ompT gal dcm hsdSB(rB- mB-)(DE3) 
BL21 C43 (DE3) F– ompT gal dcm hsdSB(rB- mB-)(DE3) 
XL1 Blue endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 F'[ ::Tn10 proAB+ lacIq Δ(lacZ)M15] 
hsdR17(rK- mK+) 
M15[pREP4] lac,ara,gal,mtl,recA+,uvr+ [pREP4,lacI,kanar] 
BB1994 MC4100 dnaK52 sidB1::Tc pDMI,1::CmR KanR 
 
2.16 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and Western 
analysis 
All samples analyzed by SDS-PAGE were resolved on a 12 % (v/v) polyacrylamide gel run at 
200V, stained with either Coomassie staining solution (0.1 % [w/v] Coomassie brilliant blue R-
250, 50 % [v/v] methanol, 10 % [v/v] glacial acetic acid) or Colloidal Coomassie staining solution 
(20 % [v/v] ethanol, 10 % [v/v] phosphoric acid, 0.12 % [w/v] Coomassie Brilliant blue G-250, 
10 % [w/v] ammonium sulphate). For Western analysis, proteins were transferred onto 
nitrocellulose membrane (Bio-Rad Laboratories, USA) for 50 minutes at 400 mA in transfer buffer 
(25 mM Tris-HCl pH 7.4, 192 mM glycine, 20 % [v/v] methanol). Ponceau stain (0.1 % [w/v] 
Ponceau stain in 1 % [v/v] acetic acid) was used to verify protein transfer. The stain was removed 
by rinsing the membrane in water and then Tris buffered saline with 1 % (v/v) Tween-20 (TBS-T 
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150 mM NaCl, 50 mM Tris-HCl pH 7.6). The membrane was incubated for 1 hour in blocking 
solution (TBS-T containing 5 % [w/v] bovine albumin serum [BSA]), followed by an overnight 
incubation with primary antibody in blocking solution (dilutions summarized in Table 2.2). The 
membrane was washed three times for 15 minutes in TBS-T. For secondary antibody incubation, 
the membrane was incubated in species specific HRP- conjugated secondary antibody (1:5000) for 
1 hour, followed by three 15 minutes washes with TBS-T. Secondary antibodies were detected 
using Clarity™ Western ECL Substrate (Bio-Rad Laboratories, USA) and visualised using AGFA 
Medical X-Ray Film Blue (AGFA Healthcare NV, Belgium) or Version™ Model 4000 imaging 
system (Bio-Rad Laboratories, USA). 
 
Table 2.2: Description of primary antibodies utilized for Western analysis  
 
Antibody/ Cat # Dilution Type/ Species Source 
Anti-DNAJC3/SC-100717 1:1000 Monoclonal/ Mouse Santa Cruz Biotech, USA 
Anti-DNAJC3/ ab70840 1:1000 Polyclonal/ Rabbit Abcam, UK 
Anti-Hsp70/Hsc70/ SC-24  1:1000 Monoclonal/ Mouse Santa Cruz Biotech, USA 
Anti-Hsp90α/β/ SC-13 1:1000 Monoclonal/ Mouse Santa Cruz Biotech, USA 
Anti-Grp78/ SMC-196D 1:1000 Monoclonal/ Mouse StressMarq, Canada 
Anti-Grp94/ SMC-105B 1:1000 Monoclonal/ Rat StressMarq, Canada 
Anti-HOP/ SRA-1500 1:1000 Monoclonal/ Mouse Assay Designs, USA 
Anti-p-p38/ SC-166182 1:200 Monoclonal/ Mouse Santa Cruz Biotech, USA 
Anti-pJNK/ SC-6254 1:200 Monoclonal/ Mouse Santa Cruz Biotech, USA 
Anti-p44/42 MAPK (T202/Y204) 1:2500 Polyclonal/ Rabbit Cell Signalling Tech, USA 
Anti-GAPDH/ SC-25778 1:1000 Polyclonal/ Rabbit Santa Cruz Biotech, USA 
Anti-GST/ SC-459 1:5000 Polyclonal/ Rabbit Santa Cruz Biotech, USA 
Anti-Histone /H3 #9715 1:2500 Polyclonal/ Rabbit Cell Signalling Tech, USA 
 
2.17 Preparation of MCF-7 carcinoma cell lysates 
MCF-7 carcinoma cells were grown to confluency in 150 cm2 dishes and the cell rinsed twice with 
PBS. The cells were lysed by incubating in 1 ml radioimmunoprecipitation assay buffer (RIPA; 
50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM Na3VO4, 1 % (v/v) NP40, 1 mM 
Na deoxycholate, 1 mM PMSF, 2 µg/ml Protease inhibitor cocktail [Sigma-Aldrich, Germany]) at 
4 °C for 1 hour. The lysed cells were centrifuged at 4 °C at 16000 x g for 20 minutes and the 
supernatant stored at -20 °C. 
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2.18 Pull down assay 
2.18.1 MCF-7 carcinoma lysate pull down assay 
A total of 20 µg of purified protein (GST protein, GST- tagged mSTI1 and GST-tagged 
DNAJC3ΔJ/ER) in 1 ml PBS, was incubated with 100 µl resuspended pre-washed Protino® 
Glutathione Agarose resin at 4 °C for 2 hours, with gentle agitation. The reaction was washed three 
times with PBS and centrifuged for 5 minutes at 5000 x g. The bound purified proteins were 
incubated overnight with 500 µl of MCF-7 carcinoma cell lysate as prepared in section 2.16. The 
reaction was washed three times with PBS and centrifuged for 5 minutes at 5000 x g and 
resuspended in SDS sample buffer (50 mM Tris-HCl, pH 6.8, 2 % SDS, 10 % glycerol, 1 % β-
mercaptoethanol, 12.5 mM EDTA, 0.02 % bromophenol blue) prior to Western analysis for Hsp90, 
Hsp70, Grp78 and Grp94. 
2.18.2 Purified protein pull down assay 
The purified protein pull down assay protocol was a modified from that published by Staron et al., 
2011. A total 10 µg of purified protein (GST protein, GST- tagged mSTI1 and GST-tagged 
DNAJC3ΔJ/ER) was bound to Protino® Glutathione Agarose as previously described in section 
2.17.1. The bound proteins were incubated separately with 1 µg of recombinant Hsp90 
(StressMarq, Canada), Hsp70 (StressMarq, Canada), Grp94 (Abcam, UK), His-tagged Grp78 or  
His-tagged Grp94284-543 at 4 °C with shaking in binding buffer (20 mM HEPES pH 7.2, 50 mM 
KCl, 5 mM MgCl2, 20 mM Na2MO4, 0.5 % (v/v) NP40, 1 mM ATP). The reactions were washed 
three times in binding buffer before being analyzed by SDS-PAGE and Colloidal Coomassie 
staining.  
2.18.3 Assessment of substrate binding by ELISA 
Malate dehydrogenase (MDH, Roche Diagnostics GmbH, Germany) and β-galactosidase (Sigma 
Aldrich, Germany) were used as model substrate (Freeman and Morimoto, 1996, Rampelt et al., 
2012) and heat denatured for 1 hour at 50°C and 30 minutes at 65 °C, respectively. A total of 50 
µg/ml of native and heat denatured MDH or β-galactosidase was coated onto the surface of 96 well 
medium binding  ELISA microplates (Greiner Bio-ONE GmbH, Germany) by incubating 
overnight at 4 °C. Nonspecific binding was blocked by incubating the coated wells in ELISA 
blocking solution ( 5 % [w/v] BSA in buffer A [20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5 mM 
CaCl2, 0.05 % (v/v) Tween-20, 1 mM ATP]) overnight at 4 °C. Varying concentrations (10 µg/ml, 
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50 µg/ml, and 100 µg/ml) of GST, GST-DNAJC3ΔJ/ER and His-Grp78 in blocking solution were 
added to wells and incubated for 12 hours at 4 °C. Wells were washed three times in wash buffer 
(1 % (w/v) BSA in buffer A), followed by incubation in anti-GST or anti-His primary antibody 
(1:1000) in blocking solution for 1 hour at room temperature. The wells were washed three times 
in wash buffer before being incubated with secondary antibody (1: 2000) in blocking buffer for 1 
hour at room temperature and subsequently washed again five times with wash buffer. The  
3,3’,5,5’-Tetramethylbenzidine (TMB) substrate (0.1 mg/ml TMB in 0.05 M phosphate-citrate 
buffer, pH 5) was added to each well and incubated in the dark for 20 minutes. After incubation, 
the reaction was stopped by the addition of 2 M H2SO4 and absorbance read at 450 nm.  
2.18.4 Complex formation assay 
Pull down assay 
A total of 10 µg of purified protein (GST protein, GST-DNAJC3ΔJ/ER and His-Grp78) was bound 
to Protino® Glutathione Agarose or nickel charged Chelating Sepharose™ Fast Flow resin for 3 
hours in 1 ml PBS or His lysis/binding buffer. The reaction was washed three times with PBS or 
His lysis/binding buffer and centrifuged for 5 minutes at 5 000 x g. The bound proteins were 
incubated with 10 µg/ml heat denatured β-galactosidase and either 5 µg/ ml GST, GST-
DNAJC3ΔJ/ER or 2 µg/ml Grp94 in binding buffer. The reactions were incubated at 4 °C 
overnight with gentle shaking, followed by three washes with binding buffer. The reactions were 
analyzed by SDS-PAGE and Colloidal Coomassie staining.  
ELISA 
A total of 50 µg/ml of His-Grp78 was coated onto the surface of 96 well medium binding ELISA 
microplates by incubating overnight at 4 °C. Nonspecific binding was blocked by incubating the 
coated wells in ELISA blocking solution overnight at 4 °C. Varying concentrations (50 µg/ml and 
100 µg/ml) of heated denatured β-galactosidase and 20 µg/ml of GST or GST-DNAJC3ΔJ/ER 
were added and incubated for 12 hours at 4 °C. Wells were washed three times with wash buffer, 
followed by incubation in anti-GST antibody (1:1000) in blocking solution for 1 hour at room 
temperature. The wells were washed three times wash buffer before being incubated in secondary 
antibody (1: 2000) in blocking buffer for 1 hour at room temperature, after which the wells were 
washed five times in wash buffer. Reactions were analyzed as described in section 2.17.3. 
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2.18.5 Luciferase refolding assay  
The protocol for the refolding of chemically denatured luciferase was modified from that published 
by Buchberger et al 1994 and Freeman et al., 1995. A stock solution of QuantiLum® recombinant 
luciferase (Promega. USA) was prepared at 4 mg/ml in 1 M glycylglycine (pH 7.4). Chemical 
denaturation of luciferase was conducted by 2-fold dilution of the substrate into 1 M glycylglycine 
(pH 7.4), followed by a 6.4-fold dilution into denaturation buffer (25 mM HEPES pH 7.5, 50 KCl, 
5 mM MgCl2, 5 mM β-mercaptoethanol, 6 M guanidine-HCl) and incubated at 37 °C for 30 
minutes. The denatured luciferase was diluted 125-fold into refolding buffer (25 mM HEPES pH 
7.5, 50 mM KCl, 5 mM MgCl2, 10 mM dithiothreitol [DTT], 1 mM ATP) supplemented with 
different combinations of GST, GST-DNAJC3ΔJ/ER and His-Grp78 at 3.2 µM. The refolding 
procedure was initiated by adding 2 µl of denatured luciferase to a 50:50 mixture (100 µl) of 
refolding buffer and firefly luciferase assay reagent (FLAR) buffer (20 mM Tris-HCl (pH 7.8), 
100 µM EDTA, 1.07 mM MgCO3, 2.67 mM MgSO4, 17 mM DTT, 250 µM ATP and 250 µM D-
luciferin [Promega. USA]) in a white 96 high binding well plates (Greiner Bio-ONE GmbH, 
Germany). The refolding reactions were monitored by measuring luminescence (luciferase 
activity) at 10 minute intervals for 2 hours at 37 °C using the Synergy Mx Multi-Mode Reader 
(BioTek, Instruments, Inc., USA) .Native luciferase was used as a positive control and diluted to 
the same extent as denatured luciferase. Luciferase activity in the refolding reactions was 
calculated as a percentage of the activity of denatured luciferase without the addition of GST, 
GST-DNAJC3ΔJ/ER or His-Grp78 
2.19 Analysis of expression of DNAJC3 under induced stress conditions 
To determine the expression profile of DNAJC3 under different stress conditions, HEK293T cells 
were treated as listed in Table 2.3. After each treatment, cells were harvested and resuspended in 
5X SDS sample buffer and equal amount of protein was analyzed by SDS-PAGE and Western 
analysis. 
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Table 2.3: Description of various treatments used to simulate a variety of stress conditions 
Stress Condition Treatment* Concentration 
(mM) 
Treatment time 
(Hours) 
Recovery time 
(Hours) 
Normal Untreated - - 24 
ER Stress Tunicamycin (Tun)  2.38 24 - 
ROS H2O2 0.5 0.25 2 
Hypoxia CoCl2 0.1  24 - 
Tumor inducer PMA 5 x 10-5  2 24 
Proteosome 
Inhibition 
MG132 0.01  2 24 
Heat Shock Heat (42 °C) - 2 2 
UV stress Short UV (254 nm) - 0.02 2 
UV stress Long UV (366 nm) - 0.02 2 
* Tunicamycin (Sigma-Aldrich, Germany), Phorbol 12-myristate 13-acetate (PMA [Sigma-Aldrich, Germany]), Z-
Leu-Leu-Leu-al (MG132 [Sigma-Aldrich, Germany]) 
 
2.20 Effects of Novobiocin (NOVO) and Geldanamycin (GA) on the expression of DNAJC3 
in MCF-7 carcinoma cells 
MCF-7 carcinoma cells were grown to 90 % confluency and treated with, 0.1, 1 and 10 µM of GA 
(Biomol International Inc, USA) or 5, 50 and 500 µM of NOVO (Sigma-Aldrich, USA). Cells 
were also treated with DMSO, the vehicle used to resuspend GA, in order to ensure the effects 
observed were not due to DMSO. At 24 hours post treatment cells were collected and analyzed by 
SDS-PAGE and Western analysis. 
2.21 Transient siRNA transfections for knockdown of DNAJC3 
For transient knockdown of DNAJC3, MCF-7 carcinoma cells were grown to 80 % confluency 
and transfected with negative control siGENOME Non-Targeting siRNA Pool #2 (cat # D-001206-
14-05) and siGENOME SMARTpool Human DNAJC3 (cat # M-012251-00-0005) (Dharmacon 
Technologies, UK) to a final concentration of 25 nM using Dharmafect 1 transfection reagent 
(Thermo Scientific, USA) according to manufacturer’s specifications. Cells were harvested at 0 
hours, 48 hours and 72 hours post-transfection and analyzed by Western analysis.   
2.22 Transient transfections of HEK293T cells with HRas plasmids 
mEGFP-HRas (Addgene, 18664), mEGFP-HRas G12V (Addgene, 18666) and mEGFP-HRas 
S17N (Addgene, 18665) plasmids, which coded for EGFP-tagged wild type Ras, EGFP-tagged 
constituently active Ras, and EGFP-tagged dominant negative Ras, respectively, were extracted 
using the GenElute™ endotoxin-free plasmid midiprep kit (Sigma-Aldrich, Germany) according 
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to manufacturer’s specifications. HEK293T cells were grown to 80 % confluency overnight in 24 
well plates. At 2 hours prior to transfection, spent media was replaced with 500 µl fresh complete 
media without PSA. For each well, 0.5 µg of plasmid DNA was incubated with 1µl PureFection™ 
transfection reagent (System Biosciences, USA) in 50 µl complete media. The reaction tubes were 
vortexed for 10 minutes, centrifuged briefly and incubated for 15 minutes at room temperature, 
after which the reaction was added to the wells. Transfection mixtures were incubated with cells 
for 48 hours at 37 °C in a 5 % CO incubator. The transfections were analyzed by Western blot and 
confocal microscopy. 
2.23 Indirect immunofluorescence staining and confocal microscopy 
Cells grown on glass coverslips and treated accordingly were fixed in ice cold 100 % ethanol, and 
washed in PBS. Cells were permeabilized in PBS containing 0.1 % (v/v) Tween-20 for 20 minutes 
with shaking at room temperature (all subsequent steps were conducted at room temperature with 
shaking unless stated otherwise). Cells were rinsed twice for 10 minutes in wash buffer (PBS 
containing 0.1 % [w/v] BSA) and blocked in blocking solution (PBS containing 1 % [w/v] BSA) 
for 30 minutes. Cells were incubated in primary antibodies (mouse anti-DNAJC3 [1:200], rat anti-
Grp94 [1:200] and goat anti-Hsp90 [1:100]) prepared in blocking solution overnight at 4 °C. Cells 
were washed twice for 10 minutes in wash buffer and then incubated in species-specific Alexa-
Fluor 488, Alexa-Fluor 546 (Molecular probes, Invitrogen, UK) or Dylight  660 (Abcam, UK)-
conjugated secondary antibodies for 30 minutes. Three 10 minute washes in wash buffer were 
conducted with the third wash containing 1 µg/ml Hoechst 33342 (Pierce Biotechnology, Inc 
Thermo Scientific, USA) to stain the cell nucleus. Coverslips were mounted onto glass slides using 
Dako fluorescence Mounting Medium (Dako North America, Inc, CA, USA) and stored at 4 °C. 
Cells were visualized using the inverted LSM 510-Meta confocal laser scanning microscope (Carl 
Zeiss, Germany) using the 60x oil immersion objective lens. The lasers at wavelengths 405, 488, 
543, 633 nm were used to excite Hoechst 33342, Alexa-Fluor 488, Alexa-Fluor 546 and Dylight 
660, respectively. Images were analyzed using the Axionvision LE/SE freeware software (Carl 
Ziess, Germany). Quantification of colocalization analysis was conducted using the Image J 
software and processed using Microsoft Office PowerPoint 2007. 
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Chapter 3: In silico analysis of DNAJC3 TPR domains 
 
3.1 Introduction 
This chapter describes the bioinformatics analysis of the different TPR domains of DNAJC3. 
DNAJC3, also known as p58IPK, has a cleavable ER retention signal at the N-terminus, nine TPR 
motifs and a J-domain at the C-terminus. Currently there are two resolved structures of DNAJC3 
available, mouse DNAJC3, which is missing the ER signal peptide and the J domain (Tao et al., 
2010) and human DNAJC3 with the J domain included (Svärd et al., 2011). The availability of 
these structures enabled the prediction of the protein’s function based on analysis on the various 
domains making up its tertiary structure. DNAJC3 was selected for study due to the fact that two 
of its domains, the TPR and J domain, are well characterized domains commonly found in the co-
chaperones of Hsp90 and Hsp70. DNAJC3 is only one of two DNAJ proteins to have TPR 
domains, the other being DNAJC7 (Kampinga and Craig, 2010). 
DNAJC7, or TPR2, is a member of the DNAJC group that was first discovered during a screening 
process for proteins that interacted with the GAP-related domain of neurobromin, a protein that 
regulates Ras (Murthy et al., 1996). Structurally, DNAJC7 has seven TPR domains and a J domain 
located at the C-terminus of the protein. Through a yeast two-hybrid system, DNAJC7 was 
identified as a cytosolic protein that could interact with both Hsp70 and Hsp90 (Brychzy et al., 
2003). The ability of DNAJC7 to interact with both Hsp90 and Hsp70 was examined during the 
refolding of the glucocorticoid receptor. Brychzy et al (2003) found that during the refolding of 
the receptor, the J domain of DNAJC7 stimulated the ATPase activity of Hsp70 which resulted in 
ATP hydrolysis, increasing the binding affinity of Hsp70 for its substrate. However, DNAJC7 
caused the dissociation of Hsp90 from the substrate, which did not occur with Hsp70. Mutational 
studies identified the TPR domains of DNAJC7 as being responsible for mediating the 
dissociation, leading Brychzy and co-workers to conclude that the TPR domains induced an ATP-
independent disassociation of Hsp90 from substrates (Brychzy et al., 2003, Moffatt et al., 2008).  
 
Although structurally similar, DNAJC3 and DNAJC7 are localized in different compartments of 
the cell. DNAJC7 is cytosolic, while DNAJC3 is found mainly in the ER lumen, although a 
subpopulation of the protein can be found in the cytosol due to the fact that the ER signal peptide 
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is somewhat inefficient in mediating the translocation of DNAJC3 to the ER (Rutkowski et al., 
2007). In addition, while the TPR domains of DNAJC7 have been shown to be able to interact 
with both Hsp90 and Hsp70, this has not been proven for DNAJC3. The only co-chaperone related 
function currently proposed for DNAJC3 TPR domains is that TPR1 of the protein binds 
selectively to unfolded protein through its hydrophobic peptide-binding groove, while functioning 
as a co-chaperone to Grp78 via the J domain (Tao et al., 2010). Similar to DNAJC7, the J-domain 
of DNAJC3 has been shown to be able to stimulate the ATPase activity of Grp78 during UPR 
caused due to ER stress, where it helps to restore ER homeostasis (Oyadomari et al., 2006, 
Rutkowski et al., 2007, Tao et al., 2010; Svärd et al., 2011). Since DNAJC3 is proposed to have 
three functional TPR domains (Tao et al., 2010 and Svärd et al., 2011), and currently there has 
only been a proposed function for one of these domains, the function of the other two domains are 
unknown. The objective of this study was to use various bioinformatics tools to analyse the TPR 
domains and predicted possible functions of the protein not yet discovered. The specific objectives 
were: 
 To conduct multiple sequence analysis and phylogenetic analysis on DNAJC3 from various 
species; 
 To conduct motif identification for DNAJC3 and known Hsp90 and Hsp70 TPR-containing 
co chaperones and conduct multiple sequence alignment on the TPR domains; 
 Determine sequence, structural and electrostatic potential similarities between DNAJC3 
TPR domains and structural homologues. 
3.2 Results  
3.2.1 DNAJC3 is a highly conserved protein found in numerous species  
3.2.1.1 DNAJC3 Multiple sequence alignment 
In order to determine the conservation of DNAJC3 across a wide range of species, multiple 
sequence alignment was conducted on DNAJC3 amino acid sequences from 35 different species 
identified through BLAST and Psi-BLAST (Table 3.1). The selected species represented different 
groups including mammals, fish, birds, insects, fungi and plants.   
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Table 3.1: Accession number, E-value, sequence identity and sequence percentage coverage 
of DNAJC3 amino acid sequences from 35 species used in the study. 
Accession number  Species  Common name  E value  Sequence 
identity  
% 
Coverage  
 NP_006251.1  Homo Sapiens  Human  0  100  100  
 XP_001138934.1  Pan troglodytes  Chimpanzee  0  99  100  
 XP_003257442.1  Nomascus leucogenys  White-cheeked 
gibbon  
0  99  100  
 NP_001253333.1  Macaca mulatta  Rhesus monkey  0  99  100  
 XP_003832176.1  Pan paniscus  Bonobo  0  99  95  
 XP_002752533.1  Callethrix jacchus  Marmoset  0  98  100  
 XP_003928253.1  Saimiri boliviensis  Squirrel monkey  0  98  100  
 XP_002918691.1  Ailuropoda melanoleuca  Panda  0  98  100  
 NP_032955.2  Mus musculus  Mouse  0  97  100  
 NP_001177113.1  Sus scrofa  Wild boar  0  97  100  
 NP_001011485.1  Xenopus tropicalis  Clawed frog  0  97  100  
 XP_534166.3  Canis lupus familiaris  Dog  0  97  95  
 NP_777181.1  Bos Taurus  Cow 0  96  100  
 XP_003495288.1  Cricetulus griseus  Hamster  0  96  94  
 XP_001492322.1  Equus caballus  Horse  0  96  95  
 XP_003409693.1  Loxodonta Africana  Elephant  0  95  95  
 NP_071568.1  Rattus norvegicus  Rat  0  94  100  
 XP_002824422.1  Pongo abelii  Orangutan  0  94  100  
 XP_003765831.1  Sarcophilus harrisii  Tasmanian devil  0  92  100  
 XP_001366332.1  Monodelphis domestica  Opossum  0  91  100  
 XP_003430813.1  Orinithorhynchus anatinus  Platypus  0  90  94  
 XP_003203294.1  Meleagris gallopavo  Turkey  0  80  95  
 NP_001008437.1  Gallus  Chicken  0  80  100  
 XP_003218715.1  Anolis carolinensis  Carolina anole  0  80  100  
 NP_955904.2  Danio rerio  Zebrafish  0  71  100  
 NP_001134029.1  Salmo salar  Atlantic salmon  0  70  84  
 XP_003699497.1  Megachile rotundata  Leafcutter bee  0  48  93  
 EFN69747.1  Campontus floridanus  Carpenter ant  0  47  96  
 XP_312173.2  Anopheles gambiae  Mosquito  0  46  94  
 NP_649916.1  Drosophila melanogaster  Fruit fly  0  44  94  
 XP_001824393.1  Aspergillus oryzae  Yellow koji mold  2 e-178  31  98  
 XP_002152681.1  Penicillium marneffei  Mold 8 e-169  29  95  
 NP_001234332.1  Solamun lycpersicum  Tomato  4 e-150  32  80  
 NP_195936.1  Arabidopsis thaliana  Thale cress  2 e -138  30  87  
 AAP41819.1  Nicotiana benthamiana  Wild tobacco  1 e- 127  29  83  
 
Sequence alignment was conducted using four different multiple sequence alignment programs, 
namely ClustalW, MAFFT, T-COFFEE and Promals3D. Alignment results obtained using the 
Promals3D program were selected for further analysis. BioEdit was use to annotate and present 
the results (Figure 3.1). 
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Figure 3.1: Multiple sequence alignment of DNAJC3 amino acid sequence from 35 species. Multiple sequence alignment generated by 
Promals3D and edited using BioEdit. Residues highlighted as follows; black shading represents identical residues and grey shading represents similar residues. 
The Hsp40 defining domain, the J domain is underlined double broken black line and the HPD residues involved in stimulation of the ATPase activity of Hsp70 
(Tsai and Douglas, 1996), are indicated by black arrows. The ER signal peptide and TPR1, 2 and 3 are underlined by different black lines.  
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DNAJC3 has three distinct TPR domains located at the N terminus of the protein which are 
underlined by different black lines (Figure 3.1). An ER signal peptide located at the N-terminus of 
the sequence, is underlined black. The ER signal peptide is cleaved once the protein has 
translocated to the ER, resulting in DNAJC3 being an ER lumen residential protein (Rutkowski et 
al., 2007). The J domain, the domain that defines a protein as a member of the DNAJ family is 
underlined by a double black line, while the HPD motif, known to be required for the stimulation 
of the ATPase activity of Hsp70 (Tsai and Douglas,1996), is indicated by black arrows (Figure 
3.1). The black and grey shading represents identical and similar amino acid residues, respectively, 
the conservation of which illustrated that the DNAJC3 protein was highly conserved amongst the 
species analyzed. This was also depicted by the percentage identity matrix, with percentage 
similarity ranging from 98 % to 85 % between the human protein and other mammalian protein 
(results not shown). DNAJC3 protein sequences from insects (leafcutter bee, carpenter ant, 
mosquito and fruit fly), plants (tomato, wild tobacco and thale cress) and fungi (mold and yellow 
koji mold) were an exception. This was indicated by the numerous amino acid residue 
substitutions, deletions and additions (Figure 3.1) as well as the low identity percentage, with plant 
proteins sequences having as low as 30% sequence identity (data not shown). The limited sequence 
conservation seen in Figure 3.1 for insects, plants and fungi correlated with the limited sequence 
identity percentage and low E value score results from the BLAST and Psi-BLAST analysis (Table 
3.1). To further examine the relationship between the DNAJC3 proteins of the 35 species in this 
study, a phylogenetic analysis was conducted. 
3.2.1.2 DNAJC3 phylogenetic analysis 
Based on the results obtained from the multiple sequence alignment, additional analysis was 
conducted to examine the interrelationship of the DNAJC3 proteins across the various species. 
The results obtained from the Promals3D alignment (Figure 3.1) was utilized for the phylogenetic 
analysis, which was conducted using MEGA5.1 (Figure 3.2). 
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Figure 3.2: Evolutionary relationships of DNAJC3 proteins from various species. The 
evolutionary history was generated using the Maximum likelihood statistical method. The bootstrap consensus tree 
inferred from 1000 replicates was taken to represent the evolutionary history of the taxa analyzed. The percentage of 
replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) is shown next to 
the branches. Branches partitions replicated in less than 75% of the bootstrap analyzes were collapsed The 
evolutionary distances were computed using the Jones-Taylor- Thornton (JTT) model and are in the units of the 
number of amino acid substitutions per site. The analysis involved 35 amino acid sequences. All positions containing 
gaps and missing data were eliminated. There were a total of 396 positions in the final dataset. Evolutionary analyses 
were conducted in MEGA5.1. 
 
Several branches can be observed from the phylogenetic tree. The mammals formed a monocluster 
that separated them from other families, with the high bootstrap value of, 99 % illustrating the 
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significance of the split. The Tasmanian devil and opossum formed an additional monocluster that 
split from the main mammalian clade, while the same was observed for the platypus which had a 
branch that split from the rest of the mammals earlier, possibly indicating an evolutionary 
difference between the proteins in higher and lesser mammals (Figure 3.2).  A similar trend was 
observed for the other species within the same family, which formed their own clades as seen in 
the case of birds (turkey and chicken, 100%), fish (zebra fish and salmon, 80%) and insects 
(mosquito, fruit fly, carpenter ant and leafcutter bee, 100%).Interestingly the insects split into 
subclades which separated the ant and bee from the mosquito and fruit fly, representing a 
divergence that separated non winged insects from winged insects. The most interesting 
observation from the phylogenetic tree was the outlier branch that separated the plants (tomato, 
wild tobacco and thale cress) from the rest of the species. The difference in the plant DNAJC3 
protein from the human protein was also observed with the alignment analysis, where these 
sequences had the lowest sequence identity to all the other protein sequences analyzed.  
3.2.2 DNAJC3 TPR domains differ from TPR domain that interact with Hsp90 and Hsp70 
and are more similar to TPR domains with functions independent of Hsp90 and Hsp70 
3.2.2.1 Domain identification  
Literature lists the number of different domain types present within DNAJC3 as three, an ER signal 
peptide, TPR domains and a J domain (Tao et al., 2010 and Svärd et al., 2011). The TPR domain 
and J domain are defined as co-chaperone domains, although the TPR domain can have other 
functions not linked to co-chaperoning activity (Lamb et al., 1995, D’Andrea and Regan, 2003). 
Only one other DNAJ protein, DNAJC7, is known to contain TPR domains and a J domain in 
combination, both of which function as co-chaperone domains. The TPR domains of DNAJC7 
interact with both Hsp90 and Hsp70 in a co-chaperone capacity (Brychzy et al., 2003, Moffatt et 
al., 2008). Due to the similarity of DNAJC3 and DNAJC7 further analysis was conducted in an 
attempt to elucidate the possible functions of DNAJC3 using published data on DNAJC7. Also 
included in the analysis were TPR-containing proteins known to co-chaperone either Hsp90, 
Hsp70 or both chaperones. In order to identify specific domains of DNAJC3, DNAJC7 and known 
co-chaperones of Hsp90 and or Hsp70, amino acid sequences were submitted to four different 
motif identification software programs to increase the probability of identifying all possible motifs. 
The results from the programs were compiled and represented using the DOG 2.0 software (Figure 
3.3).  
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Selected for analysis were known TPR-containing co-chaperones of Hsp70 (HIP), Hsp90 (PP5 and 
TOM34) and of both Hsp90 and Hsp70 (HOP, DNAJC7, CHIP and SGT). Figure 3.3 showed that 
DNAJC3 protein was composed of three different types of motif, namely an ER signal peptide at 
the N-terminus, eight TPR motifs in the middle and a J domain at the C-terminus, which involved 
in Hsp70 and DNAJ interactions (Tsai and Douglas, 1996). The domain identification analysis 
results reported here are similar to previous findings (Kampinga and Craig, 2010), although the 
majority of studies list the number of TPR motifs as nine (Tao et al., 2010 and Svärd et al., 2011). 
The TPR motif was found in all the co-chaperones of Hsp90 and Hsp70 analyzed; however the 
number and position of the motif differed (Figure 3.3). A functional TPR domain is comprised of 
three or more TPR motif clustered in a group (Lamb et al., 1995), and the domain is known to 
mediate protein-protein interactions. DNAJC3 and DNAJC7 follow the same pattern with the 
exception of the middle motifs, in which only two or a single TPR motif were predicted, 
respectively (Figure 3.3). The identification of eight TPR motifs suggested that DNAJC3 
potentially has two functional TPR domain as opposed to the proposed three, or that one of the 
three domains is incomplete (Tao et al., 2010, Svärd et al., 2011). DNAJC3 and DNAJC7 also 
have the J domain at the C-terminus in common. HIP and HOP, as well as HIP and CHIP also 
share common domains, namely the DP domain and the coiled coil domain, respectively. The 
phosphatase and Ubox domains were only found in PP5 and CHIP, respectively.  
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Figure 3.3: Domain identification of DNAJC3, DNAJC7 and selected Hsp90 and Hsp70 co-chaperones. The number on the top left of 
each protein indicate the N-terminus and the number at the top right indicate the C-terminus. Domain architecture was constructed using the DOG 2.0 software
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3.2.2.2 TPR domain multiple sequence alignment  
Based on the motif identification and comparison conducted in section 3.2.2.1, the TPR domain 
was identified as the common feature amongst all the analyzed co-chaperones of Hsp90 and Hsp70 
and DNAJC3. Multiple sequence alignment was conducted on the TPR domains of known Hsp90 
and Hsp70 interacting co-chaperones as well as the three TPR domains of DNAJC3 (Figure 3.4). 
 
The TPR motif consensus sequence, W4, G8, Y11, G15, Y17, A20, Y24, A27 and P32 (D’Andrea and 
Regan, 2003), was identified after the alignment. However, apart from the TPR motif consensus 
sequence, no sequence conservation or similarity was observed between the co-chaperones and 
DNAJC3 TPR domains (Figure 3.4). The residues involved in the formation of the carboxylate 
clamp with the C-terminal EEVD of Hsp90 or Hsp70 (boxed red, Figure 3.4), usually a positively 
charged residue (K, N or R), was observed to be conserved in Hsp70 and Hsp90 interacting 
proteins and absent in all three DNAJC3 TPR domains. The same was observed for the residues 
involved in determining the binding specificity between of TPR binding and Hsp90 or Hsp70. 
Interestingly, although the residues involved in determining specificity between Hsp90 and Hsp70 
differed, the topological position of the residues was identical (boxed blue, Figure 3.4). However, 
although it was noted that there was no sequence conservation, the Promals3D alignment also 
included structural prediction of TPR domains and from the analysis it was suggested that the 
analyzed TPR domains were made up of helical structures (red arrows, Figure 3.4). From the latter 
analysis, each TPR motif (34 amino acid residues) appeared to form two alpha helical structures, 
which is similar to previous observations of TPR domains (D’Andrea and Regan, 2003).  
Since the carboxylate clamp residues were identified to be important in the TPR domain for 
Hsp90/Hsp70 interaction and found to be lacking in DNAJC3 TPR domains, additional analysis 
was conducted to understand the consequence of the lack of the clamp residues in DNAJC3 TPR 
domains. 
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Figure 3.4: Multiple sequence alignment of DNAJC3 TPR domains and TRP domains of known Hsp90 and Hsp70 co-
chaperones. Amino acid sequence of TPR domains involved in the interaction with Hsp90 and or Hsp70 were isolated and alignment against DNAJC3 TPR 
domains 1-3 using Promals3D and analyzed using the BioEdit software. Black box highlights DNAJC3 TPR domains; red box highlights amino acid that form the 
carboxyl clamp and blue box highlights amino acid residues shown in HOP to be involved in determining specificity for either Hsp90 or Hsp70 (Odunuga et al., 
2003). Black and grey shading indicate identical and similar amino acids, respectively. The blue, grey and yellow lines indicate co-chaperone proteins known to 
interact with Hsp70, Hsp90 / Hsp70 and Hsp90, respectively. The red arrows represent predicted helical secondary structure. 
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3.2.2.3 Electrostatic potential analysis of TPR domains, interaction analysis of the TPR domains 
and EEVD motif and mutational studies of DNAJC3 TPR domains 
Based on the multiple sequence alignment conducted in section 3.2.2.2 between DNAJC3 TPR 
domains and Hsp90 and Hsp70 co-chaperones, it was noted that DNAJC3 TPR domains were 
missing five residues (K8, N12, N59, K96, R100), that were highly conserved in both Hsp90 and 
Hsp70 co-chaperones (Figure 3.4). These five residues form the carboxylate clamp, which is 
essential for the interaction of the TPR domain with the C–terminal EEVD motif of Hsp90 and 
Hsp70 (Scheufler et al., 2000, Odunuga et al., 2003). Mutational analyses were conducted on the 
TPR domains of DNAJC3, in which the aforementioned five residues in the three DNAJC3 TPR 
domains were mutated in silico as follows; DNAJC3 TPR1: L8K, K12N, R59N, A96K and 
Q100R; DNAJC3 TPR2: R8K, Q12N, L59N, E96K and K100R; and DNAJC3 TPR3 :I8K, E12N, 
R59N, E96K and D100R. These mutations were conducted to introduce the five carboxylate clamp 
residues. DNAJC3 TPR domain mutation models were constructed using HHpred and using the 
original DNAJC3 sequence as the template, models were verified using MetaMQAP and 
Verify3D. 
Electrostatic potential analysis (at pH 7 and default protonation state for all residues) of the 
interacting TPR domain grooves of HOP, DNAJC7 (modelled using DNAJC3 as template), 
DNAJC3 and mutated DNAJC3 TPR domains, was conducted to examine the different charge 
distribution of the TPR interacting groove (Figure 3.5). For TPR domains, the groove is mostly 
known as the interface for protein-protein interaction (D’Andrea and Regan, 2003), thus the 
electrostatic potential analysis and comparison was focused on that area. Electrostatic potential for 
each protein was determined by submitting the corresponding pdb file to Deepview/Swiss-
PdbViewer (Guex and Peitsch, 1997). The program assigns a numerical value to each amino acid 
residue based on its charge and represents the assigned charge in a color code; namely blue to 
represent positively charged residues, white for neutral residues and red for negatively charge 
residues.
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Figure 3.5: Electrostatic potential analysis and comparison of TPR domains from HOP, 
DNAJC7, DNAJC3 and TPR mutated DNAJC3. Red represents negatively charged regions, blue 
represents positively charged regions and white shading represents neutral areas 
 
The TPR domains of HOP were included in the comparison (Figure 3.5, top panels), as they have 
been extensively characterized (Odunuga et al., 2003), the structures resolved (Scheufler et al., 
2000) and are known to interact with both Hsp90 and Hsp70. Two out of the three TPR domains 
of HOP had a positively charged groove (Figure 3.5). The groove of HOP TPR-1 was surrounded 
by neutral regions and the centre of the groove was highly positive. HOP TPR-2A had an overall 
positive charge, even on areas outside of the TPR groove. The electrostatic distribution TPR-2B 
was a mixture of neutral, positive and negative charged regions. TPR1 and TPR3 of DNAJC7 were 
mainly positively charged at the TPR groove, while TPR2 was negatively charged (Figure 3.5, 
upper middle panels). DNAJC3 TPR1 domain was mainly neutrally charged at the groove, while 
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TPR2 and TPR3 (in particular) were negatively charged (Figure 3.5, lower middle panels). The 
presence of the carboxylate clamp residues results in a positively charged TPR groove that is 
responsible for the interaction with the negatively charged EEVD motif, ensuring a stable 
interaction (Scheufler et al., 2000). The lack of the positively charged groove in DNAJC3 TPR 
domains is at least partly due to the absence of the five residues forming the carboxylate clamp. 
The in silico mutation of DNAJC3 TPR domains to include the carboxylate clamp residues altered 
the electrostatic charge distribution drastically, especially for DNAJC3 TPR1 (Figure 3.5 lower 
panels). TPR1 of the mutated DNAJC3 had a positively charged groove, while the second TPR 
domain groove had a mixture of both positive and negative regions. TPR3 was still mainly 
negatively charged but the inner centre of the groove was neutral (Figure 3.5, lower panels). 
Comparing the mutated DNAJC3 TPR domains, the mutation of the five residues in DNAJC3 
TPR1, altered the electrostatic charge distribution of the groove to closely resemble that of HOP 
TPR-1 and DNAJC7 TPR1 and 3, which all have positive TPR grooves. The mutation of TPR2 of 
DNAJC3 resulted in a domain with one side being negatively charged and the other positive; none 
of the other TPR domains exhibited this trait. After mutation, DNAJC3 TPR3 changed from being 
mostly negatively charged to having a slightly neutral TPR groove, similar to that of DNAJC7 
TPR2. 
The carboxylate clamp residues of a TPR domain are not only involved in creating the charged 
groove that ensures a stable interaction with an EEVD motif. Direct residue interactions in the 
form of hydrogen bonds occur between the side chains of the carboxylate clamp residues and 
EEVD motif residues (Scheufler et al., 2000). The orientation and charge of the carboxylate clamp 
residues were analyzed in relation to the EEVD motif by superimposing the resolved structure of 
HOP TPR1 in complex with the Hsc70 EEVD motif (1ELW, Scheufler et al., 2000) to that of 
DNAJC7 TPR1, DNAJC3 TPR1 and mutated DNAJC3 TPR1 (Figure 3.6). The orientation of the 
EEVD motif present in these structural alignments is therefore not a true representation of the 
orientation or placement of the EEVD in complex with the mentioned TPR domains, but was 
utilized to illustrate the general area or space the EEVD motif might occupy if in complex with 
the TPR domains. DNAJC3 TPR1 was selected for further analysis based on the electrostatic 
charge distribution results (Figure 3.5), where the mutation studies suggested that this domain was 
more similar to that of known Hsp70/90 interacting TPR domains. 
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Figure 3.6: Analysis of the orientation and charge of the sidechain of the carboxylate clamp 
residues in complex with Hsp70 EEVD motif. Analysis was conducted aligning the resolved structure of 
HOP TPR1 in complex with Hsp70 EEVD motif (1ELW, green) to that of DNAJC7 TPR1 (blue), DNAJC3 TPR1 
(purple) and mutated DNAJC3 TPR1 (yellow). The EEVD motif from Hsc70 (as in the 1ELW structure) is represented 
in grey sticks and the carboxylate residues or corresponding residues represented in stick form and black dotted lines 
represent hydrogen bonds. 
 
The resolved structure of HOP TRP1 in complex with the EEVD motif of Hsp70 (Figure 3.6, 
shown in green) was used as the template to illustrate how the carboxylate clamp residues or 
equivalent residues of DNAJC7 TPR1 (blue), DNAJC3 TPR1 (purple) and mutated DNAJC3 
TPR1 (yellow), would appear when in complex with the EEVD residues of Hsp70, as no resolved 
structures are available. Both HOP TPR1 and DNAJC7 TPR1 have been shown to have the 
conserved carboxylate clamp residues and, in the case of HOP, the charge of the side chains of 
those residues are known to form hydrogen bonds with the E, E and D residues of the EEVD motif, 
as well as interactions with residues upstream of the EEVD motif (Scheufler et al., 2000. Odunuga 
et al., 2003). Since DNAJC7 has been shown to interact with Hsp70 in a similar manner to HOP, 
the latter interactions are also likely for DNAJC7 (Brychzy et al., 2003). The bulk size of the 
carboxylate clamp residues (K, R), results in the residues being able to extend into the space where 
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the EEVD motif docks, permitting a physical interaction. The residues on DNAJC3 TPR1 (Figure 
3.6, purple) that correspond to those of the carboxylate clamp residues are either too short and 
uncharged (A, V) or are polar but uncharged (Q). The consequence of differences is the lack of the 
ability to form hydrogen bonds with the EEVD motif that is required for the interaction. The 
mutation of the corresponding residue on DNAJC3 TPR1 to those that form the carboxylate clamp 
(Figure 3.6 yellow), resulted in the formation of hydrogen bonds with the EEVD motifs (data not 
shown). This suggested that the absence of these conserved residues at the exact positions in 
DNAJC3 TPR1 would not permit interaction with the EEVD motif. However, it should be noted 
that the mutation of DNAJC3 TPR2 and TPR3 to introduce the carboxylate clamp residues, did 
not infer the ability of these domains to form physical interactions with the EEVD motif (data not 
shown). Also the introduction of the mutations did not change the electrostatic charge distribution 
to that required for a stable interaction to occur, especially for TPR3 (Figure 3.5, lower panels). 
These results suggest that DNAJC3 TPR1 might be the only TPR domain to possibly interact with 
the EEVD motif, but only if the carboxylate clamp residues occurred naturally on the domain.  
DNAJC3 TPR domains were predicted not to be able to interact with both Hsp70 and Hsp90 due 
to the absence of the carboxylate clamp residues, therefore additional analysis was conducted to 
identify possible alternative binding sites. 
3.2.2.4 Repressor of DNAJC3, p88rIPK ,shares limited structural homology with the charged 
linker region of both Hsp90 and Grp94 introducing a potential alternative binding site for 
DNAJC3 TPR domains 
The ER homologues of Hsp70 and Hsp90, Grp78 and Grp94, respectively lack the EEVD motif 
that is required to interact with TPR domains (Argon and Simen, 1999, Fewell et al., 2004). The 
alignment of cytosolic and organelle Hsp90, Grp94 and TRAP1, demonstrates that Grp94 and 
TRAP1 lack the EEVD motif. GRP94 has the ER retention motif, KDEL instead, although Grp94 
also has an EEVD-like motif upstream of the KDEL motif (Figure 3.7). However, whether this 
EEVD-like motif of Grp94 is able to interact with TPR domains has not been demonstrated.   
DNAJC3 is usually inactive in the cell under normal conditions due to its association with its own 
repressor protein, p88rIPK, which inhibits DNAJC3’s inhibitory effects on PKR activity by binding 
to the seventh TPR motif via an unknown mechanism (Gale et al., 1998, 2002, Luig et al., 2010). 
Previous studies have shown that a region at the N-terminus of p88rIPK shared limited structural 
homology with the charged linker region of Hsp90 (Gale et al., 1998). From the multiple sequence 
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alignment of Hsp90 isoforms, both Grp94 and the cytosolic Hsp90 isoforms have a charged linker 
region and this region is highly conserved (Figure 3.7).  
The identified region on p88rIPK (86 – 200 amino acids) and the charged linker regions of Hsp90 
(170 – 300 amino acids) and Grp94 (231 – 346 amino acids) (Figure 3.8, A) were aligned using 
Promals3D to determine whether p88rIPK shared structural homology with Grp94 (Figure 3.8, B). 
The alignment results illustrated a lack of primary sequence conservation between the three 
proteins as illustrated by the absence of numbers above the alignment representing the degree of 
conservation between aligned residues. However, the region of p88rIPK seemed to share some 
degree of structural homology with both Hsp90 and Grp94 as indicated by the red residues and the 
highlighted “h” under the alignment, which represent predicted alpha helical structures (Figure 
3.8, B). 
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Figure 3.7: Multiple sequence alignment of Hsp90 protein sequences. Multiple sequence alignment generated by Promals3D and edited using 
BioEdit. Residues highlighted as follows: black shading represents identical residues and grey shading represents similar residues. The charged linker region is 
underlined by a dashed black line, the EEVD motif and EEVD-like motif in Grp94 is indicated by a dashed black box and the KDEL by a solid black box.
73 
 
 
 
Figure 3.8: DNAJC3 inhibitor p88rIPK shares limited structural homology with the charged 
linker regions of Hsp90 and Grp94. (A) Schematic representation of structural homology between p88rIPK, 
Hsp90 and Grp94. The area highlighted in black indicates the region of p88rIPK (residues 86 – 200) that shares limited 
homology with the charged linker region of Hsp90 (residues 170 – 300) and Grp94 (residues 231 – 346). (B) Multiple 
sequence alignment of p88rIPK and the charged linker regions of Hsp90 and Grp94. Residues in blue (e highlighted in 
blue) and red (h highlighted in pink) represent beta sheets and alpha helices, respectively. Highly conserved residues 
are marked by bold uppercase letters, + represent positively charged residues, b represents bulky residues, h represents 
hydrophobic residues, l represents aliphatic residues p represents polar residues, c represents charged residues, s 
represents small residues, o represents alcohol residues and the number above the residues represent degree of 
conservation.  
 
3.2.2.5 Analysis of DNAJC3 TPR domains and structural homologues 
The bioinformatics analyses conducted on the TPR domains of DNAJC3, suggested that the 
domains cannot interact with the EEVD motifs of Hsp90 and Hsp70 due to the absence of the 
carboxylate clamp forming residues. We therefore conducted analysis into deducing possible 
alternative functions of the three TPR domains of DNAJC3 based on structural information. 
Structural homologues of each TPR domain were identified using the HHpred server. Majority of 
identified homologues have functions independent of Hsp90 and Hsp70 such as peptidyprolyl 
isomerase, PEX-5, PEX-related protein, MamA, PcrH and SycD. However, known co-chaperones 
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of Hsp90 and Hsp70, HOP and SGT were also identified as structural homologues of DNAJC3 
TPR domains (Table 3.2). 
The first analysis conducted was multiple sequence alignment using Promals3D, alignment was 
conducted for each DNAJC3 TPR domain and its identified structural homologues (Figure 3.9, 
3.10, 3.11). 
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Table 3.2: Summary of the identified structural homologues of DNAJC3 TPR domains  
PDB ID Protein name Function  Reference 
1A17 PP5 Serine/threonine phosphatase protein, responsible for the dephosphorylation 
of various proteins, ensuring the regulation of numerous cellular processes.  
Barford, 1996, Das et al., 1998 
1ELR HOP TPR-2A TPR domain in HOP known to interact with Hsp90 Scheufler et al., 2000, Odunuga et al., 
2003, Southworth and Agard, 2011, 
Lee et al., 2012 
1ELW HOP TPR-1 TPR domain in HOP known to interact with Hsp70 Scheufler et al., 2000, Southworth and 
Agard, 2011, Lee et al., 2012 
1HXI PEX-5 Receptor involved in protein import into the peroxisomal matix.  Schliebs et al., 1999, Kumar et al., 
2001 
1ZU2 TOM20 Importer receptor involved in the import of proteins from the cytosol into the 
mitochondria 
Lithgow et al., 1995, Perry et al., 2006 
2C2L CHIP Ubiqutin protein ligase, known to modulate the chaperone activity of Hsp90 
and Hsp70  
Ballinger et al., 1999, Zhang et al., 
2005 
2LNI HOP TPR-2B Third TPR domain in HOP, function unknown but though to contribute to the 
dimerization of HOP 
Longshaw et al., 2009, Southworth 
and Agard, 2011, Lee et al., 2012, 
Tang et al., Unpublished (pdb 
structure) 
2VGX SycD Cytosolic protein necessary for the secretion of the YopE and YopH proteins 
in Yersinia 
Woestyn et al., 1996, Neyt and 
Cornelis, 1999, Büttner et al., 2008,  
Schreiner and Neimann, 2012 
2XCB PcrH Pseudomonas translocator chaperone  Job et al., 2010 
3RKV Peptidylprolyl 
isomerase 
Known to catalyze the cis-trans isomerisation of proline peptide bonds in 
folded and unfolded proteins  
Fischer et al., 1989, Osipuik et al., 
Unpublished (pdb structure) 
3SZ7 SGT Known to interact and modified by parvovirus non-structural proteins Cziepluch et al., 1998, Chartron et al., 
2011 
3VTX MamA Involved in controlling the assemble of biomineralized magnotosomes in 
magnetotatic bacteria  
Zeytuni et al., 2011 
4EQF PEX-5 related protein Accessory subunit for the hyperpolarization-activated cyclic nucleotide-gate 
(HCN) channels  
Santoro et al., 2011, Bankston et al., 
2012 
4GA2 E3 SUMO-protein 
ligase 
Involved in the SUMOylation of various proteins  Chu and Yang, 2011, Kussube et al., 
2012 
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Figure 3.9: Promals3D multiple sequence alignment of DNAJC3 TPR1 and structural homologues retrieved from HHPred. 
Multiple sequence alignment of DNAJC3 TPR1 and homologues: 1A17 (PP5), 1ELR (HOP TPR-2A), 1ELW (HOP TPR-1), 1ZU2 (TOM20), 3SZ7 (SGT), 3VTX 
(MamA) and 4EQF (PEX-related protein) and 4GA2 (E3 SUMO-protein ligase). Black and grey highlight identical and similar amino acids, respectively. The 
black arrows represent predicted helical secondary structure. 
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Figure 3.10: Promals3D multiple sequence alignment of DNAJC3 TPR2 and structural homologues retrieved from HHPred. 
Multiple sequence alignment of DNAJC3 TPR2 and homologues: 1ELR (HOP TPR-2A), 1ZU2 (TOM20), 2C2L (CHIP), 2LNI (HOP TPR-2B), 2VGX (Chaperone 
SycD), 3SZ7 (SGT), (3VTX MamA) and 4GA2 (E3 sumo-protein ligase).  Black and grey highlight identical and similar amino acids, respectively. The black 
arrows represent predicted helical secondary structure. 
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Figure 3.11: Promals3D multiple sequence alignment of DNAJC3 TPR3 and structural homologues retrieved from HHPred. 
Multiple sequence alignment of DNAJC3 TPR3 and homologues: 1A17 (PP5), 1HX1 (PEX-5), 1ZU2 (TOM20), 2VGX (Chaperone SycD), 2XCB (Regulatory 
protein PcrH), 3RKV (Peptidyprolyl isomerase), 3SZ7 (SGT), 4GA2 (E3 sumo-protein ligase). Black and grey highlight identical and similar amino acids, 
respectively. The black arrows represent predicted helical secondary structures.  
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Multiple sequence alignment was conducted to determine sequence conservation between 
DNAJC3 TPR domains and their identified structural homologues. Sequence conservation could 
indicate similarities between DNAJC3 TPR domains and structural homologues absent in the 
alignment previously conducted with known co-chaperones of Hsp90 and Hsp70 (Figure 3.4). 
Some of the identified homologues (PP5, HOP TPR-1 and HOP TPR-2A), had previously been 
aligned with DNAJC3 TPR domains. It was pertinent to determine whether the presence of 
additional TPR-containing proteins with different functions could alter the alignment and illustrate 
sequence similarities that were not detected in the previous alignments. Similar to the previous 
analysis, there was no sequence conservation observed (Figure 3.9, 3.10, 3.11). However, the 
alignment indicated that the sequences seemed to be grouped in large clusters followed by smaller 
ones. Promals3D results output identified these clusters as alpha helices (black arrows, Figure 3.9, 
3.10, 3.11), suggesting that there was conservation of the proteins at the secondary structure level, 
despite the lack of identity or similarity at the primary sequence level. The absence of sequence 
conservation or similarity observed in this analysis was similar to that found in literature. TPR 
domains are known to not share sequence conservation or similarity with the exception of the TPR 
motif consensus sequence (D’Andrea and Regan, 2003). In light of this observation, it was decided 
to analyze conservation at secondary and tertiary structure level. Structural alignments of the 
putative structural homologues to DNAJC3 TPR domains was conducted, analyzed and visualized 
in Pymol. The root mean square deviation (RMSD) value obtained for each structural alignment 
is also illustrated (Figure 3.12, 3.13, 3.14). 
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Figure 3.12: Structural alignment of HHpred identified homologues and DNAJC3 TPR1 domain in Pymol. DNAJC3 TPR1 domain  
(green) and structural homologues: PP5/ 1A17 (light blue), HOP TPR-1/ 1ELW (yellow), SGT/3SZ7 (grey), MamA/3VTX (blue), PEX-5 related protein/4EQF 
(orange), TOM20/1ZU2 (pink), E3 SUMO-protein ligase/4GA2 (sand) and HOP TPR-2A/1ELR (light purple). The RMSD value for each alignment is also 
presented with the structural alignment. 
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Figure 3.13: Structural alignment of HHpred identified homologues and DNAJC3 TPR2 domain in Pymol. DNAJC3 TPR2 (green) 
and structural homologues: TOM20/1ZU2 (pink), HOP TPR-2A/1ELR (light purple), CHIP/2C2L (maroon), HOP TPR-2B/2LNI (dark blue), chaperone 
SycD/2VGX (dark grey), SGT/3SZ7 (grey), MamA (blue) and E3 SUMO-protein ligase/4GA2 (sand). The RMSD value for each alignment is also presented with 
the structural alignment. 
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Figure 3.14: Structural alignment of HHpred identified homologues and DNAJC3 TPR3 domain in Pymol. DNAJC3 TPR3 (green) 
and structural homologues: PP5/1A17 (light blue), TOM20/1ZU2 (pink), chaperone SycD/2VGX (dark grey), regulatory protein PcrH/2XCB (magenta), 
peptidylprolyl isomerase/3RKV (dark pink), SGT/3SZ7 (grey), E3 SUMO-protein ligase/ 4GA2 (sand) and PEX-5/1HXI (peach). The RMSD value for each 
alignment is also presented with the structural alignment. 
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When a structural alignment is conducted between two structures, a root mean-square deviation 
(RMSD) value is generated as an indicator of structural similarity. The RMSD is a quantitative 
measurement of the similarity between equivalent atoms from two protein structures (Carugo and 
Pongor, 2001). RMSD values of 0 indicates identical structures or a good alignment, while an 
increase in the value represents structural differences between molecules (Carugo and Pongor, 
2001).  
Out of the eight structural homologues of DNAJC3 TPR1, HOP TPR-1 and STG displayed the 
lowest and highest RMSD value of 1.226 and 8.555, respectively (Figure 3.12). For DNAJC3 
TPR2, MamA (1.332) and HOP TPR-2A (8.555) displayed the highest and lowest RMSD values 
(Figure 3.13), while PcrH (0.248) and PEX-5 (13.119) had the highest and lowest RMSD values, 
respectively out of DNAJC3 TPR3 identified homologues (Figure 3.14).  
Although the RSMD value is considered a dependable measurement of structural similarity 
between aligned structures, visual analysis of the alignment also needs to be considered to ensure 
that RMSD value is a true representation of the alignment. RMSD values generated during the 
alignments are influenced by the number of alpha carbon atoms aligned between the structures 
(Carugo and Pongor, 2001). If few atoms are aligned, the RMSD generated might be closer to 0 
which could give the false impression that the two structures align perfectly, whilst only a small 
portion of the structures align and the majority of the structures are not aligned or have poor 
alignment. In contrast, although a RMSD value greater than 5 usually represents poor alignment, 
depicting poor alignment of the overall structure, visual analysis might be able to identify small 
regions within the alignment that are significant to the study and may have been missed if 
considering the RMSD value alone. Structural analysis was conducted and presented using Pymol 
(Figure 3.12, 3.13, 3.14). 
DNAJC3 and structural homologues TPR domains are made up of alpha helices joined by short 
loops, with the only difference between the structures being the number and length of the different 
helices (Figure 3.12, 3.13, 3.14). This observation coincides with the known structural features of 
TPR motifs, where each motif is arranged as a helix turn helix structure (D’Andrea and Regan, 
2003). The structures with the least structural alignment to DNAJC3 TPR1 based on visual analysis 
were MamA, PEX-5 related protein, TOM20 and SGT (Figure 3.12). The best alignment was 
observed for the co-chaperones PP5 and HOP TPR-1, while the alignment for E3 SUMO-protein 
ligase and HOP TPR-2A were considered acceptable (Figure 3.10). Visual analysis of DNAJC3 
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TPR2 and homologue alignment (Figure 3.13), illustrated that, while all the alignments were poor, 
HOP TPR-2A, HOP TPR-2B and MamA, had better structural alignment to DNAJC3 TPR2, while 
TOM20, SycD and SGT had the worst alignment (Figure 3.13). Unlike the other domains, 
DNAJC3 TPR3 had only two homologues that showed acceptable structural alignment, PcrH and 
E3 SUMO-protein ligase, although only a small part of the structures aligned (Figure 3.14). The 
remaining homologues showed little to no alignment to DNAJC3 TPR3, as illustrated by the 
absence of any contact between the two structures (Figure 3.14). When compared, the RMSD 
values and visual structural alignment results seemed to correlate in terms of best and worst 
alignments, although there were some discrepancies between the RMSD value and the visual 
analysis.  
3.2.2.6 Electrostatic potential analysis of identified structural homologues of DNAJC3 TPR 
domains 
Subsequent to the structural alignment results (section 3.2.2.5), electrostatic potential analysis was 
conducted on identified homologues, as electrostatic charge distribution is known to participate in 
protein-protein interaction between TPR domains and substrates. Electrostatic potential analysis 
was conducted in a manner similar to that described in section 3.2.2.5. Analysis was focused on 
the groove of the TPR domain (Figure 3.15). The electrostatic charge distribution of the analysed 
TPR domain grooves varied vastly (Figure 3.5). TOM20, PEX-5, PEX-5 related protein, SycD and 
regulatory protein PcrH had had negatively charged grooves, while SGT, HOP TPR-1/2A, E3 
SUMO-protein ligase and PP5 had positively charged TPR grooves and MamA and HOP TPR-2B 
were the only proteins with TPR grooves that were mainly neutral (Figure 3.5). It was observed 
that HOP TPR-1/2A, SGT, PP5, and CHIP, which are known co-chaperones of Hsp90 and Hsp70, 
possessed positively charged grooves. Based on electrostatic potential analysis, DNAJC3 TPR1 
was found to be more similar to HOP TPR-1, while DNAJC3 TPR3 was most similar to TOM20 
and PcrH. However, none of the electrostatic distribution patterns of structural homologues 
resembled that of DNAJC3 TPR2. Overall, based on the electrostatic charge potential analysis and 
structural alignment (visual analysis and RMSD value), HOP TPR-1, MamA and PcrH were 
thought to be more similar to DNAJC3 TPR1, TPR2 and TPR3, respectively (Figure 3.16). These 
results suggested that DNAJC3 TPR domains may function in a similar manner to the identified 
structural homologues. It was also interesting to note that for DNAJC3 TPR2 and TPR3, the 
homologues identified to be most similar have functions independent of Hsp90 and Hsp70. 
85 
 
 
 
Figure 3.15: Electrostatic potential analysis of DNAJC3 TPR domains structural homologues. Red represents negative charged regions, 
white represents neutral regions and blue represents positively charged regions. 
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Figure 3.16: DNAJC3 TPR domains are more similar to TPR-containing proteins that 
have independent functions to Hsp90 and Hsp70, with the exception of DNAJC3 TPR1. 
Red represents negatively charged regions, white represents neutral regions and blue represents positively charged 
regions of the protein.  
 
3.3 Discussion 
Analysis of DNAJC3 from various species through multiple sequence alignment and 
phylogenetic analysis revealed that the protein was highly conserved, although that of species 
from the insect and plant families were least similar to that of mammals, with sequence 
similarity as low as 45 % and 30 %, respectively. Although, there were differences found in 
the DNAJC3 proteins from various species, it was noted that the structural arrangement of the 
protein domains was highly similar. This high degree of structural conservation could suggest 
functional similarity of the protein within different species. Motif identification of DNAJC3 
identified an ER signal peptide at the N-terminus, eight TPR motifs in the middle and a J 
domain at the C terminus, similar to the findings of Kampinga and Craig (2004), although most 
literature list the number of TPR motifs as nine (Tao et al., 2010 and Svärd et al., 2011). The 
discrepancy in the number of TPR motifs could be linked to the middle TPR domain. Each 
TPR motif is made up of two helical structures and a TPR domain made up of three or more 
TPR motifs.  When looking at the structure of DNAJC3, the middle domain was only composed 
of five helical structures and the sixth helical structure usually counted as part of this domain 
is an extended helix between the first and middle TPR domains. This extended helix has been 
shown to function more as stabilizing, solubilizing or capping helix at the C terminus of a TPR 
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domain. Although first discovered in PP5, it has been shown that the extended helix is not 
unique to PP5 but has been seen in almost all TPR structures resolved to date (D’Andrea and 
Regan, 2003). This possibly suggests that DNAJC3 has only two functional domains, TPR1 
and TPR3, since they are made up of three TPR motifs, which is one of the requirements for a 
TPR domain to be considered functional (Lamb et al., 1995). This suggested that DNAJC3 
TPR2 might function more as a linker region responsible for structural flexibility rather than a 
functional domain and could explain how an elongated protein like DNAJC3 could possibly 
pass substrates bound by TPR1 to Grp78 during its co-chaperoning activities (Tao et al., 2010). 
However, even though TPR2 of DNAJC3 could possibly be non-functional, it can still be 
involved in protein-protein interactions, as TPR motif 6 has been shown to be the possible 
binding site for PKR during the inhibitory function of DNAJC3 during viral infection (Gale et 
al., 1996).  
Multiple sequence alignment of the three identified DNAJC3 TPR domains with TPR domains 
of known Hsp90 and Hsp70 co-chaperones (Figure 3.4), revealed that although DNAJC3 TPR 
domains contained the majority of the TPR consensus sequence (D’Andrea and Regan, 2003), 
conserved residues necessary for the formation of the carboxylate clamp involved in the 
protein-protein interaction with the EEVD of Hsp90 or Hsp70 and Hsp90 and Hsp70 specificity 
residues (Scheufler et al., 2000, Odunuga et al., 2003), were absent. Tao et al. (2010) found 
similar results when they aligned mouse DNAJC3 TPR domains to that of HOP TPR-1, 
TOM70, PP5 and CHIP (Tao et al., 2010). The carboxylate clamp residues have been shown 
to be necessary for the formation of a positively charged TPR groove that is needed to for stable 
interactions with the EEVD motif as the clamp residues are involved in direct physical contact 
with the EEVD motif through hydrogen bonds (Scheufler et al., 2000 and Odunuga et al., 
2003).  
Electrostatic potential analysis showed that similar to the analysis conducted by Tao et al., 
(2010) the groove of DNAJC3 TPR1 was mainly neutral, while both TPR2 and three grooves 
were negatively charged (Figure 2. 5) suggesting that the absence of a positively charge groove 
prevented DNAJC3 TPR domains from creating the necessary environment needed to form a 
stable interaction with the EEVD motifs. Also, the absence of the carboxylate clamp residues 
would prevent the formation of physical contact in the form of hydrogen bonds between 
DNAJC3 TPR domains, due to the clamp corresponding residues being mostly uncharged and 
in addition, the size of the side chains lacked the bulk of the clamp residues preventing the 
residues from protruding further into the region were the interaction occurred (Figure 3.6). 
However, when the corresponding clamp residue on DNAJC3 TPR domains were mutated to 
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carboxylate clamp residues, the electrostatic potential distribution of DNAJC3 TPR1 changed 
to resemble that of HOP TPR-1, containing a positively charge groove in the middle, and also 
the charge and bulky size of the mutated residues extend into the space where the EEVD motif 
was docked, increasing the chances of a physical interaction occurring. Since the positive 
charge of HOP TPR-1 groove is known to play a vital role in the interaction with the negatively 
charges EEVD motif of Hsp70 (Kajander et al., 2009), the change in the groove of DNAJC3 
TPR1 to resemble that of HOP TPR-1 might suggest that the mutated domain has the potential 
to interact with the EEVD motif.   
Since the Hsp70 and Hsp90 ER homologues, Grp78 and Grp94, are known to lack the EEVD 
motif at the C-terminus, the absence of the carboxylate forming clamp residues might be a 
direct response and an adaptation for DNAJC3 to form other interactions with Grp78 and 
Grp94 that do not involve the EEVD motif. Alternatively, the absence of those residues 
suggested that the TPR domains of DNAJC3 might be adapted for protein-protein interactions 
that might be not be linked to co-chaperoning activity. However, the charged linker regions of 
Hsp90 has been shown to share limited structural homologue with the N terminal region of 
p88rIPK, the natural repressor of DNAJC3 (Gale et al., 2002) and this study extended that known 
observation to include the linker region of Grp94 (Figure 3.8, B).This may be a possible 
alternative binding site between Hsp90 or Grp94 and DNAJC3 TPR domains which is 
independent of the EEVD motif and carboxylate clamp forming residues. Full length DNAJC3 
has been shown to be part of a complex with Grp94 through a pull down assay (Jansen et al., 
2012), but whether this is due to a direct or indirect interaction remains unclear.  
The lack of sequence conservation or similarity between DNAJC3 TPR domains and known 
TPR co-chaperones suggests that the DNAJC3 TPR domains might be involved in protein-
protein interactions independent of Hsp90 or Hsp70. Multiple sequence alignment of DNAJC3 
TPR domains and TPR-containing structural homologues highlighted the lack of sequence 
conservation or similarity, however when structural alignment was conducted, conservation 
was observed in the helical structure of the TPR domain as previously shown within all TPR 
domains (D’Andrea and Regan, 2003). Although all TPR domains are known to have a helical 
structure, structural alignment, along with the RMSD values, also identified HOP TPR-1, 
MamA and the regulatory protein, PcrH as the homologues with the highest degree of structural 
similarity to DNAJC3 TPR1, 2 and 3, respectively. 
Several studies have indicated that certain protein-protein interactions involving TPR domains 
were mediated by the electrostatic distribution on the surface of the proteins, as seen in the case 
of interactions between TPR domains and Hsp90/70 EEVD motifs. When compared to the 
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electrostatic potential of the structural homologues, DNAJC3 TPR1 domain was mostly similar 
to HOP-TPR-1, the TPR domain on HOP known to interact with the EEVD motif of Hsp70 
(Scheufler et al., 2000, Odunuga et al., 2003). The electrostatic potential of DNAJC3 TPR2 
was found to be more similar to that of MamA, an adaptor protein involved in controlling the 
assembly of biomineralized magnotosomes in magnetotatic bacteria (Zeytuni et al., 2011), 
suggesting it functions as a scaffolding protein. The electrostatic potential of DNAJC3 TPR3, 
which was mainly negative, was found to be similar to a large array of the analyzed structural 
homologues. The electrostatic distribution pattern of the latter was similar to that of PEX-5, 
TOM20, PcrH, SycD and PEX-5 related protein. Since the function and interacting partners of 
the listed proteins varies immensely, which hints at a large array of potential binding partners 
for DNAJC3 TPR3. Based on structural alignment, RMSD values and electrostatic potential 
distribution, PcrH was found to be most similar to DNAJC3 TPR3. PcrH is known to function 
as a chaperone for translocator proteins PopB and PopD, the end result being a functional 
translocon that ensures efficient substrate translocation (Page and Parsot, 2002, Parsot et al., 
2003). Since DNAJC3 is known to translocate from the cytosol to the ER lumen, the presence 
of a TPR domain such as TPR3, that is highly similar to translocator TPR proteins, could 
suggest that DNAJC3 might also function as a chaperone for translocator proteins that are 
involved in the translocation of substrates from the cytosol to the ER lumen. However, no 
studies have been conducted to determine whether DNAJC3 can function as a chaperone, 
independent of Hsp70 and or Hsp90 nor have there been reports of additional functions and 
binding properties of its TPR domains. 
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Chapter 4: Development of bacterial systems to over-
express DNAJC3 and other chaperones for functional 
studies. 
 
4.1 Introduction 
Similar to other DNAJ proteins, the J-domain of DNAJC3 has been shown to be able to 
stimulate the ATPase activity of Grp78 during UPR caused due to ER stress, where it helps to 
restore ER homeostasis (Oyadomari et al., 2006, Rutkowski et al., 2007, Tao et al., 2010; Svärd 
et al., 2011). DNAJC3 also stimulates the ATPase activity of Hsp70 during Influenza virus 
infection (Melville et al., 1999). In addition, although DNAJC3 is known to also have three 
functional TPR domains, at present a proposed function for these domains is limited to TPR1, 
which is thought to interact with denatured proteins (Tao et al., 2010 and Svärd et al., 2011). 
In order to elucidate additional functions of DNAJC3 TPR domains, recombinant proteins were 
required. Hence, the main aim of this chapter was to engineer bacterial constructs for the 
expression of DNAJC3 for utilization in biophysical characterization analysis. The objectives 
were to: 
 Construct bacterial expression systems for DNAJC3 
 Overexpress and purify GST-tagged DNAJC3FL and DNAJC3dJ protein 
 Overexpress and purify of chaperone proteins for interaction studies 
4.2 Results 
4.2.1 Cloning, overexpression and purification of GST-tagged DNAJC3 recombinant 
proteins 
In order to generate GST-tagged DNAJC3FL and DNAJC3dJ bacterial expression vectors, 
from mammalian expression vectors, the mP58.FL1-pCDNA3 (Addgene, 21883) and 
mP58.dJ1-pCDNA3 (Addgene, 21884) plasmids were first verified by restriction analysis 
using the enzymes BamH1 and Xho1 (Figure 4.1, A and B).  
91 
 
 
 
Figure 4.1: Verification of mP58.FL1-pCDNA3 and mP58.dJ1-pCDNA3 constructs by 
restriction analysis. Plasmid map of (A) mP58.FL1-pCDNA3 and (B) mP58.dJ1.pCDNA3 constructed using 
BioEdit software. The pCDNA vector has an ampicillin resistance gene (Amp_R) used for selective screening. 
The construct is lacking a tag on either side of the insert, which is flanked between the restriction enzyme sites, 
BamH1 and Xho1. Restriction analysis of the (A) mP58.FL1-pCDNA3 and (B) mP58.dJ1.pCDNA3 plasmid using 
the restriction enzymes BamH1 and Xho1. The restriction plasmid DNA was resolved on a 1% agarose gel. Lane 
1: Lambda DNA digested with Pst1, Lane 2: mP58.FL1-pCDNA3 or mP58.dJ1.pCDNA3 digested with BamH1 
and Xho1. The arrows indicate the pCDNA3 backbone and the DNAJC3FL or DNAJC3dJ DNA fragment. The 
expected sizes of the pCDNA3 vector and DNAJC3FL and DNAJC3dJ DNA fragment are 5446 bp, 1841 bp and 
1329 bp respectively. 
 
The coding regions for DNAJC3FL and DNAJC3dJ were digested from mP58.FL1-pCDNA3 
and mP58.dJ1-pCDNA3 plasmids using the restriction sites (BamH1 and Xho1) and ligated 
into pGEX4T-1 vector in frame with the GST tag resulting in the expression vectors 
pLZMC3FL and pLZMC3dJ (Figure 4.2), which encoded for GST-tagged DNAJC3FL and 
DNAJC3dJ. The resulting GST-tagged DNAJC3FL and DNAJC3dJ expression constructs 
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were confirmed by restriction digest analysis (Figure 4.2, A and B) and sequencing (data not 
shown). 
 
 
 
Figure 4.2: Verification of the GST-tagged DNAJC3FL and DNAJC3dJ expression 
constructs pLZMC3FL and pLZMC3dJ by restriction analysis. Plasmid map of (A) 
pLZMC3FL and (B) pLZMC3dJ constructed using BioEdit software. The pGEX4T-1 vector has an ampicillin 
resistance gene (Amp_R) used for selective screening. The GST tag is located upstream of the PCR fragment, 
which is shown between the restriction enzyme sites, BamH1 and Xho1, used for ligation. Restriction analysis of 
the (A) pLZMC3FL and (B) pLZMC3dJ plasmid using the restriction enzymes BamH1 and Xho1. The restriction 
plasmid DNA was resolved on a 1% agarose gel. Lane 1: Lambda DNA digested with Pst1, Lane 2: pLZMC3FL 
or pLZMC3dJ digested with BamH1 and Xho1. The arrows indicate the pGEX4T-1 backbone and the DNAJC3FL 
or DNAJC3dJ DNA fragment. The expected sizes of the pGEX4T-1 vector and DNAJC3FL and DNAJC3dJ DNA 
fragment is 4960 bp, 1841 bp and 1329 bp respectively. 
 
Expression of GST-tagged DNAJC3FL and DNAJC3 proteins was optimised in various E. coli 
expression strains (Table 2.2, Figure 4.3, A-E) and using a range of IPTG concentrations and 
expression temperatures. Examples of the expression profiles from selected optimization 
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treatments are shown in Figure 4.3. Despite repeated efforts at optimization, substantial protein 
expression was not observed. 
 
 
Figure 4.3: SDS-PAGE analysis of the expression profile of GST-tagged DNAJC3FL and 
GST-tagged DNAJC3dJ proteins in various E. coli expression strains. Expression of GST-
tagged DNAJC3Fl and GST-tagged DNAJC3dJ in (A and B) BL21 (DE3) cells, (C and D) BL21 C43 (DE3) cells 
and (E and F) BB1994 cells. Lane M: Molecular marker, Lanes 0-4: DNAJC3FL and DNAJC3dJ protein samples 
collected at hourly intervals from 0 to 4 hours post induction with 1mM IPTG. 
 
SDS-PAGE and Western blot analysis of both proteins samples at 0 to 3 hours post induction 
in a selected expression strains (BL21 C41 (DE3) E. coli cells) using GST specific antibodies 
indicated the presence of bands at 26 and 30 kDa band and not the expected bands at 85 kDa 
and 70 kDa, which should have corresponded to GST-tagged DNAJC3FL and DNAJC3dJ, 
respectively (Figure 4.4, A and B). 
 
94 
 
 
 
Figure 4.4: SDS-PAGE and Western analysis of GST-tagged DNAJC3FL and DNAJC3dJ 
in BL21 C41 (DE3) cells. (A) SDS-PAGE and (B) Western analysis of the expression profile of GST-tagged 
DNAJC3FL and DNAJC3dJ using anti-GST antibodies. Lane M: Molecular marker, Lanes 0-3: DNAJC3FL and 
DNAJC3dJ protein samples collected at hourly intervals from 0 to 3 hours post induction with 1 mM IPTG. 
 
The lack of GST-tagged DNAJC3FL and DNAJC3dJ protein detected following induction 
suggested that there was a problem in expressing both proteins in the current form. The 
DNAJC3 protein is known to have a cleavable ER signal peptide at the N terminus, a signal 
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peptide which was present in the initial construct (Figure 4.5, A and B, Rutkowski et al., 2007). 
The cleavage of the ER signal peptide after protein synthesis in E. coli could explain the 
observation of only a 30 kDa protein during western blot analysis (Figure 4.4, B). This band 
could possible represent the GST tag and the ER signal peptide (Figure 4.5, A), since the 
pGEX4T-1 vector used encoded an N-terminal GST tag (Figure 4.2). This suggests that the 
remaining protein of the DNAJC3FL and DNAJC3dJ proteins were not detected using GST 
specific antibodies since it was no longer tagged. Alternatively, the truncated protein observed 
could be a consequence of the physical properties of the ER signal peptide, which consists of 
numerous hydrophobic amino acids as indicated by the Kyte and Doolittle plot (Figure 4.5, C). 
Regions above 0 represent hydrophobic residues and regions below 0 represent hydrophilic 
regions (Kyte and Doolittle, 1982). It was observed that the first 25 amino acid residues of 
DNAJC3 which code for the ER signal peptide, display values above 0 (Figure 4.5 C). This 
hydrophobic nature of the ER signal peptide could be causing early termination of protein 
synthesis, resulting in truncated GST-tagged DNAJC3 proteins. 
An alternative strategy for obtaining GST-tagged DNAJC3FL and DNAJC3dJ protein was 
formulated, and this involved removing the 25 amino acids at the N-terminus of the protein 
that made up the cleavable ER signal peptide Primers were designed to PCR amplify the coding 
regions of DNAJC3FL and DNAJC3dJ from the mP58.FL1-pCDNA3 plasmid, excluding the 
region that coded for the cleavable ER signal peptide (henceforth the coding regions lacking 
the ER signal peptide will be referred to as DNAJC3ΔER and DNAJC3ΔJ/ER) (Figure 4.6, A 
and C). The PCR fragments of DNAJC3ΔER and DNAJC3ΔJ/ER were ligated into the 
expression vector pGEX4T-1 using the restriction sites BamH1 and Xho1 introduced during 
the PCR procedure. Verification of the resulting constructs was conducted by restriction digest 
(Figure 4.6, B and D) and sequencing (data not shown). 
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Figure 4.5: DNAJC3 has a cleavable ER signal peptide that is highly hydrophobic. (A) 
Schematic representation of GST tagged DNAJC3 ER signal peptide. (B) SignalP3.0 prediction for the DNAJC3 
signal peptide (green line/region above pink dotted line), cleavable region (blue line) and cleavable site/residue 
(red line). (C) Kyte and Doolittle plot indicating the hydrophobic (values above 0) and hydrophilic regions (values 
below 0) of the DNAJC3 ER signal peptide 
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Figure 4.6: PCR cloning of bacterial expression vectors for DNAJC3ΔER and 
DNAJC3ΔJ/ER. PCR amplification of the coding region of (A) DNAJC3ΔER and (C) DNAJC3ΔJ/ER which 
excluded the ER signal peptide region. Lane 1: Lambda DNA digested with Pst1, Lane 2: PCR product. Plasmid 
map of (B) pLZMC3ΔER and (D) pLZMC3ΔJ/ER constructed using BioEdit software. The pGEX4T-1 vector 
has an ampicillin resistance gene (Amp_R) used for selective screening. The GST tag is located upstream of the 
PCR fragment, which is shown between the restriction enzyme sites, BamH1 and Xho1, used for ligation. 
Restriction digest analysis was carried out for the (B) pLZMC3ΔER and (D) pLZMC3ΔJ/ER plasmids using the 
restriction enzymes BamH1 and Xho1. The restriction digestion of the plasmid DNA was resolved on a 1% agarose 
gel. Lane 1: Lambda DNA digested with Pst1, Lane 2: pLZMC3ΔER or pLZMC3ΔJ/ER digested with BamH1 
and Xho1. The arrows indicate the pGEX4T-1 backbone and the DNAJC3ΔER or DNAJC3ΔJ/ER DNA fragment 
at the expected size of 4969 bp, 1700 bp and 1150 bp, respectively.  
 
Plasmids coding for the N terminus GST-tagged DNAJC3ΔER and DNAJC3ΔJ/ER proteins 
were transformed into competent E. coli BL21 (DE3) cells and 1 mM IPTG used to overexpress 
the proteins over 4 hours and the expression profile analyzed by SDS-PAGE (Figure 4.7, A 
and B). Analysis of the gel representing the expression profile of GST-tagged DNAJC3ΔER 
(Figure 4.7, A) showed a faint increase in the expression of a protein which resolved to a similar 
position as the 85 kDa marker band at 1 hour post induction. The expected size of GST-tagged 
DNAJC3ΔER was 75 kDa. The protein band observed could possibly represent DNAJC3ΔER 
being expressed, as the equivalent band is absent in the sample collected before induction (0 
hours). The expression profile gel of GST-tagged DNAJC3ΔJ/ER (Figure 4.7, B), in contrast 
showed an increase in protein resolving around 70 kDa, from 1 hour post induction. Since the 
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expected size of GST-tagged DNAJC3ΔJ/ER was 65 kDa, strongly suggesting that the protein 
observed around 70 kDa was the GST-tagged DNAJC3ΔJ/ER. Initial attempts to purify both 
GST-tagged DNAJC3ΔER and DNAJC3ΔJ/ER proteins revealed that the proteins were located 
in the pellet fraction, suggesting that the proteins were insoluble (Figure 4.7, C and D). 
 
 
 
Figure 4.7: Expression and purification of GST-tagged DNAJC3ΔER and GST-tagged 
DNAJC3ΔJ/ER. (A and B) Induction profile of GST-tagged DNAJC3ΔER and GST-tagged DNAJC3ΔJ/ER, 
respectively.  Lane M: Molecular marker, Lanes 0-5: protein samples collected at hourly intervals from 0 to 4hours 
post induction with 1mM IPTG. (C and D) GST batch purification of GST-tagged DNAJC3ΔER and GST-tagged 
DNAJC3ΔJ/ER. Lane M: Molecular weight marker, Lane TP: total protein fraction, Lane P: insoluble fraction, 
Lane S: soluble fraction, lane UB: unbound protein fraction, Lane W1-W3: wash fractions and Lane E1-E3: 
elution fractions. 
 
A solubility study was conducted using various modifications of the expression protocol or 
lysate preparation conditions in order to increase the yield of soluble protein. These 
modifications included the addition of various detergents (N-Laurylsarcosine [Sac], Nonidet-
P 40 [NP40], Tween-20 and Durrapol-2000 [Schlager et al., 2012]), modification of growth 
medium (glucose MM and auto-induction medium), use of additives including 2% (w/v) 
glucose ( San-Miguel et al., 2013) and 0.5 M sorbitol (Sandee et al., 2005) and induction and 
growth conditions including reducing the inducer concentration to 0.5 mM IPTG (Winograd et 
al. 1993) and using a lower induction temperature of 20 ˚C (Vasina and Baneyx, 1997) and a 
shorter induction time of 0.5 hours (for further details see section 2.12). 
SDS-PAGE analysis of the insoluble and soluble fractions from the treatments suggested that 
the protein was still located mainly in the insoluble protein fraction (Figure 4.8). Although not 
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obvious on the SDS-PAGE gels, western blot analysis of the soluble fractions from the various 
treatments proved that with the exception of the detergent treated samples, all other treatments 
resulted in an increase in soluble protein (Figure 4.9). Three GST-tagged bands were detected 
in the soluble fraction, one at 65 kDa, which was the expected size for GST-tagged 
DNAJC3ΔJ/ER, a second at 50 kDa, which could represent a truncated GST-tagged 
DNAJC3ΔJ/ER and the third at 26 kDa, which is the expected size of the GST tag.
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Figure: 4.8: SDS-PAGE analysis of the optimization of GST-tagged DNAJC3ΔJ/ER protein solubility by means of various treatments and 
growth conditions. TP: total protein, P: pellet fraction and S: soluble fraction.  
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Figure 4.9: Western analysis of the optimization of GST-tagged DNAJC3ΔJ/ER protein solubility by means of various treatments. Equivalent 
volume of soluble fraction derived from the same number of bacterial cells was loaded. Anti-GST antibodies were used for Western analysis. Lane 1: Pellet fraction from 
untreated sample. Lanes 2-13 represent the soluble fraction (Supernatant) from the following: Lane 2: Standard protocol (untreated), Lane 3: 7.5 % (v/v) Sac, Lane 4: Tween-
20, Lane 5: NP40, Lane 6: Durrapol-2000, Lane 7: expression for 0.5 hours, Lane 8: induced by 0. 5 mM IPTG, Lane 9: expressed at 20 ˚C, Lane 10: 2X YT supplemented 
with 2 % (w/v) glucose, Lane 11: 2X YT supplemented with 0.5 M sorbitol, Lane 12: Auto-induction medium and Lane 13: Glucose MM medium.  
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After optimization, expression of the GST-tagged DNAJC3ΔER and DNAJC3ΔJ/ER was induced 
at 18°C for 0.5 hours using 0.5 mM IPTG and purified as previously described. The success of the 
purification procedure was analyzed by SDS-PAGE and Western analysis. Despite numerous 
attempts at optimization, there was no improvement in the expression of GST-tagged 
DNAJC3ΔER protein (data not shown), which resulted in no protein being observed at the end of 
the purification procedure. In the case of DNAJC3ΔJ/ER, the combination of changing the 
expression temperature, time and inducer concentration, resulted in an increase in the solubility of 
GST-tagged DNAJC3ΔJ/ER, allowing better purification as indicated in SDS-PAGE and Western 
analysis by the presence of a protein band of about 65 kDa in the elution fraction after purification 
(Figure 4.10, A and B). Additional protein bands were also observed in the purified samples 
(Figure 4.10, A and B, Lanes 8-9), namely a 50 kDa protein which could represent a truncated 
GST-tagged DNAJC3ΔJ/ER and a 26 kDa protein, which could be the GST protein itself as it is 
known that this tag is 26 kDa in size. 
 
         
 
Figure 4.10: Batch purification of GST-tagged DNAJC3ΔJ/ER. (A) SDS-PAGE and (B) Western 
analysis using anti-GST antibodies. Lane M: Molecular weight marker, Lane TP: total protein fraction, Lane P: 
insoluble fraction, Lane S: soluble fraction, lane UB: unbound protein fraction, Lane W1-W3: wash fractions and 
Lane E1-E2: elution fractions. 
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4.2.2 Cloning, overexpression and purification of GST-tagged DNAJC7  
DNAJC7 is a known TPR-containing DNAJ similar to DNAJC3, which interacts with both Hsp90 
and Hsp70 (Brychzy et al., 2003, Moffatt et al., 2008). Because DNAJC7 is highly similar to 
DNAJC3, recombinant DNAJC7 protein would make an appropriate positive control during the 
binding interaction characterization of DNAJC3 TPR domains.  
Total RNA was successfully extracted from MCF-7 carcinoma cells using Trizol Reagent® 
(Figure 4.11, A). The isolated RNA was used to synthesize cDNA through RT-PCR and the 
resulting cDNA was used in the PCR amplification of the DNAJC7 gene. The PCR reaction was 
analyzed by agarose gel electrophoresis and two DNA products of approximately 1480 bp and 850 
bp were observed (Figure 4.10, B). The expected size of the DNAJC7 gene was 1484 bp, 
suggesting that the larger and fainter band observed on the gel was likely DNAJC7 and the smaller 
and brighter band might represent an alternative amplicon. The PCR product of DNAJC7 was 
inserted into the N-terminus GST-tagged expression vector pGEX4T-1 as previously described. 
Using the restriction sites introduced during the PCR procedure the coding region of DNAJC7 was 
ligated into pGEX4T-1 in frame with the GST tag resulting in the expression vector pLZMC7 
(Figure 4.11, C), which encoded GST-tagged DNAJC7. The pLZMC7 expression vector was 
verified by restriction digest analysis (Figure 4.11, D) and sequencing (data not shown). 
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Figure 4.11: Generation of a bacterial expression system for the over expression and 
purification of GST- tagged DNAJC7. (A) 1 % (w/v) agarose gel analysis of total RNA and DNA isolated 
from MCF-7 breast carcinoma. Lane 1: Lambda DNA digested with Pst1, Lane 3: Isolated total RNA, Lane 5: Isolated 
MCF-7 DNA.   (B) PCR amplification of DNAJC7 gene. Lane 1: Lambda DNA digested with Pst1, Lane 2: DNAJC 
7 PCR product. The expected size of DNAJC7 fragment was 1484 bp. (C) Plasmid map of pLZMC7 constructed using 
BioEdit software. The pGEX4T-1 vector has an ampicillin resistance gene (Amp_R) used for selective screening. The 
GST tag is located upstream of the DNAJC7 gene, which is shown between the restriction enzyme sites, BamH1 and 
Sal1, used for ligation. (D) Restriction analysis of the pLZMC7 plasmid using the restriction enzymes BamH1 and 
Sal1. The resulting plasmid DNA fragments were resolved on a 1% (w/v) agarose gel. Lane 1: Lambda DNA digested 
with Pst1, Lane 2: pLZMC7 digested with BamH1 and Sal1. The expected sized of pGEX4T-1 vector and DNAJC7 
DNA fragment were 4690 bp and 1483 bp, respectively. 
 
Expression of the GST protein (as a control) and GST-tagged DNAJC7 was conducted by 
transforming E. coli XL1 Blue cells with the pGEX4T-1 and pLZMC7 plasmids, and inducing 
protein production using 1 mM IPTG at 37 °C. Expression of the GST protein and GST-tagged 
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DNAJC7 was analyzed by SDS-PAGE (Figure 4.12, A and B). Protein expression for both proteins 
was observed from 1 hour post induction as indicated by the presence of a 26 kDa band on the 
GST protein expression gel (Figure 4.12, A) and a 85 kDa band on the GST-tagged DNAJC7 
expression profile acrylamide gel (Figure 4.12, B). Purification of the GST protein and GST-
tagged DNAJC7 was attempted using the GST affinity batch purification method. The success of 
the purification method was analyzed by SDS-PAGE (Figure 4.12, C and D). For the GST protein, 
the majority of the protein was soluble as indicated by the prominent band at 26 kDa in the 
supernatant fraction (Figure 4.12, C). However, purification of the GST-tagged DNAJC7 protein 
was unsuccessful since most of the protein was found to be insoluble as indicated by the presence 
of the bulk of the protein in the pellet fraction (data not shown). The addition of the detergent N-
Lauroylsarcosine (Sac) at a final concentration of 7.5% (v/v), which is known to increase protein 
solubility (Schlager et al., 2012), did not improve the solubility or purification of DNAJC7 (Figure 
4.12, D). 
 
              
 
Figure 4.12: Overexpression and batch purification of GST-tagged DNAJC7. (A and B) 
Expression profile of GST and GST-tagged DNAJC7, Lane 1: Molecular marker, Lanes 0-5: protein samples collected 
at hourly intervals from 0 to 5 hours post induction with 1mM IPTG. (C and D) GST batch purification of GST and 
GST-tagged DNAJC7, Lane M: Molecular weight marker, Lane TP: total protein fraction, Lane P: insoluble fraction, 
Lane S: soluble fraction, lane UB: unbound protein fraction, Lane W1-W3: wash fractions and Lane E1-E2: elution 
fractions. 
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4.2.3 Overexpression and purification of His-tagged Grp78 and Grp94284-543 
Plasmids coding for N terminal His-tagged Grp78/BiP and His-tagged Grp94284-543 (pQE10-BiP, 
a kind donation from Prof. Richard Zimmermann (Universität des Saarlandes, Germany) and 
HSP90B1 (Addgene plasmid, 39076), encoding the middle domain of Grp94 from residues 284-
543)) were transformed into M15 [pREP4] and BL21 (DE3) competent cells, respectively and 
protein production induced by addition of 1 mM IPTG at 37 °C for Grp78 and 0.5 mM IPTG at 18 
°C for Grp94284-543. SDS-PAGE was used to analyze the expression profile of the proteins (Figure 
4.13, A and B). An increase in the expression of protein of molecular weights of approximately70 
kDa and the 40 kDa were observed for Grp78 and Grp94284-543, respectively. These sizes 
corresponded to the expected sizes for both the latter proteins, which suggested that the protein 
bands represented His-tagged Grp78 and His-tagged Grp94284-543. Nickel affinity purification was 
successful in purifying both proteins as illustrated by the large amount of protein recovered in the 
elution fractions (Figure 4.13 C and D). 
 
 
Figure 4.13: Expression and purification of His-tagged Grp78 and His-tagged Grp94284-543 
(A) Expression profile of His-tagged Grp78. Lane M: Molecular marker, Lanes 0-6: protein samples collected at 
hourly intervals from 0 to 6 hours post induction with 1mM IPTG. (B) Expression profile of His-tagged Grp94284-543. 
Lane M: Molecular marker, Lanes 0-O/N: protein samples collected at hourly intervals from 0 to 3 hours and overnight 
post induction with 1mM IPTG. (C and D) Nickel affinity purification of His-tagged Grp78 and His-tagged Grp94284-
543 Lane M: Molecular weight marker, Lane TP: total protein fraction, Lane P: insoluble fraction, Lane S: soluble 
fraction, lane UB: unbound protein fraction, Lane W1-W3: wash fractions and Lane E1-E2: elution fractions. 
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4.3 Discussion 
In order to conduct biophysical characterization of DNAJC3, recombinant proteins had to be 
produced. Expression of recombinant proteins in bacterial systems followed by affinity 
purification is one of the ways utilized to accomplish this (Smith and Johnson, 1988, Guan and 
Dixon, 1991). For this study, two types of affinity purification tags, namely GST and His, were 
utilized to make purification of the proteins of interest possible from bacterial lysates. The use of 
different tags was required for the subsequent interaction studies, which required the bait and prey 
proteins to have different tags. The His tag is generally preferred as it is small, does not usually 
impact on the protein conformation and permits both native and denaturing purification procedure 
(Terpe, 2003). Although the GST tag is larger and known to dimerize, this tag was selected for the 
DNAJC3 constructs because it has been shown to increase protein solubility and improve protein 
folding (Kaplan et al., 1997), leading to good expression and recovery of expressed proteins. 
Despite this however, this was not the observed outcome in this study, as all GST-tagged proteins 
(DNAJC7, DNAJC3FL and DNAJC3dJ, DNAJC3ΔER and DNAJC3ΔJ/ER) were highly 
insoluble. The addition of the detergent, N-Laurylsarcosine during the lysis step of GST-tagged 
DNAJC7 expressing cells did not improve the protein solubility of the protein resulting in no 
protein being purified.  
Initial attempts were made to express both GST-tagged DNAJC3FL and DNAJC3dJ with the ER 
signal peptide still present at the N-terminus of the proteins. However it was observed in SDS-
PAGE analysis that full length GST-tagged DNAJC3FL and GST-tagged DNAJC3dJ were not 
being expressed, but rather a 30 kDa protein was observed in different expression strains (Figure 
4.3). Western analysis using GST specific antibodies (Figure 4.4, B) illustrated that the 30 kDa 
protein was GST-tagged, suggesting that this protein consisted of the GST tag (26 kDa) and the 
ER signal peptide (4 kDa), which has been shown to be cleavable at least in mammalian cell lines, 
and might be undergoing the same process in bacterial cells (Rutkowski et al., 2007, Figure 4.5, 
A and B). Alternatively, the hydrophobic nature of the ER signal peptide (Figure 4.5, C) could be 
causing early protein synthesis termination, as hydrophobic proteins like membrane proteins have 
been shown to promote protein unfolding and aggregation resulting in protein degradation 
(Schwarz et al., 2008). Cell-free expression systems have been used successfully in the production 
of hydrophobic recombinant proteins (membrane proteins) due to their ability to create an artificial 
hydrophobic environments which is able to maintain hydrophobic proteins in their soluble state 
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(Schwarz et al., 2008). Therefore, this may be a possible alternative method to use in the 
production of other proteins with large patches of hydrophobic residues such as the ER signal 
peptide of DNAJC3 (Figure 4.5, C). 
Alternative constructs (pLZMC3ΔER and pLZMC3ΔJ/ER) that removed the ER signal peptide 
were constructed, resulting in GST-tagged DNAJC3ΔER and DNAJC3ΔJ/ER, respectively. Both 
GST-tagged DNAJC3ΔER and DNAJC3ΔJ/ER were successfully expressed in BL21 (DE3) cells 
(Figure 4.7, A and B), although expression of GST-tagged DNAJC3ΔER was low. Initial attempts 
to purify GST-tagged DNAJC3ΔER and DNAJC3ΔJ/ER were unsuccessful (Figure 4.7, C and D), 
as most of the expressed protein was found to be in the insoluble fraction (pellet), prompting the 
need to improve the solubility of the proteins through various methods.  
Several methods are usually adopted when attempting to improve protein solubility, these could 
include changing expression strains, lowering expression time and temperature, altering 
concentration of the inducer, addicting additives to the media, co-expressing recombinant proteins 
with chaperones, cofactors or special plasmids (i.e. pRARE), changing the composition or type of 
media or using fusion proteins (Fox and Waugh, 2003, Golovanov et al., 2004, Sᴓrensen and 
Mortensen, 2005, Kobayashi et al., 2009, San-Miguel et al., 2013, Voulgaridou et al., 2013). In 
this study, several of the listed modifications were attempted to improve protein solubility. The 
first method tried was the use of various detergents, which are known to permeabilize membranes 
and release trapped proteins (Schlager et al., 2012). The following modification involved reducing 
the concentration of the inducer (IPTG), reducing the expression temperature and expression time. 
Reducing the inducer concentration, expression time or temperature is known to decrease the rate 
of protein synthesis, ensuring that synthesized proteins are folded correctly, preventing protein 
aggregation that normally occurs as a result of protein overcrowding caused by rapid protein 
synthesis and protein misfolding (Winograd et al., 1993, Vasina and Baneyx, 1997). The other 
modifications exploited were changing growth medium (auto induction medium and glucose 
minimum medium) or supplementation with additives such as sorbitol and glucose. Auto induction 
medium ensures that the rate of protein expression is reduced, while glucose minimum medium 
ensures tight regulation of the lac promoter, controlling expression. Addition of glucose to growth 
medium has been shown to repress induction of the lac operon by lactose thereby having a tighter 
control on the protein expression, in a way similar to that of glucose minimal medium (San-Miguel 
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et al., 2013), while sorbitol is known to stabilize the native structure of the protein, preventing 
unfolding and aggregation (Sandee et al., 2005).   
In this study, the addition of detergents did not improve the solubility of GST-tagged DNAJC3ER. 
However, solubility of DNAJC3ΔJ/ER was slightly improved by changing the growth medium 
and growth conditions. This suggested that GST-tagged DNAJC3ΔJ/ER was insoluble as a result 
of protein aggregation, rather than being trapped in membranes, since detergents which are known 
to permeabilize membranes (Bhairi and Mohan, 2007) were unable to improve DNAJC3ER 
solubility.  
In literature, a few studies have successfully expressed and purified the full length and truncated 
(without J domain) DNAJC3 with the ER signal peptide using a bacterial expression system. The 
majority of the studies used alternative tags such as the His-tag (Lee et al., 1994, Bilgin et al., 
2003, Svärd et al., 2011, Wen et al., 2011), HA-tag (Oyadomari et al., 2006), (GAL4 DNA binding 
domain) BD-tag (Gale et al., 1996) or  (DNA activation domain) AD-tag (Bilgin et al., 2003). Lee 
et al., also found DNAJC3 to be highly insoluble, and since they used the His-tag, they were able 
to use a denaturing and refolding purification protocol (Lee et al., 1994). However this approach 
cannot be used with a GST-tagged protein because the GST tag will also be denatured since it is a 
proteins that relies on the three-dimensional structure in order to bind to its ligand during affinity 
chromatography.  
In the few studies that have been able to purify GST-tagged DNAJC3 (Lee et al., 1994, Tan and 
Katze, 1998), the expression of DNAJC3 was induced with 0.1 or 1 mM IPTG at 37 °C for 3-4 
hours, which was similar to the original protocol utilized in this study. Studies have used the 
expression and purification protocol from Lee et al., for producing recombinant GST-tagged 
DNAJC3 (Gale et al., 1996, 1998, Melville et al., 1997, 1999, Yan et al., 2010), however none of 
these studies have ever published their purification results, making it difficult to compare the yield 
and purity of the purified protein. YanLong et al (2009) were able to express and purify a GST-
tagged DNAJC3 recombinant protein by using a specialized E. coli expression strain Rosetta 
(YanLong et al., 2009), however attempts to express DNAJC3 in specialized expression strains 
(BL21 C41 [DE3] and BL21 C43 [DE3]) were unsuccessful. 
Ultimately, the combination of lowering the expression temperature, time and IPTG concentration, 
resulted in increased solubility of the GST-tagged DNAJC3ΔJ/ER protein which allowed 
purification of sufficient quantities of the protein to be possible. Although GST-tagged 
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DNAJC3ΔJ/ER was purified successfully, two proteins at 50 kDa and 26 kDa were consistently 
being co-purified with DNAJC3ΔJ/ER, and through Western analysis with GST specific 
antibodies, were found to be GST-tagged (Figure 4.9). Although not conducted in this study, size 
exclusion chromatography could be performed on the elution fractions to remove the co-eluting 
contaminants. The presence of co-eluting contaminants in the elution fractions could negatively 
impact subsequent interaction assays as the contaminants have the potential to participate and 
influence the interaction results. However, the co-eluting contaminants in this study were 
determined to be GST tagged, suggesting that they were truncations of DNAJC3ΔJ/ER, hence size 
exclusion chromatography was not conducted.  Since the focus of the study was to evaluate binding 
by the TPR motifs within DNAJC3, these results were deemed sufficient to allow the in vitro 
interaction analysis using the DNAJC3ΔJ/ER protein. 
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Chapter 5: In vitro analysis of protein-protein interactions of 
DNAJC3 TPR domains 
 
5.1 Introduction 
DNAJC3 TPR domains lack the residues required to form the carboxylate clamp and the 
electrostatic charged environment necessary to form and maintain a stable interaction with the 
EEVD motifs of Hsp90 and Hsp70 (Figure 3.4, 3.5, 3.6) (Tao et al., 2010). The ER homologues 
of Hsp90 and Hsp70, Grp94 and Grp78 lack the EEVD motif at the C-terminal required to interact 
with TPR domains of co-chaperones such as HOP (Argon and Simen, 1999, Scheufler et al., 2000, 
Odunuga et al., 2003, Fewell et al., 2004). Although DNAJC3 interacts with and stimulates the 
ATPase activity of Hsp70 (Melville et al., 1999) and Grp78 (Oyadomari et al., 2006, Rutkowski 
et al., 2007, Tao et al., 2010; Svärd et al., 2011), this interaction is mediated by the J domain. 
DNAJC3 exists in a complex with Grp78 and Grp94 (Jansen et al., 2010), but it is unknown 
whether DNAJC3 and Grp94 interact directly. The protein p88rIPK, a known inhibitor of DNAJC3, 
has been shown to share limited structural homology with the charged linker region of Hsp90 (Gale 
et al., 1998) and in this study we have expanded this analysis to include the charged linker region 
of Grp94 (Figure 3.8, B). This chapter sought to test in vitro whether the TPR domains of DNAJC3 
to interact with chaperones. The specific objectives were to: 
 
 Determine whether DNAJC3 TPR domains interact with purified chaperones 
 Determine whether DNAJC3 TPR domains bind native and heat denatured substrates 
 Determine whether DNAJC3 TPR domains form complexes with heat denatured substrate, 
Grp78 and/or Grp94 in vitro 
 Determine whether DNAJC3 TPR domains have refoldase activity 
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5.2 Results 
5.2.1 DNAJC3 TPR domains do not form a direct interaction with Grp94 or Hsp90 
DNAJC3 TPR domains lack the residues crucial for the interaction with Hsp90 through the EEVD 
motif, while at the same time the ER homologue of Hsp90, Grp94 lacks the EEVD motif. (Argon 
and Simen, 1999) DNAJC3 and Grp94 have been shown to exist in a complex together (Jansen et 
al., 2012) and multiple sequence alignment has illustrated that the charged linker region of both 
Hsp90 and Grp94 shared limited structural homology with p88rIPK, an inhibitor of DNAJC3. A 
pull down assay was conducted to determine whether DNAJC3 TPR domains interact with both 
Grp94 and Hsp90, independent of the carboxylate clamp residues and the EEVD motif. A total of 
10 µg of GST tagged bait protein (GST, mSTI1 DNAJC3ΔJ/ER) was incubated overnight at 4 °C 
with 1 µg of Hsp90, Grp94 or Grp94284-543 (encoding the middle domain and the C-terminal end 
of the charged linker region of Grp94), washed and the pull down reactions analyzed by SDS-
PAGE and Colloidal Coomassie staining (Figure 5.1). mSTI1 is the mouse homologue of HOP, a 
TPR-containing protein know to interact with both Hsp90 and Hsp70 through the TPR domains 
(Scheufler et al., 2000, Odunuga et al., 2003), similar to DNAJC7. As the purification of GST-
DNAJC7 was unsuccessful (Figure 4.12, D), recombinant GST-tagged mSTI1 was utilized as a 
positive control. 
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Figure 5.1: DNAJC3 TPR domains do not interact directly with Hsp90 or Grp94. 
DNAJC3ΔJ/ER protein-protein pull down assay with (A) Hsp90 (B) Grp94 (C) Grp94284-543. Lane 1: Marker, Lane 2: 
Input. Lane 3-5: triplicate pull down reactions with GST protein, Lane 6: GST tagged mSTI1 and Lane 7-8: triplicate 
pull down reactions with GST tagged DNAJC3ΔJ/ER. (D) Densitometry analysis of interaction between bait proteins 
and (upper) Hsp90 and (lower) Grp94 middle domain 
 
DNAJC3ΔJ/ER did not interact directly with purified Hsp90, Grp94 or Grp94284-543 in this study 
(Figure 5.1, A, B and D, Lane 7-9). Although bands were observed in the DNAJC3ΔJ/ER lanes 
that correlated to Hsp90 and Grp94284-543 (compared to the input lane), bands were present in GST 
samples, which served as a negative control (Figure 5.1, A and C, compare lanes 3-5 and lanes 7-
8). GST protein has previously been shown to bind indiscriminately to various purified proteins, 
prompting the need to conduct densitometry analysis to determine the total amount of Hsp90 or 
Grp94284-543 bound directly to DNAJC3ΔJ/ER and not the GST tag. The value of Hsp90 or 
Grp94284-543 bound to the GST protein was subtracted from the value of Hsp90 or Grp94284-543 
bound to GST-tagged DNAJC3ΔJ/ER (Figure 5.1, D). The difference was taken as a representation 
of the amount Hsp90 and Grp94284-543 bound directly to DNAJC3ΔJ/ER. Based on the 
densitometry analysis, the difference in levels of Hsp90 or Grp94284-543 bound to GST compared 
to GST-tagged DNAJC3ΔJ/ER was not significant.  
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5.2.2 DNAJC3 TPR domains interacted with both native and denatured substrate  
Interaction of full length DNAJC3 with Grp78 and Hsp70 is mediated by the J domain (Melville 
et al., 1999, Oyadomari et al., 2006, Rutkowski et al., 2007, Tao et al., 2010; Svärd et al., 2011). 
In order to determine whether DNAJC3 TPR domains could interact with Hsp70 and Grp78 
independent of the J domain, a pull down assay was conducted. A total of 10 µg of GST tagged 
bait protein (GST, mSTI1 or DNAJC3ΔJ/ER) was incubated overnight at 4 °C with 1 µg of either 
Hsp70 or Grp78, washed and the reactions analyzed by SDS-PAGE and Colloidal Coomassie 
staining (Figure 5.2). 
 
 
 
Figure 5.2: DNAJC3 TPR domains do not interact directly with Hsp70 or Grp78. 
DNAJC3ΔJ/ER protein-protein pull down assay with (A) Hsp70 (B) Grp78. Lane 1: Marker, Lane 2: Input. Lane 3-
5: triplicate pull down reactions with GST protein, Lane 6: GST tagged mSTI1 and Lane 7-8: triplicate pull down 
reactions with GST tagged DNAJC3ΔJ/ER.  
 
DNAJC3ΔJ/ER did not interact in this assay with either purified Hsp70 or Grp78 as illustrated by 
the absence of a band below the 85 kDa marker (Figure 5.2, A and B, Lane 7-9). However, mSTI1 
was able to interact with Hsp70 but not with Grp78, as Grp78 lacks the EEVD motif needed to 
mediate the interaction (Fewell et al., 2004) (Figure 5.2, A and B, Lane 6). 
The TPR1 domain of DNAJC3 TPR1 has been shown to bind denatured proteins through its 
hydrophobic pocket during its co-chaperone functions to Grp78 during UPR (Tao et al., 2010). 
Previously, DNAJC3 TPR domains were shown been to have selective binding affinity for 
chemically denatured luciferase compared to native luciferase (Tao et al., 2010). An ELISA was 
conducted to determine whether the three DNAJC3 TPR domains bound discriminately to heat 
denatured or native substrates, using two model substrates, MDH and β-galactosidase (Figure 5.3). 
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As previously stated, the GST protein is known to bind indiscriminately to purified proteins, 
therefore GST alone was included in the ELISA as a negative control and His-tagged Grp78 was 
used as a positive control for substrate binding as it has been shown to bind to denatured substrate 
(Tao et al., 2010). 
Grp78 bound both denatured and native substrates, although the chaperone had greater binding 
affinity for heat denatured MDH than β-galactosidase (Figure 5.3, A and B). DNAJC3∆J/ER 
bound both native and heat denatured β-galactosidase and MDH (Figure 5.3 A and B). 
DNAJC3∆J/ER bound denatured β-galactosidase with greater affinity than native β-galactosidase 
(Figure 3.3 A), however there was no substantial difference in the binding affinity between native 
or denatured MDH (Figure 3.3, B). there was a dose dependent increase in the binding of both 
native and denatured MDH to the TPR domains of DNAJC3, while β-galactosidase binding was 
dose dependent up to 50 µ/ml (Figure 5.3, A and B). 
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Figure 5.3: DNAJC3 TPR domains interacted with both native and heat denatured model 
substrate proteins. 50 µg/ml of native and heat denatured substrate (A) β-galactosidase and (B) MDH were 
coated onto high binding 96 well plates, none specific binding was blocked with 5 % BSA, followed by incubation 
with different concentrations (10 – 100 µg/ml) of bait proteins (GST, DNAJC3∆J/ER and His-Grp78). Wells were 
incubated with GST or His specify primary and secondary antibodies. TMB substrate solution and H2SO4 were used 
to develop and stop the reaction, respectively, absorbance was read at 450 nm.  
 
To further characterize the functions of DNAJC3 TPR domains, complex formation analysis was 
conducted to determine the ability of DNAJC3 TPR domains to form complexes with Grp78 and 
or Grp94 and denatured substrate in vitro. The complex formation assay was conducted using two 
methods, namely purified proteins pull down assay and ELISA. For the ELISA analysis, two 
different concentrations of heat denatured β-galactosidase (50 and 100 µg/ ml) were incubated 
with fixed concentrations of His-Grp78 (50 µg/ ml) and DNAJC3ΔJ/ER (20 µg/ ml) and the 
capacity of DNAJCΔJ/ER to bind Grp78 was compared in the presence or absence of heat 
denatured β-galactosidase. For the pull down method, different combinations as DNAJC3ΔJ/ER, 
Grp78 and Grp94 where incubated in the presence or absence of heat denatured β-galactosidase, 
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with GST being used as a negative control. However, DNAJC3ΔJ/ER was unable to form a 
complexes with either Grp94 or Grp78 or a combination of both in the presence or absence of heat 
denatured β-galactosidase in vitro (data not shown), although full length DNAJC3, Grp94 and 
Grp78 have been found in a complex together in vitro (Jansen et al., 2012). A guanidine-HCl 
denatured luciferase refolding assay was conducted in an attempt to further characterize a potential 
refoldase function for the of DNAJC3 TPR domain. However, DNAJC3ΔJ/ER was unable to 
refold chemically denatured luciferase into a functional enzyme or enhance the refolding capacity 
of Grp78 (data not shown), suggesting that DNAJC3 TPR domains do not exhibit refoldase 
activity.  
5.2.3 DNAJC3 TPR domains are able to pull down Hsp90 and Grp94 from MCF-7 carcinoma 
cell lysates 
DNAJC3 has previously been shown to be part of a complex consisting of Grp94 and Grp78, 
through a lysate pull down reaction using Grp78 as the bait protein (Jansen et al., 2012). A lysate 
pull down was conducted using DNAJC3∆J/ER to determine whether DNAJC3 TPR domains 
could mediate interacts with cytosolic and ER Hsp90 and Hsp70 proteins ex vivo.  
The expression levels of DNAJC3, Hsp90 and Hsp70, and the ER homologues Grp94 and Grp78, 
was examined in five different cancerous cell lines (Figure 5.4). The chaperones were found to be 
expressed in detectable amounts in all cell lines analyzed, however the expression levels of the 
chaperones differed between the cell lines. The MCF-7 carcinoma cell line was chosen for use in 
subsequent experiments, although the expression level of Hsp90 in this cell line was low compared 
to the other cell lines. 
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Figure 5.4: Expression profile of chaperones in five mammalian cancer cell lines: An equal 
amount of total protein (50 µg) from each cell line was analyzed. Expression levels of Hsp90, Hsp70, Grp78, Grp94 
and DNAJC3 were detected using monoclonal mouse anti-Hsp90, anti-Hsp70 and anti-Grp78, monoclonal rat anti-
Grp94 and polyclonal rabbit anti-DNAJC3. 
 
To conduct the lysate pull down assay, 20 µg of purified recombinant protein, GST (negative 
control), GST-tagged mSTI1 (positive control, kind donation from Samantha Beckley, Rhodes 
University) and GST-tagged DNAJC3ΔJ/ER were incubated with MCF-7 cell lysates overnight at 
4 °C, washed and analyzed by Western analysis for the presence of Hsp90, Hsp70, Grp78 and 
Grp94 (Figure 5.5). 
Negative control GST showed no signal for the analyzed proteins with the exception of a faint 
signal for Hsp70 and Grp94 in one of the independent replicate samples (Figure 5.5, Lane 3). As 
expected, mSTI1 was able to pull down Hsp70 as previously illustrated (Odunuga et al., 2003), 
however Hsp90 which has also been shown to interact with mSTI1 was not detected in the same 
samples (Figure 5.5, lane 5-6). GST-tagged DNAJC3ΔJ/ER was unable to pull down both Grp78 
and Hsp70 as previously shown (Rutkowski et al., 2007). However, the protein was able to pull 
down both Hsp90 and Grp94 (Figure 5.5, lane 7-8). Previous studies have shown that endogenous 
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full length DNAJC3 can be pulled down in a complex that consists of both Grp78 and Grp94 
(Jansen et al., 2012).  
 
 
 
Figure 5.5: DNAJC3 TPR domains are able to pull down Hsp90 and Grp94 and not Hsp70 
or Grp78 from MCF-7 cell lysates. Pull down assays were conducted by incubating 20 µg of purified bait 
protein (GST and GST-DNAJC3ΔJ/ER) with MCF-7 lysates overnight and analyzed by Western analysis.  Lane 1: 
MCF-7 cell lysate, Lane 2-4: GST protein, Lane 5-6, GST-mSTI1 and Lane 7-9: GST-DNAJC3ΔJ/ER. n=3. 
 
5.3: Discussion 
This chapter described the in vitro interaction analysis of DNAJC3 TPR domains with chaperones. 
DNAJC3 TPR domains did not interact directly with purified Hsp90, Hsp70 or the ER 
homologues, Grp94 and Grp78, although the TPR domains were able to pull down Grp94 and 
Hsp90, but not Hsp70 or Grp78, from MCF-7 carcinoma cell lysates. In addition, DNAJC3 TPR 
domains were able to bind both native and heat denatured substrates but could not form complexes 
with denatured substrates, Grp78 and/or Grp94 and did not exhibit independent refoldase activity.  
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Previously, full length DNAJC3 has been shown to be in a multicomplex with Grp94 and other 
chaperones such as Grp78 and refolding enzyme, PDI (Jansen et al., 2012), but whether this 
interaction was due to direct binding was unknown. This study showed experimentally that 
DNAJC3 TPR domains cannot interact directly with either Hsp90 or Grp94. Interaction between 
Hsp90 with TPR containing co-chaperones such as HOP is dependent of the interaction of the 
carboxylate clamp forming residues of TPR domains and the EEVD motif located on the C-
terminal domain of Hsp90 (Odunuga et al., 2003). However, Grp94 lacks the EEVD motif (Figure 
3.7) (Argon and Simen, 1999, Tastan Bishop et al., 2013). In addition, DNAJC3 TPR domains 
lack the carboxylate forming residues found in co-chaperones such as HOP (Figure 3.4) (Tao et 
al., 2010), suggesting that any potential interactions that occur between DNAJC3 and Grp94 and 
or Hsp90 would be EEVD motif and carboxylate clamp independent. We initially predicted that 
the limited structural homology of p88rIPK with the charged linker region of Hsp90 (Gale et al., 
1998) and of Grp94 (Figure 3.8), might indicate a possible alternative interaction site between 
DNAJC3 TPR domain and Hsp90 and or Grp94. However, our data suggest that DNAJC3 TPR 
domains cannot interact directly with Hsp90 or Grp94, irrespective of the EEVD motif, and the 
charged linker region of both Grp94 and Hsp90 is not a possible alternative binding site for 
DNAJC3 via its TPR domain. These observations suggest that the interaction between DNAJC3 
and Grp94 with in the isolated complex was mediated by other proteins present in the complex 
such as Grp78 and PDI or the client protein (Jansen et al., 2012). Cytosolic Hsp90 chaperone 
activity is dependent on the assistance of numerous co-chaperones such as p23, Aha1 and Cdc37, 
there are no known co-chaperones of Grp94. Although DNAJC3 was found not to interact directly 
with Grp94 in vitro in this study, their co-existence in a complex could suggest DNAJC3 acts a 
co-chaperone to Grp94 in concert with other proteins. Cyclophilin B, an ER isoform of Hsp90 co-
chaperone Cyp40 that lacks the TPR domain was pulled down in a multiprotein complex that 
contained several chaperones including Grp94. (Meunier et al., 2002). These two examples of 
proteins with known co-chaperoning activity existing in complexes with Grp94, strongly suggests 
that the later protein could have potential co-chaperones that have yet to be identified. Cell lysate 
pull down using Grp94 as bait protein, along with mass spectrometry could be conducted to 
identify proteins that interact with the chaperone that could possible function as co-chaperone. 
Assays such as ATPase, substrate aggregation suppression, refolding and complex formation assay 
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could be conducted to determine if the identified protein do determine whether they exhibit co-
chaperone activity towards by assisting and enhancing Grp94 chaperoning activity.  
DNAJC3 TPR domains in the absence of the J domain were also unable to interact directly with 
either Hsp70 or Grp78 in vitro. The TPR domains of DNAJC3 are known to bind denatured 
proteins through the hydrophobic pocket of TPR1 (Tao et al., 2010) while the J domain stimulates 
the ATPase activity of both Hsp70 (Melville et al., 1999) and Grp78 (Oyadomari et al., 2006, 
Rutkowski et al., 2007, Tao et al., 2010; Svärd et al., 2011). This suggested that the J domain is 
required to mediate interactions between DNAJC3 and Hsp70 or Grp78 (Green et al., 1998, 
Kampinga and Craig, 2010, Gao et al., 2012). mSTI1, known to interact through the carboxylate 
clamp residue with the EEVD motif found in cytosolic Hsp70 (Odunuga et al., 2003) was able to 
interact with Hsp70. Grp78 also lacks the EEVD motif found in cytosolic Hsp70 and was found to 
not interact with both mSTI1 and DNAJC3ΔJ/ER, illustrating the importance of both the EEVD 
motif and the carboxylate clamp forming residues to mediate binding.  
DNAJC3ΔJ/ER was however found to be able to bind both native and heat denatured model 
substrates, MDH and β-galactosidase (Figure 5.3). Mouse DNAJC3 TPR1 has been shown to have 
higher binding affinity toward chemically denatured luciferase than native luciferase (Tao et al., 
2010). The human DNAJC3 TPR domains used in this study, were able to bind both native MDH 
and β-galactosidase at levels comparable to heat denatured MDH and β-galactosidase (Figure 5.3). 
Mouse and human DNAJC3 proteins are highly conserved at both the primary (Figure 3.1) and 
secondary structural levels (Svärd et al., 2011) which strongly suggests functional similarities. The 
ability of human DNAJC3 TPR domains to bind to both native and denatured substrates observed 
in the mouse counterparts could possibly be linked to the subtle difference observed between in 
the overall shape of the TPR domains in mouse and human DNAJC3 proteins (Svärd et al., 2010). 
The differences were found to be a result of the rotations of the long seventh and thirteenth helices 
that connect TPR1 to TPR2 and TPR2 to TPR3, respectively. The rotations brought the three 
human TPR domains closer, resulting the DNAJC3 having a more curved shape than mouse 
DNAJC3 (Svärd et al., 2011). However the possibility that the structural difference observed could 
affect the physiological function of the proteins is yet to be determined. Alternatively, the 
indiscriminate binding to both native and denatured substrates, could be linked to substrate 
specificity, as even between the two different substrates, DNAJC3ΔJ/ER seemed to bind β-
galactosidase with greater affinity compared to MDH (Figure 5.3). Therefore, the human DNAJC3 
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TPR domains can bind denatured substrates, MDH and β-galactosidase, similar to mouse DNAJC3 
TPR1 domain which bound luciferase (Tao et al., 2010). Human DNAJC3 TPR2 and TPR3 could 
possibly be selectively binding to native MDH and β-galactosidase, with greater affinity for β-
galactosidase, illustrating substrate specify. However, this suggestion is purely conjecture as 
substrate binding capabilities of TPR2 and TPR3 of DNAJC3 have not been studied. We can 
conclude from the murine study that it is likely that TPR2 and 3 of human DNAJC3 act in a similar 
manner to TPR1. In silico analysis conducted in Chapter 3 of this study strongly suggested that 
DNAJC3 TPR2 and TPR3 had the capability to interact with diverse substrates. The domains were 
demonstrated to share structural (Figure 3.12, 3.13, 3.14) and chemical (Figure 3.16) similarities 
to TPR-containing proteins such as MamA, a known adaptor protein involved in the assembly of 
proteins in magnetotatic bacteria (Zeytuni et al., 2011) and PcrH, a chaperone of PopB and PopD, 
translocator proteins involved in the translocation of protein across membranes (Page and Parsot, 
2002, Parsot et al., 2003).  
DNAJC3ΔJ/ER could not form a complex with Grp78 and or Grp94 in the absence or presence of 
denatured β-galactosidase (data not shown) and altering the range of concentrations of denatured 
substrate did not improve binding (data not shown). These observations suggested that although 
DNAJC3 TPR domains were capable of binding denatured β-galactosidase (Figure 5.3, A), they 
could not mediate the formation of substrate complexes with Grp78 and or Grp94. Indeed, the 
presence of DNAJC3 may have prevented binding of chaperones to substrate proteins. The J 
domain is known to be crucial for the interaction of DNAJ and Hsp70 proteins (Greene et al., 
1998, Kampinga and Craig, 2010, Gao et al., 2012), and DNAJ and Hsp70 through their 
interaction, are components of the early complex in Hsp90 mediated substrate folding or 
maturation (Figure 1.2) (Mahalingam et al., 2009, Li et al., 2013). These data might suggest 
DNAJC3 TPR domain cannot induce substrate-chaperone interactions in the absence of the J 
domain. Alternately, the formation of complexes between DNAJC3, Grp78 and or Grp94 could be 
substrate specific, especially in the case of Grp94. Unlike Grp78, which was shown by use to be 
able to bind denatured model substrates, Grp94 is known to be highly selective of the client protein 
it chaperones (Randow and Seed, 2001, Yan et al., 2005, Morales et al., 2009). This might suggest 
that the substrate used in this study β-galactosidase, could not mediate the formation of a complex 
because it was not a true representation of substrates that require DNAJC3, Grp78 and or Grp94 
for its maturation. Follow up studies could attempt the complex formation assay using a known 
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client of Grp78 and Grp94, however majority of Grp94 client proteins are transmembrane and 
secretory proteins and these proteins are known to be difficulty to express in E.coli cells (Melnick 
et al., 1994, Randow and Seed, 2001, Marzec et al., 2012).  
Despite being previously shown to bind denatured luciferase, DNAJC3ΔJ/ER did not exhibit any 
refoldase activity or enhance the refoldase activity of Grp78 (data not shown). Several members 
of the DNAJA and DNAJB proteins have been shown to have chaperone activity independent of 
Hsp70 and Hsp90, where they can bind newly synthesised protein and supress protein aggregation 
or maintain them in a conformation favourable for folding (Langer et al., 1992, Cyr, 1995, Freeman 
and Morimoto, 1996, Meacham et al., 1999, Lee et al., 2002). Numerous TPR-containing protein 
have also been shown to have chaperoning activity independent of Hsp90 or Hsp70, such as PcrH, 
a chaperone for translocator protein PopB and PopD in Pseudomonas aeruginosa (Page and Parsot, 
2002, Brӧms et al., 2003, 2006, Parsot et al., 2003, Jobs et al., 2010) and another chaperone SycD 
also involved in chaperoning translocator protein YopD and YopB in E. coli (Neyt and Cornelis, 
1999, Schreiner and Neimann, 2012. The observed results suggested that DNAJC3 TPR domains 
do not have refoldase activity, observed in other DNAJ proteins. However, at present Hsp90 and 
Hsp70 independent chaperone activity has only been detected in members of DNAJA and DNAJB 
proteins and not DNAJC proteins (Langer et al., 1992, Cyr, 1995, Freeman and Morimoto, 1996, 
Meacham et al., 1999, Lee et al., 2002). DNAJC3 is a member of the DNAJC family, which 
possibly indicated that the likelihood of DNAJC3 exhibit ATP dependent chaperoning activity 
similar to DNAJA and DNAJB members was improbable. The incapability of DNAJC3ΔJ/ER to 
enhance Grp78 refoldase activity observed could be linked to the absence of the J domain, which 
is known to stimulate Grp78 ATPase dependent protein refolding (Freeman et al., 1995, 
Oyadomari et al., 2006, Galam et al., 2007, Rutkowski et al., 2007). Although DNAJC3 TPR 
domains were illustrated to not exhibit refoldase in this study, other chaperoning activities such as 
substrate aggregation suppression or translocation could be examined in the future.  
Pull down assay experiments conducted in this study showed that DNAJC3 TPR domains did not 
interact with Grp94, Grp78, Hsp90 or Hsp70 in vitro. Therefore, we conducted a mammalian cell 
lysate pull down assay. As previously shown by Odunuga and colleagues, mSTI1, mouse 
homologue of HOP used as a positive control was able to pull down Hsp70 (Odunuga et al., 2003) 
but not Grp78. DNAJC3ΔJ/ER was unable to consistently pull down either Hsp70 or Grp78 from 
MCF-7 carcinoma cell lysate (Figure 5. 5, lanes 5-6 and 7-9), coinciding with the findings of 
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Rutkowski et al., 2007. This observation further supported the idea that DNAJC3 and Grp78 
interaction is mediated and dependent on the J domain.  
Although full length DNAJC3 has been shown to be part of a complex with Grp78 and Grp94 in 
vivo through a pull down assay using Grp78 as bait protein (Jansen et al., 2012), the current study 
was the first to demonstrate the ability of DNAJC3 TPR domains to pull down both Hsp90 and 
Grp94 from a cell lysate. However, our data suggest that the ability of DNAJC3 TPR domains to 
pull down both Hsp90 and Grp94 is not a result of direct interaction between with the chaperones. 
This suggested that DNAJC3 and Grp94 or Hsp90 might be components of a complex that is Grp78 
or Hsp70 independent and mediated by DNAJC3 TPR domains. The interaction between DNAJC3 
and Grp94 might be facilitated by a specific cellular substrate protein, distinct from the as the 
model substrate β-galactosidase which was unable to mediate the formation of a complex between 
DNAJC3 TPR domains and isolated Grp94 in vitro (data not shown). Grp94 is known to be highly 
discriminate with respect to client proteins (Ostrovsky et al., 2009, 2010).  
The absence of Grp78 from the complex could possibly be a result of the chaperone not being 
required for the folding or maturation of the unknown substrate. The maturation of IGF, a known 
Grp94 client, has been shown to require the chaperoning activity of Grp94 without assistance from 
Grp78 (Ostrovsky et al., 2009, 2010). Alternatively, a number of proteins have been shown to 
require assistance from Grp78 and Grp94 at different stages of their maturation or folding (Eletto 
et al., 2010). To further understand the interaction between DNAJC3 TPR domains and Hsp90 or 
Grp94, the pull down assay could be repeated in the presence of known Hsp90 and Grp94 
inhibitors such as GA and NOVO to determine whether the inhibition of Hsp90 and Grp94 ATPase 
activity affects the interaction. In addition to inhibition studies, the pull down assay could be 
repeated and the co-precipitating proteins identified by mass spectrometry in an attempt to identify 
the substrate mediating the interaction between DNAJC3 TPR domains and Hsp90 or Grp94. Mass 
spectrometry analysis of the pull down assay could also potentially identify additional proteins 
that might interact with DNAJC3 TPR domains directly or indirectly.  
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Chapter 6: Preliminary ex vivo analysis of DNAJC3 in 
mammalian cells 
 
6.1 Introduction 
This chapter describes the preliminary analysis of DNAJC3 functions in mammalian cells. Studies 
have shown that DNAJC3 plays a role in diseases such as cancer, diabetes and viral infection. The 
upregulation or downregulation of DNAJC3 appers to have different consequences in different 
diseases. In mice, the knockdown of DNAJC3 has been shown to activate apoptosis genes, leading 
to an increase in β-cell failure, which has been shown to result in moderate diabetic phenotypes 
(Ladiges et al., 2005). DNAJC3 has also been implicated in a variety of cancers such as colon 
cancer (Ghosh et al., 2011) and breast cancer (Gao et al., 2012). Overexpression of DNAJC3 has 
been found to induce malignant tumor formation in mice (Barber et al., 1994) and in colon cancer, 
DNAJC3 expression was reported to be upregulated in the metastatic cell line (SW620) compared 
to the primary tumor (SW480). (Ghosh et al., 2011). Due its inhibitory activity on PRK/PERK 
activity, DNAJC3 has been shown to have anti-apoptotic properties in several cancers (Tang et al., 
1999, Gao et al., 2012, Huber et al., 2013). Additionally, DNAJC3 has also been found to regulate 
or be regulated by the phosphorylation of kinases downstream of the RAS signalling pathway such 
as p-38 during influenza virus infection (Luig et al., 2010) or AKT during CBV3 infection (Zhang 
et al., 2010b). In order to further understand the role of DNAJC3 in these diseases, it is important 
to first understand its basic functions and any links to other chaperones and signalling pathways. 
The specific objectives were to: 
 Determine the effects of various stress conditions on the expression and localization of 
DNAJC3 in HEK293T cells 
 Determine the effects of Hsp90 inhibitors GA and NOVO, on DNAJC3 expression in 
MCF-7 carcinoma cells 
 Determine effects of HRas and HRas mutants on the localization and expression of 
DNAJC3 in HEK293T cells 
 Determine the effects of DNAJC3 knockdown on the expression profile of different 
chaperones and co-chaperones in MCF-7 carcinoma cells 
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6.2 Results 
6.2.1 DNAJC3 is expressed in numerous mammalian cancer cell lines from different tissues 
Previous analysis has shown that DNAJC3 is conserved in numerous species (Figure 3.1). Through 
Western analysis, endogenous DNAJC3 was found to be expressed in nine cancer cell lines from 
different tissues (Figure 6.1). Tissues represented in the analyses were; breast (Hs578T, MCF-7 
and MDA-MB-231), colon (SW620 and SW480), lung (A549), monocytes cell (U937), cervix 
(HeLa) and kidney (HEK293T). 
 
 
 
Figure 6.1: Expression of endogenous DNAJC3 in various mammalian cancer cell lines. 
DNAJC3 was detected in a variety of mammalian cancer cell lines by Western analysis using mouse monoclonal anti-
DNAJC3 antibodies. Cell lysate from each cell line was loaded as following: Lane 1: HEK293T, Lane 2: HeLa, Lane 
3: Hs578T, Lane 4: A549, Lane 5: U937, Lane 6: MDA-MB-231, Lane 7: MCF-7, Lane 8: SW620 and Lane 9: SW480 
 
6.2.2 Effects of different stress conditions on the expression and localization of DNAJC3 in 
mammalian cells 
DNAJC3 is known to localize and be retained mainly in the ER due to the cleavable ER signal 
peptide located at the N- terminus of the protein, although a sub population has also been found in 
the cytoplasm and this is due to the inefficiency of the signal peptide (Rutkowski et al., 2007). In 
order to determine whether localization of DNAJC3 is altered by different stresses, HEK293T cells 
were subjected to various treatments to induce a wide variety of stress conductions (Table 6.1).  
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Table 6.1: Summary of treatments used to induce stress in HEK293T cells  
Stress Condition Treatment Concentration (mM) Treatment time 
(Hours) 
Normal Untreated - - 
ER Stress Tunicamycin (Tun)  2.38 24 
ROS H2O2 0.5 0.25 
Hypoxia CoCl2 0.1  24 
Tumor inducer PMA 5 x 10-5  2 
Proteosome Inhibition MG132 0.01  2 
Heat Shock Heat (42 °C) - 2 
UV stress Short UV (254 nm) - 0.02 
UV stress Long UV (366 nm) - 0.02 
 
The changes in DNAJC3 localization during stress were compared to that of the control (untreated) 
cells and Grp94 and Hsp90 were used as indicators of ER and cytoplasmic localization, 
respectively (Figure 6.2,). In the control cells, DNAJC3 signal was found to be mainly localized 
around the nucleus with some cytoplasmic staining in all analyzed samples (Figure 6.2, red 
column). Grp94, a known ER resident protein was also found to be localized around the nucleus 
(Figure 6.2, green column) similar to DNAJC3. Hsp90 signal was found to be mostly cytoplasmic 
with faint perinuclear staining in a few cells (Figure 6.2, purple column). 
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Figure 6.2: Colocalization analysis of DNAJC3, Grp94 and Hsp90 under various stress conditions in HEK293T cells. HEK293T 
cells were grown on glass coverslips for 24 hours and subjected to various stress conditions as indicated in Table 2.1. After each treatment cells were fixed in ice-
cold ethanol, permeabilized and stained with anti-DNAJC3, anti-Grp94 and anti-Hsp90 antibodies. Primary antibodies were detected with species specific Alexa 
Fluor 546- conjugated secondary antibodies for DNAJC3, Alexa Fluor 488- conjugated secondary antibodies for Grp94 and Alexa Fluor 660- conjugated secondary 
antibodies for Hsp90. Colocalization analysis was done using ImageJ according to published methods (Zinchuk et al., 2010) 
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Colocalization analysis using ImageJ was also conducted as an additional method to determine 
whether DNAJC3 and Grp94 or Hsp90 localized to the same organelles or compartments. The 
analysis was done by determining the signal intensity of the  fluorescence signals (DNAJC3 and 
Grp94 or DNAJC3 and Hsp90) to establish points where they overlap, which could be used as 
quantitative analysis of colocalization (Zinchuk et al., 2010). For this study, fluorescence 
scattergrams (Figure 6.2) were used to demonstrate the degree of colocalization between DNAJC3 
and Grp94 and DNAJC3 and Hsp90. Perfect colocalization using the scattergrams can be described 
as the alignment or overlap of both signals at the linear line of progression. (Zinchuk et al., 2010). 
In the control cells, the scattergram for DNAJC3 and Hsp90 signals (Figure 6.2, far right column 
[red and purple]), aligned on the linear line of progression, suggesting pixel on pixel colocalization 
between the two signals. When compared to the various stress treatments, no changes were 
observed to the DNAJC3 fluorescence scattergrams suggesting that the various stress conditions 
analyzed did not affect the localization of DNAJC3 relative to Hsp90. Similar to DNAJC3 and 
Hsp90, in the scattergram for DNAJC3 and Grp94 (Figure 6.2, far left column [red and green]), 
the two signals overlapped at the linear line of progression which suggested colocalization. The 
pattern of the fluorescence scattergram did not change substantially in cells subjected to hypoxia 
(CoCl2), heat shock (42 °C), proteasome inhibition (MG132) and tumour promoting (PMA) stress 
conditions. This observation suggested that these stress conditions did not alter the localization of 
DNAJC3 in relation to Grp94. However, cells exposed to ER stress (Tun), ROS (H2O2) and DNA 
damage (UVL and UVS) dispalyed fluorescence scattergrams that showed a different pattern to 
that of the unstressed (untreated) cells, suggesting a change in localisation of DNAJC3 in relation 
to Grp94. It could thus be interpreted that these stress conditions have an effect on the ER, as the 
cytosolic localization (DNAJC3 and Hsp90 scattergrams) were not altered by the same treatments. 
In addition to changes in localization, changes in expression levels of DNAJC3 were also analysed 
by Western analysis to determine whether the expression pattern of DNAJC3 differed under the 
different stress conditions compared to untreated cell (Figure 6.3. A). Hsp70 was used as marker 
of stress, as it has been shown to be upregulated in cells during stress conditions (Lindquist and 
Craig, 1988). 
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Figure 6.3 Expression levels of DNAJC3 under different stress conditions. (A). Levels of DNAJC3 
and Hsp70 were detected by Western analysis in HEK293 T cell lysates subjected to various treatments to stimulate 
different stress conditions using mouse monoclonal anti-DNAJC3 and mouse monoclonal anti-Hsp70, Histone H3 
was used as a loading control and detected using rabbit polyclonal anti-Histone H3. (B) Densitometry analysis used 
to compare the expression levels of DNAJC3 and Hsp70 under various stress conditions, where the ratio of DNAJC3 
or Hsp70 to histone was normalized to the untreated sample which was taken as 1. Data shown are representatives of 
duplicate experiments with similar results. 
 
Densitometry analysis of the expression levels of DNAJC3 in stressed cells compared to normal 
unstressed cells, illustrated that none of the stress treatments substantially altered the expression 
levels of DNAJC3 (Figure 6.3, B). Looking at the expression levels of Hsp70 in the stressed 
samples in comparison to the unstressed cells, it appeared that the Tun (ER stress) and PMA (tumor 
promoter) concentrations utilized in this study did not elicit a stress response, while the other 
treatment did induce an increase in Hsp70 expression, suggesting the  stress response was induced 
(Figure 6.3, B). The lack of a stress response in Tun treated cells might be the reason why an 
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expected increase in DNAJC3 expression was not observed, as it has been shown that treatment 
with Tun results in ER stress which should lead to the upregulation of DNAJC3 (Oyadomari et al., 
2006, Rutkowski et al., 2007).  
It was interesting to note that there was no apparent correlation in the changes in DNAJC3 
localization and expression. As mentioned, no changes were observed in the expression profile of 
DNAJC3 in stressed samples when compared to the control. However, a few of the stress 
treatments did alter the localization of DNAJC3 in relation to ER Grp94, although none was 
observed in its relation to the cytosolic Hsp90. 
6.2.3 High concentrations of the Hsp90 inhibitor NOVO decrease DNAJC3 protein levels 
GA is a known inhibitor of Hsp90 and Grp94 ATPase activity, that binds to the N-terminal ATP 
sites of the proteins (Chavany et al., 1996, Grenert et al., 1997, Prodromou et al., 1997a, Schulte 
et al., 1998, 1999). NOVO is known to bind to the ATP site at the C-terminus of Hsp90 (Marcu et 
al., 2000). The sequence associated with NOVO binding to Hsp90 is not conserved in Grp94, 
however it has been suggested that binding of NOVO to Hsp90 and its inhibition of ATPase 
activity could be linked to the conformation state of the protein rather than the sequence itself 
(Dollins et al., 2007, Marzec et al., 2012). Therefore, as Grp94 demonstrations identical 
conformational states to Hsp90, NOVO may be predicted to interact with this chaperone (Ratzke 
et al., 2010).  
MCF-7 carcinoma cells were treated with different concentrations of GA and NOVO for 24 hours 
and the lysates analyzed by Western analysis to determine the consequence of Hsp90 and Grp94 
inhibition on DNAJC3 protein levels (Figure 6.4). The preliminary results showed that, at all tested 
concentrations GA did not affect the protein levels of DNAJC3 compared to the DMSO sample, 
which was used as the vehicle control (Figure 6.4, A). NOVO did not alter the protein levels of 
DNAJC3 at the lower concentrations of 5 and 50 µM, when compared to the untreated sample. 
However, a dramatic decrease in the protein levels of DNAJC3 was observed in cells treated with 
500 µM of NOVO. Since these results are from a single experiment, additional replicates will 
however need to be conducted to determine if the observed trends are a true representation of the 
inhibitors effects on DNAJC3 protein levels. 
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Figure 6.4: Preliminary analysis showed that DNAJC3 expression is reduced by high 
concentrations of novobiocin (NOVO) but not geldanamycin (GA). (A) Levels of DNAJC3 and 
were detected by Western analysis in MCF-7 carcinoma cell lysates treated with different concentrations of GA (0.1, 
1, 10 µM) and NOVO (5, 50, 500 µM) for 24 hours using mouse monoclonal anti-DNAJC3, Histone H3 was used as 
a loading control and detected using rabbit polyclonal anti-Histone H3. (B) Densitometry analysis used to compare 
the expression levels of DNAJC3 after treatment with different concentrations of GA and NOVO, where the ratio of 
the DNAJC3 relative to Histone was calculated and normalized against the untreated sample, which was taken as 1. 
 
6.2.4 DNAJC3 expression and localization is not affected by expression of HRas 
HRas is a protein translated from the Harvey rat sarcoma viral oncogene homolog gene and is 
involved mainly in regulating cell division, by relaying signals (growth factor stimulation) from 
outside the cell to the nucleus through a process called signal transduction (McCormick , 1996, 
Ayllón and Rebollo 2001). 
Several mutations have been identified on the HRAS gene. HRas G12V is a mutation at the twelfth 
amino acid, which results in the HRas protein being constitutively active within the cell (Seeburg 
et al., 1984). HRas S17N is a mutation that occurs at the seventeenth amino acid residue which 
results in a dominant negative mutant HRas protein (Stacey et al., 1991). 
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HEK293T cells were transfected with EGFP tagged HRas and mutant plasmids for 48 hours. 
Images were taken at 24 hours post transfection to determine the success of the procedure. An 
EGFP signal was detected in HRas, HRas G12V and HRas S17N cells and not the untreated cells 
(Figure 6.5, A). The transfection efficiency of all 3 plasmids appeared to be comparative. At 24 
hours post transfection, the EGFP signal was mainly diffuse in the cytosol for all 3 HRas plasmids, 
although a few cells showed the EGFP signal concentrated next to the nucleus (Figure 6.5, A white 
arrow). 
At 48 hours post transfection, cells were fixed, stained for DNAJC3 and analyzed by confocal 
microscopy (Figure 6.5, B). In the control cells (Figure 6.5, B upper panels), DNAJC3 signal was 
found mainly surrounding the nucleus in a punctate pattern, with faint staining in the cytosol and 
no EGFP signal detected. The distribution pattern of EGFP in HRas and HRas mutant transfected 
cells differed to the pattern observed 24 hours post transfection. In HRas transfected cells, the 
EGFP signal had an elongated fibril-like pattern, HRas G12V cells showed a more diffuse and 
grainy pattern and in HRas S17N cells the EGFP signal diffused uniformly in the cytoplasm 
(Figure 6.5, B). The concentrated EGFP signal found around the nucleus at 24 hours post 
transfection was absent in HRas and HRas G12V transfected cells and only a small population in 
HRas S17N cells still exhibited the staining pattern (Figure 6.5, B  lower panels, yellow arrow). 
However, the presence of HRas and HRas mutated proteins did not alter substantially the 
localization of DNAJC3 (Figure 6.5, B middle column) and colocalization between DNAJC3 and 
the HRas proteins was not observed as illustrated by the lack of overlapping signals (Figure 6.5, 
B, Merge). 
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Figure 6.5: HRas, HRas G12V and HRas S17N plasmids did not alter the subcellular localization of DNAJC3 in HEK293T cells. 
HEK293T cells were grown on glass coverslips for 24 hours and transfected with EGFP- tagged HRas, HRas G12V and HRas S17N plasmids. After 24 hours (A), 
images of each transfection were captured to determine the success of the procedure. After 48 hours (B) cells were fixed in cold ethanol, permeabilized and stained 
with anti-DNAJC3. DNAJC3 primary antibody was detected with species specific Alexa Fluor 546- conjugated secondary. 
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The expression of DNAJC3 and the phosphorylation of selected proteins downstream of the Ras 
signalling pathway, namely ERK, JNK and p38 was analyzed by Western blot in HEK293T cells 
transfected with HRas and mutant plasmids for 48 hours (Figure 6.6). From the preliminary 
analysis, the expression levels of DNAJC3 were not affected by the expression of HRas or the 
mutants HRas G12V and S17N. The expression of HRas and HRas mutants had little to no effect 
on the levels of phosphorylated ERK. However, subtle changes were observed in the levels of 
phosphorylated JNK and p38 in cells transfected with the HRas S17N plasmid, were a decrease in 
phosphorylated protein levels can be observed (Figure 6.6). 
 
                                      
 
Figure 6.6: The effect of HRas, HRas G12V and HRas S17N plasmids on the expression levels 
of DNAJC3 and the activation (phosphorylation) of proteins, p42/44 ERK, JNK and p38 in 
HEK293T cells. Expression levels of DNAJC3 and the levels of phosphorylated proteins ERK, JNK and p38 was 
determined by western analysis in HEK293T cells transfected with HRas, HRas G12V and HRas S17N plasmids using 
mouse monoclonal anti-DNAJC3, anti-pJNK, anti-p-p38 and rabbit polyclonal Anti-p44/42 MAPK (T202/Y204). 
Histone H3 was used as a loading control and detected with rabbit polyclonal anti-Histone H3 antibodies.  
 
6.2.5 Transient DNAJC3 knockdown reduced levels of the co-chaperone HOP  
DNAJC3 is a known co-chaperone of Grp78 in the ER and Hsp70 in the cytosol, where it 
stimulates the ATPase activities of the two proteins, assisting them in their chaperoning functions 
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(Melville et al., 1999, Oyadomari et al., 2006, Rutkowski et al., 2007, Tao et al., 2010; Svärd et 
al., 2011). In order to determine the consequence of reducing protein levels of DNAJC3 on the 
protein levels of chaperones and co-chaperones, MCF-7 carcinoma cells were treated with 
DNAJC3 targeting small interfering RNA (siRNA) and non-targeting (NT) siRNA for 72 hours 
and analyzed by western analysis (Figure 6.7, A). 
 
 
 
Figure 6.7: DNAJC3 knockdown decreased the expression of the co-chaperone HOP but not 
the ER chaperones, Grp78 and Grp94. (A) Levels of DNAJC3, HOP, Grp94 and Grp78 were detected by 
Western analysis in MCF-7 carcinoma cell lysates treated with DNAJC3 siRNA and NT siRNA for 72 hours using 
mouse monoclonal anti-DNAJC3, anti-Grp78 and anti-HOP and rat monoclonal anti-Grp94. Histone H3 was used as 
a loading control and detected using rabbit polyclonal anti-Histone H3. (B) Densitometry analysis was used to compare 
the expression levels of DNAJC3, HOP, Grp78 and Grp94 after DNAJC3 siRNA treatment, where the ratio of the 
chaperone or co-chaperone relative to Histone was calculated and normalized against the untreated sample, which was 
taken as 1. 
 
After treating with DNAJC3 siRNA for 72 hours, DNAJC3 protein levels were reduced to about 
60 % compared to the untreated sample, although a slight increase in DNAJC3 was observed in 
NT siRNA treated cells (Figure 6.7, B, blue column). The knockdown of DNAJC3 did not seem 
to have altered the protein levels of Grp94 (Figure 6.7, B, green column) and Grp78 (Figure 6.7, 
B, purple column). However, the knockdown of DNAJC3 resulted in a drastic reduction of HOP 
protein compared to the untreated and NT siRNA sample (Figure 6.7, B, red column). 
However, the consistent knockdown of DNAJC3 in the MCF7 cell line was not reproducible and 
therefore to analyze the relationship between HOP and DNAJC3 further, DNAJC3 expression 
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levels were analyzed by Western analysis in HEK293T cells in which HOP had been depleted by 
RNA interference (Figure 6.8, A) 
 
 
 
Figure 6.8: Knockdown of the co-chaperone HOP increased the expression levels of DNAJC3 
in HEK293T cells. (A) Levels of HOP and DNAJC3 and were detected by Western analysis in HEK293T lysates 
transfected with HOP shRNA and non-targeting (NT) shRNA for 48 hours and 72 hours using mouse monoclonal 
anti-HOP and anti-DNAJC3. GAPDH was used as a loading control and detected using rabbit polyclonal anti-
GAPDH. (B) Densitometry analysis used to compare the expression levels of HOP and DNAJC3 after HOP 
knockdown using shRNA, where the ratio of HOP or DNAJC3 to GAPDH loading control was normalized to the 
untreated sample which was taken as 1. Data is representative of duplicate experiments with similar results. 
 
Triplicate HOP shRNA knockdown cells, along with a control NT shRNA cells were analyzed to 
determine the level of HOP knockdown and its effect on DNAJC3 expression. HOP knockdown 
was found to be greater in cells transfected with HOP shRNA 1 and 2, with shRNA 3 showing 
lower levels of HOP knockdown compared to the controls (Figure 6.8, B). The same lysates were 
analyzed to determine the expression levels of DNAJC3 when HOP proteins levels were low 
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(Figure 6.8). It was observed that in cells with greater HOP knockdown (shRNA 1 and 2), the 
protein levels of DNAJC3 increased compared to untreated and NT cells (Figure 6.8, B). 
A stable polyclonal cell line expressing HOP shRNA 2 was created as part of another study (Lara 
Contu, unpublished). After transfection, expressions of the HOP shRNA 2 construct which has a 
puromycin selection marker and a TurboRFP fluorescence marker was induced with doxycycline. 
Puromycin was used to select for successful transfectants which were expanded, while the 
TurboRFP fluorescence tag was used to assess HOP shRNA expression (data not shown). A time 
course study using the stable HOP knockdown polyclonal cell line showed that HOP expression 
was reduced significantly after 72 hours induction with doxycycline compared to 48 hours. At 72 
hours post induction, protein levels of DNAJC3 increased slightly compared to the NT control and 
48 hours post induction samples. 
6.3 Discussion 
The focus of this chapter was to analyze DNAJC3 in mammalian cells. This was accomplished by 
examining the expression of endogenous DNAJC3 in cancer cell lines, determining the effects of 
different stress conditions on the localization and expressions of DNAJC3, determining the effect 
of HRas and two HRas mutants on the expression and localization of DNAJC3 and determining 
the consequences of knocking down DNAJC3 on chaperones and other co-chaperones. DNAJC3 
did not appear to be generally stress inducible, nor was its expression or localization effected by 
the HRas oncogene. However, some of the stress conditions induced an apparent re-distribution of 
the protein in cells. DNAJC3 was found to be sensitive to NOVO treatment and slightly increased 
in Hop knockdown cells, while Hop was putatively decreased in DNAJC3 knockdown cells. 
Endogenous DNAJC3 was found to be expressed in nine cancer cell lines from various tissues, 
including breast, cervix, colon and blood. DNAJC3 has previously been reported to be expressed 
in some of the cell lines analysed herein, such as MCF-7, MDA-MB-231 (Gao et al., 2012), 
SW620 and SW480 (Ghosh et al., 2011). Although endogenous DNAJC3 was detected in all tested 
cell lines, the level of protein expression was undetermined. Follow up experiments should analyze 
the levels of DNAJC3 expression as it has been shown that overexpression or knockdown of the 
protein has different consequences in different cancers (Barber et al., 1994, Gao et al., 2012, Huber 
et al., 2013). By determining and comparing the expression levels of DNAJC3 in paired cell lines 
such as SW620 and SW480 or different types of cancers from the same tissues such as MCF-7, 
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MBA-MB-231 and Hs578T (breast), the role of DNAJC3 in cancer biology may be better 
understood.  
Numerous heat shock proteins have been shown to be upregulated and undergo a change in 
localization under stress conditions (Bagatell and Whitesell, 2004). DNAJC3 is known to localize 
to the ER lumen, with a subpopulation in the cytosol (Rutkowski et al., 2007). Compared to the 
untreated cells, none of the various stress conditions altered the cytosolic localization of DNAJC3 
in relation to Hsp90 (Figure 6.2). However, the ER localization of DNAJC3 was altered slightly 
by ER stress (Tun), ROS (H2O2) and DNA damage (UVL and UVS) (Figure 6.2). However, when 
the protein levels of DNAJC3 under the different stress condition were compared to the untreated 
control, no changes were observed (Figure 6.3). Using Hsp70 as an indicator of stress, it was 
observed that the Tun and PMA treatments did not induce any stress response at the concentration 
used. This lack of stress induction could be the possible explanation as to why no upregulation of 
DNAJC3 was observed in the treatments meant to resemble ER stress, as it has been shown that 
ER stress induces the upregulation of ER chaperones including DNAJC3 (van Huizen et al., 2003). 
In literature Tun concentrations as low as 1 µg/ml (Zinszner et al., 1998) or lower (100 ng/ml) 
(Ming-Zhi et al., 2010) have been shown to induce ER stress; while double that concentration (2 
µg/ml) was utilized in this study. Although ER stress was induced for 24 hours with double the 
concentration of Tun listed in literature, the HEK293T cells seemed to have been resistant to 
chemically induced ER stress at this concentration. Future experiments will have to include dose 
and time course studies to determine the appropriate concentration and treatment period in this cell 
line. 
In addition to stress conditions, preliminary experiments were conducted to determine the effects 
of known Hsp90 inhibitors GA and NOVO on the protein levels of DNAJC3. Both drugs are 
known to bind and inhibit Hsp90 ATPase activity by binding to the ATP site at the N and C 
terminus domains of Hsp90, respectively (Grenert et al., 1997, Prodromou et al., 1997, Marcu et 
al., 2000). Currently, only GA has been established to bind to both Grp94 and Hsp90 (Chavany et 
al., 1996) and binding of NOVO to Grp94 has not yet been reported. However, the NOVO binding 
site in Hsp90, 559KKQEEKK564 (Matts et al., 2011) is not conserved in Grp94 (Tastan Bishop et 
al., 2013). However, binding of NOVO to the C-terminal ATP site of Hsp90 resulting in the 
inhibition of the chaperone’s ATPase activity is thought to not be dependent on the primary 
sequence but conformation state of the protein and Grp94 and Hsp90 are known to undergo 
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identical conformational changes as part of their ATP dependent chaperone activity (Prodromou 
et al., 1997a; 1997b; 2000). 
GA did not affect the expression levels of DNAJC3 at all tested concentrations (01, 1 and 10 µM), 
while only the highest concentration of NOVO (500 µM) dramatically decreased the protein levels 
of DNAJC3 compared to the loading control (Figure 6.4). Both inhibitors are known to bind and 
inhibit Hsp90 (Whitesell et al., 1994, Grenert et al., 1997, Prodromou et al., 1997, Marcu et al., 
2000) and GA also inhibits Grp94 (Chavany et al., 1996). The ability of NOVO to alter the protein 
levels of DNAJC3 suggested that DNAJC3 and Hsp90 and/or Grp94 might have an interaction, 
direct or indirect, that is dependent on the C-terminal domain of the protein, as the inhibitor is 
known to bind the C-terminal ATP binding site (Marcu et al., 2000). In literature and in our study, 
Grp94 was found to be in a complex with DNAJC3 in a pull down assay, although our data suggest 
that this interaction is indirect (Jansen et al., 2012). NOVO may be destabilizing the complex, 
affecting the complex between Hsp90 and/or Grp94 and DNAJC3. Marcu et al., (2000) and Yun 
et al., (2004) found similar results, where NOVO reduced the amounts of p23, a Hsp90 co-
chaperone, that co-immunoprecipitated with Hsp90 in a dose dependent manner, suggesting that 
NOVO affects Hsp90s ability to interact with co-chaperones (Marcu et al., 2000, Yun et al., 2004). 
However, the decrease in DNAJC3 protein levels observed resemble the effects mostly associated 
with Hsp90 client proteins when cells are treated with NOVO, as NOVO inhibition of Hsp90 has 
been shown to cause destabilization of the Hsp90 multi-chaperone complex, resulting in 
degradation of the client proteins within the complex (Donnelly and Blagg, 2007). In addition to 
being an Hsp90 inhibitor, NOVO is also known to bind and inhibit the activity of topoisomerases 
such as DNA gyrase which is involved in introducing and relaxing negative supercoils in DNA 
(Reece and Maxwell, 1991). Therefore, the effects on DNAJC3 protein levels observed in NOVO 
treated cells might not be limited to its effect on Hsp90 or Grp94.The role of topoisomerase in 
DNAJC3 stability could be addressed using known inhibitors like etoposide (Bromberg et al., 
2003).  
The involvement of DNAJC3 in the Ras signal transduction pathway was also analyzed by 
determining the effects of HRas and HRas mutants G12V (constitutively active form of the 
protein) (Seeburg et al., 1984) and S17N (dominant negative form of the protein) (Stacey et al., 
1991) on the localization and expression of DNAJC3. Confocal and fluorescence analysis showed 
that the transfection of the EGFP tagged HRas plasmids in to HEK293T cells was successful 
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(Figure 6.5). However, the localization and expression of DNAJC3 (Figure 6.6) were not altered 
in cells transfected with any of the HRas plasmids. Literature reports that, the expression of HRas 
G12V activates UPR, leading in the upregulation of ER chaperones such as Grp94 (Denoyelle et 
al., 2006). ER stress due to UPR has been shown to cause an upregulation in DNAJC3 expression 
(van Huizen et al., 2003), suggesting that an increase in DNAJC3 protein levels should have been 
observed in HRas G12V transfected cells. 
Several of the Ras downstream kinases have been shown to either regulate or be regulated by 
DNAJC3 (Figure 6.9). In Coxsackle virus B3 (CVB3) infected cells, phosphorylation of the kinase 
AKT was found to be reduced by the silencing of DNAJC3 but not that of ERK p42/44 (Zhang et 
al., 2010b). In influenza virus infected cells, the activation of the p38 resulted in the activation of 
downstream kinases MK2 and MK3 which recruit a complex consisting of DNAJC3 and its 
repressor p88rIPK, which activated DNAJC3 inhibitory activity against PRK/PERK, allowing 
proteins synthesis to occur (Luig et al., 2010). The same process has been suggested in highly 
mitogenic tumor cells, where the constitutive activation of ERK p42/44 by Ras or Raf recruits the 
same complex of DNAJC3 and its inhibitors and prevents protein synthesis attenuation by 
PKR/PERK (Luig et al., 2010). However, it is unclear whether the activation of DNAJC3 by 
ERKp42/44 and p38 alters expression levels of the protein. If so, levels of DNAJC3 should be 
altered in cells transfected with HRas G12V plasmids since its expression results in the production 
of the constitutively active form of the protein, which is known to lead to activation of ERK 
p42/44.  
For this study, the expression levels of the kinases p38, JNK and ERK was also analyzed in HRas 
and HRas mutant transfected cells. The levels of phosphorylated ERK p-42/44 were not altered in 
HRas transfected cells compared to untransfected cells. Similar results were observed in 
phosphorylated p38 and JNK, although a slight decrease in these two kinases was observed in 
HRasS17N transfected cells. These observations are in contrast to reports in literature, which 
showed that transfecting MCF10A cell with the HRas plasmid activated ERK and p38 but not JNK 
compared to untransfected cells (Kim et al., 2003). HRasG12V also activated (phosphorylated) 
p38, ERK p42/44 and JNK in melanocytes (Denoyelle et al., 2006) and HRas S17N did not activate 
ERK p42/44 in COS-7 cells (Lorenz et al., 2012). However, all the kinases were constitutively 
activated (phosphorylated) form and therefore this may be the reason why no differences in the 
expression levels were observed upon transfection with HRas or HRas G12V and S17N.  
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Figure 6.9: Schematic presentation of the Ras signalling transduction pathway and the 
interaction of DNAJC3 with various downstream kinases in the pathway. During influenza virus 
infection PKR inhibition is initiated by activation of MK2/3 by phosphorylated p38, which recruits p88rIPK bound to 
DNAJC3, DNAJC3 in turn binds to PKR forming a complex comprised of MK2/3, p88rIPK, DNAJC3 and PKR. The 
constitutive activation of ERK in cancer has also been shown to inhibit PKR activity via a similar pathway as in 
influenza virus infected cells (Luig et al., 2010). In Coxsackle virus B3 (CVB3) infected cells, the depletion of 
DNAJC3 has been shown to affect the activation of AKT and not ERK, negatively (Zhang et al., 2010b). 
 
From the analyses of the confocal images (Figure 6.6), the ratio of HRas transfected cells to 
untransfected cells is also very low, suggesting that the effects of the HRas proteins could be 
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masked by the large proportion of untransfected cells. Hence the anticipated changes in DNAJC3 
and kinases were not observed in transfected cells compared to the untransfected control cells. To 
resolve this problem in the future, transfected cells could enriched by FACS (Fluorescence 
Activated Cell Sorting), ensuring an equal number of transfected cells (vector and HRas) are 
analyzed and the effects of the HRas plasmid are not masked by the presence of untransfected 
cells.  
DNAJC3 knockdown experiments were conducted to determine the effects of silencing DNAJC3 
would have on the expression of the chaperones, Grp78 and Grp94 and the co-chaperone HOP. 
Transfection of MCF-7 carcinoma cells with DNAJC3 siRNA, resulted in the expression levels of 
DNAJC3 being reduced by 40 % compared to the untransfected control (Figure 6.7). However, no 
changes were observed in the expression levels of either Grp78 or Grp94, suggesting that the 
reduction of its DNAJC3 had no effect on Grp78. DNAJC3 is one of seven ER DNAJ proteins 
known to co-chaperone Grp78 activity, suggesting that one of the other six DNAJ proteins could 
have compensated for the loss of DNAJC3 (Feldheim et al., 1992, Brightman et al., 1995, Shen et 
al., 2002, Hosoda et al., 2003, Shen and Hendershot, 2005).  
Interestingly, the levels of the Hsp90/Hsp70 TPR-containing co-chaperone, HOP, were 
dramatically reduced in DNAJC3 depleted cells (Figure 6.7). In the reciprocal experiment, when 
HOP was knocked down in HEK293T cells, the protein levels of DNAJC3 were found to increase 
(Figure 6.8). HOP is mostly cytosolic and migrates to the nucleus during stress using its nuclear 
localization signal (NLS) (Daniels et al., 2008). Recently, HOP has been found in a complex with 
Hsp90 in the ER, facilitating the transportation of the rice chitin receptor, OsCERK1, from the ER 
to the plasma membrane (Chen et al., 2010). However, although DNAJC3 and HOP both TPR-
containing co-chaperones, the TPR domains in HOP and DNAJC3 seem to have different 
functions. The carboxylate clamp residues found in the HOP TPR domains that enable the protein 
to interact with Hsp90 and Hsp70 are missing in DNAJC3 TPR domains (Figure 3.4) (Odunuga et 
al., 2003, Tao et al., 2010). On the other hand, the EEVD motif crucial for Hsp70 and Hsp90 
interaction with HOP TPR domains is missing in the ER homologues, Grp78 and Grp94 (Figure 
3.7) (Argon and Simen,1999, Fewell et al., 2004, Tastan Bishop et al., 2013). This strongly 
suggested that HOP and DNAJC3 are not interchangeable when it comes to their interaction with 
the cytosolic Hsp90 and Hsp70 and ER Grp78 and Grp94. However, several studies have analyzed 
the changes in Hsp90 and or Hsp70 expression after knockdown of co-chaperones such as Cdc37 
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(Smith et al., 2013), p23 (Nguyen et al., 2012, Song et al., 2013), Aha1 (Holmes et al., 2008) and 
HOP (Willmer et. al., 2013), the effects observed differed depending on the depleted co-
chaperone. To the best of our knowledge, no published study has determined the changes in the 
protein levels of other co-chaperones, although the knockdown of HOP has been shown to increase 
the levels of Cdc37 and Aha1, but not p23 (Tarryn Willmer, MSc thesis 2012). The results from 
these knockdown studies need to be extended to examine the changes in protein levels for the 
cytosolic Hsp90 and Hsp70 and the ER Grp94 and Grp78 as well as determining the underlying 
mechanism behind the increased expression of Hop detected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
147 
 
Chapter 7: Summary, Conclusions and Future Work 
 
DNAJC3 is a member of the DNAJ family that contains TPR domains as well as the canonical J 
domain. DNAJC3 has been functionally identified as a DNAJ co-chaperone to both cytosolic 
Hsp70 and the ER Hsp70, Grp78, as well as an inhibitor of PKR and PERK kinase activity 
(Oyadomari et al., 2006, Rutkowski et al., Petrova et al., 2008, Tao et al., 2010, Svärd et al., 2011). 
TPR domains are known to mediate protein-protein interaction, and TPR domains of co-
chaperones such as HOP are known to interact with Hsp90 and/or Hsp70. In this study we extended 
the characterization of the DNAJC3 TPR domains using a combination of in silico, in vitro and ex 
vivo techniques. Despite showing structural similarity to a number of TPR containing proteins, in 
silico analysis suggested that DNAJC3 TPR domains would be unlikely to interact with either 
Hsp90 or Hsp70. The lack of direct interaction was subsequently demonstrated experimentally 
using isolated proteins in pull down assays. This was despite the identification of a putative binding 
site in the Hsp90 chaperones that shared limited structural similarity with a region of p88rIPK known 
to interact with DNAJC3 (Gale et al., 1998). It might be interesting as part of a future study to 
engineer the carboxylate clamp residues into DNAJC3 to determine whether this is sufficient to 
allow interaction of the TPR domains with Hsp90/Hsp70. The similarity between DNAJC3 and 
DNAJC7 suggest that introduction of the necessary residues would support an interaction. Our 
study demonstrated however that the TPR domains of DNAJC3 can bind to multiple model 
substrates when these substrates are in either native or denatured forms, thereby extending the 
previous substrate binding analysis (Tao et al., 2010). Murine DNAJC3 TPR domains are known 
to bind preferably to denatured substrate than native; this study found that human DNAJC3 TPR 
domains bound indiscriminately to both native and denatured substrates. In addition, the 
observation that DNAJC3 TPR domain bound to the substrate β-galactosidase with greater affinity 
to MDH might suggest substrate specificity for the DNAJC3 TPR domains. Although DNAJC3 
could bind substrate proteins in vitro, we were not able to observe a complex of Grp78 or Grp94 
with DNAJC3 and a model denatured substrate. The DNAJC3 TPR domains were able to isolate 
a complex containing Hsp90 and Grp94 from mammalian cell lysates, although this interaction 
was deemed likely to be indirect based on the direct binding assay. Taken together with the results 
of the pull down assays, we predict that the putative complex in mammalian cells includes an as 
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yet unidentified protein or proteins that are responsible for mediating the interactions between the 
chaperones and the DNAJC3 TPR domains. We predict that this may be a specialised substrate 
protein, particularly since Grp94 is known to be highly selective with respect to substrate binding 
(Randow and Seed, 2001, Yang et al., 2007, Morales et al., 2009). Indeed, it is possible that there 
are multiple independent complexes that involved the DNAJC3 TPR domains. For example, 
DNAJC3 may interact via one protein with Hsp90 in the cytosol and via another protein in the ER 
with Grp94. In silico analysis suggested that DNAJC3 TPR domains could not interact with Hsp90 
and Hsp70, hence could not function as a co-chaperone through this domain. Identification and 
analysis of structural homologues of DNAJC3 TPR domains illustrated that DNJC3 TPR domains 
were highly similar to TPR-containing proteins with functions independent of both Hsp90 and 
Hsp70. The pull down assay should be repeated and the complexes analyzed by mass spectrometry 
in order to identify proteins that interact with DNAJC3 via the TPR domains (Link et al., 1999, 
Corthals et al., 2000). Any putative interactions identified could subsequently be analysed for 
direct binding. These data would indicate potentially novel functions of the protein, or could be 
used to understand existing functions. 
Preliminary ex vivo analysis of DNAJC3 suggested that the protein was not stress inducible nor 
was its localization altered by general stress conditions. The expression of HRas and HRas mutant 
oncoproteins did not substantially alter DNAJC3 expression or subcellular localisation, suggesting 
that the role of DNAJC3 in kinase activity did not involve the Ras pathway. We demonstrated that 
the levels of the DNAJC3 protein were however, dramatically reduced by high concentrations of 
the C-terminal Hsp90 inhibitor NOVO, but not the N-terminal inhibitor, GA. This observation 
suggested that the interaction observed between DNAJC3 and Hsp90 or Grp94 might be disrupted 
by NOVO and not GA, although the lysate pull down assay conducted with DNAJC3 TPR will 
need to be repeated in the presence of a range of concentrations of both inhibitors, to verify that 
NOVO is disrupting the interaction. Knockdown of DNAJC3 reduced the protein levels of HOP, 
while levels of DNAJC3 protein were increased in a reciprocal experiment where expression of 
HOP was silenced. HOP is required for transfer of protein substrates from Hsp70 to Hsp90 and 
therefore controls entry of client proteins into the Hsp90 cycle. Therefore, the depletion of Hop 
levels might perturb the functions of a cohort of Hsp90 client proteins or indeed change the 
expression of certain proteins. It is possible that these changes might culminate in ER stress, which 
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might explain the increase in the levels of DNAJC3 (van Huizen et al., 2003, Oyadomari et al., 
2006, Rutkowski et al., 2007).  
This study is the first to demonstrate experimentally that DNAJC3 TPR domains do not bind 
directly to either Hsp90 or Grp94, although the TPR domains could bind substrate and DNAJC3 
was able to be isolated in a complex containing Hsp90 and Grp94 from a mammalian cell lysate. 
At the start of the project, we hypothesised that DNAJC3 would be involved in non-canonical 
interactions with Hsp70 and Hsp90 chaperones via its TPR motifs. Based on our observations, we 
have technically disproved this hypothesis by demonstrating experimentally a lack of direct 
interaction between the TPR domains from DNAJC3 and these Hsp90 chaperones. However, we 
did demonstrate that the TPR domains can bind model substrates, which might suggest that the 
DNAJC3 TPR domains are equivalent to the substrate binding domain of the DNAJ, which 
together with the J domain result in a functional ER resident Hsp70 co-chaperone, possibly with 
independent chaperone activity. Further work will be required in order to identify the physiological 
interacting partners for the DNAJC3 TPR domains. However, our data currently do not support a 
role for DNAJC3 as a co-chaperone for either Hsp90 or the ER Grp94. Therefore, the existence of 
ER equivalents of established cytosolic co-chaperones of Hsp90 remains to be definitively proven. 
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